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Abstract
In the UK alone over 320,000 patients per annum acquire at least one nosocomial 
infection and one in four intensive care unit (ICU) patients worldwide acquire an 
infection during their hospital stay. Frequently the organisms that cause these 
infections are opportunistic and resistant to antibiotics. The costs to the NHS are six 
times higher if ICU patients acquire a nosocomial infection and the mortality rates are 
greater (30-60 % dependent on the infection).
This study investigated the ICU environment for bacterial reservoirs, fungal reservoirs 
and antibiotic resistance determinants. It was hoped that information about the 
microorganisms and antibiotic resistance determinants within the ICU may be useful in 
optimising infection control within the hospital. Samples were taken and analysed via 
PCR for the presence of bacterial 16S rRNA genes, antibiotic resistance determinants 
(including meek and tef) and beta-lactamase genes. Parallel cultural analysis was 
used to assess the presence of fungi. Bacterial species, diversity and communities 
were identified using PCR-denaturing gradient gel electrophoresis (PCR-DGGE).
Using culture dependent and independent techniques, sequences similar to 
opportunistic pathogens were retrieved from a variety of ICU environmental sites 
(patient chair, floor and ward sink plughole). Clinically significant non-albicans Candida 
species were detected in the hospital environment where individual ICU patients were 
colonised, suggesting there is a reservoir in the ward environment. Despite the low 
detection frequency, resistance determinants of clinical relevance {meek and blajEm 
genes) were observed in the ICU environment at sites that may have infection control 
significance.
Several sites used by hospital staff and patients (ward sink plughole, floor, patient chair, 
sluice room sink plughole, handwash bottles and curtains) within the ICU environment 
were shown to act as reservoirs for particular fungal (isolates of Candida parapsiiosis, 
Candida tropicalis, Candida glabrata, Candida guillermondii) and bacterial 
(Burkholderia spp., Stenotrophomonas maltophilia, Acinetobacter spp. and isolates of 
Micrococcus spp., coaglulase negative Staphylococci) opportunistic pathogens. 
Routine ICU ward cleaning was largely effective on hard surfaces (floors and patient 
chairs). Opportunistic pathogens (Stenotrophomonas maltophilia, Burkholdena spp.) 
could be retrieved via PCR-DGGE after cleaning from ICU ward sink plugholes. There 
was a wide distribution of b/aTEM genes in the ICU environment and detection in clinical 
isolates is of significance. The results of this study indicate that changes in routine ICU 
ward cleaning of ward sink plugholes may be beneficial in removing opportunistic 
pathogens and antibiotic resistance determinants from within these sites.
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1.1 Overview
1. Introduction
Extensive work has been carried out on the transmission of nosocomial (hospital- 
acquired) infections based upon clinical isolates, however, the role of the ward 
environment as a potential source or reservoir for these organisms is much less well 
understood. The impact of nosocomial infections caused by antibiotic resistant 
organisms has been high on the political and public agenda. There is an awareness 
based on the role of the ward environment in the transmission of nosocomial infections 
and the importance of effective infection control measures. Intensive care unit (ICU) 
patients are particularly vulnerable to infections which can lead to an increase in 
hospitalisation, antibiotic usage, mortality and costs. This study uses molecular and 
cultural methods to identify the microbial (bacterial and fungal) ecology and associated 
antibiotic resistance determinants in the ICU environment, to locate, identify, 
characterise and describe the distribution and classification of potential reservoirs of 
nosocomial infection-causing organisms.
1.2 An overview of hospital acquired infections
Hospital acquired infections (HAIs) are also referred to as nosocomial infections. By 
definition these infections are either not incubating or present at the time the patient is 
admitted to hospital (or other health-care facility) (WHO, 2002; Vincent, 2003). Urli et 
al. (2002) defined ICU-acquired infections as infections occurring more than 48 hours 
after admission to the ICU.
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HAIs are a major concern, because among 9.6 million admissions to publicly-funded 
hospitals in the UK during 2002-2003, 0.5-1 million patients acquired a hospital 
infection. Added to this, 5-10% of inpatients acquired an infection during their stay 
(Wilcox, 2003).
Although all hospitalised patients are at a risk of HAIs, patients in the ICU are 
especially vulnerable. ICU patients are often severely immuno-compromised, meaning 
they have a weakened immune system as it is impaired by disease and/or treatment. 
Many organisms which cause HAIs are also opportunistic pathogens, meaning they 
generally do not cause disease/infection in healthy individuals with intact defence 
mechanisms. However, such organisms can cause infection in immuno-compromised 
patients and when introduced during invasive procedures (Mims et al., 1998a).
HAIs are often caused by antibiotic resistant micro-organisms (some are multi-drug 
resistant). The high frequency of antibiotic resistant infections among ICU patients is 
due to the extensive use of broad-spectrum antibiotics as well as the increased use of 
invasive medical techniques (Mims et al., 1998b). Examples include MRSA (meticiliin- 
and multi- resistant Staphylococcus aureus), VRE (vancomycin resistant enterococci) 
and multi-resistant Gram-negative bacilli (i.e. Klebsiella spp., Enterobacter spp., 
Pseudomonas aeruginosa and Escherichia coli) (Crowe et al., 1998; WHO, 2002; 
French, 2005).
The most frequent pathogens to cause HAIs include S. aureus, P. aeruginosa, Gram-
negative aerobes and the Candida spp. (e.g. Candida albicans, Candida glabrata,
Candida krusei) (Urli et al., 2002). HAIs are not only caused by bacteria and fungi,
they can be viral. Some examples of hospital acquired viruses are; respiratory viruses
(including influenza and respiratory syncytial virus - RSV), herpes virus (including
varicella zoster virus - VZV), hepatitis viruses, rotavirus as well as viruses acquired via
the respiratory route (including rubella and measles) (Mims eta!., 1998a).
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Hospital infections can be acquired from two sources: -
1. an endogenous source, for example from another site within the patient 
(self/auto infection) or by the patients commensal flora
2. an exogenous source, for example from another patient or the environment 
(Mims et al., 1998a).
HAIs are rarely transmitted via the airborne route; the main transmission route (cross­
infection) is by hospital workers (either directly or indirectly) (Wilcox, 2003). The most 
common HAIs are pneumonia, urinary tract infections (UTIs), central venous catheter 
(CVC) infections and CVC-related sepsis (Urli et al., 2002). Bacteraemia can arise 
from multiple sources and can be primary i.e. by the direct inoculation of organisms into 
the patient's blood from contaminated intravenous fluids. Or it can arise secondary to a 
focus of infection already present, for example UTIs (Mims et al., 1998a). Each of 
these infections carries significant mortality rates for ICU patients. UTIs (which may 
include cases of urosepsis) have an extremely high mortality rate of 25-60 % among 
ICU patients (Leone et al., 2001). For those with pneumonia or bacteraemias mortality 
is approximately 34 % (Biot et al., 2002; Rello et al., 2003).
The host response to any infection is dependent upon a number of factors. For 
example very young individuals are highly susceptible due to the immaturity of their 
immune system. Similarly, the elderly are at a greater risk due to pre-disposing 
underlying disease, immobility, impaired blood supply and general decline in immune 
function (Mims et al., 1998a; Urli et al., 2002). However, in all age groups underlying 
disease and treatment can pre-dispose to infection, resulting in all ICU patients being 
at risk.
3
1.3 intensive care units
Patients in ICUs are extremely vulnerable to infections, largely because ICU patients 
are extremely immuno-compromised. According to prevailing medical practice in UK 
hospitals there are four major priorities which determine whether a patient is 
considered for admission to the ICU: -
1. Patients who are critically ill and are in a medically unstable state which 
requires monitoring and treatment (i.e. they require an intensive level of care)
2. Those who require intensive monitoring but may also need emergency 
interventions
3. Patients who are either medically unstable or critically ill but have a chance of 
recovery (due to the severity of their illness or trauma)
4. Patients who are not eligible for admission to the ICU as they are not expected 
to survive. If a patient falls into this category the director of the ICU needs to 
give their approval before admission (Gulli et a l 2006).
There are several types of intensive care unit: -
General ICU -  for the general treatment of critically ill patients 
Coronary care unit (CCU)
Paediatric ICU (PICU) - for the treatment of critically ill children 
Newborn ICU (NICU) - for the care of premature and critically ill neonates 
Surgical ICU (SICU) - for the treatment of postoperative patients (Gulli et al., 2006)
The ICUs studied were classed as general ICUs, for the treatment of critically ill 
patients after trauma or underlying diseases.
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The cost to the NHS is greater for ICU patients compared with patients on other wards 
because of the need for specialist care (Dean et al., 2002). 0.13 % of the annual 
budget for the NHS is spent on ICU services. The total annual budget for the NHS was 
£90.7 billion in 2007-2008 which resulted in £1700 per patient in England (HIVI 
Treasury, 2008). The average financial cost of treating a patient in the ICU increases 
six-fold if the patient has or develops sepsis (characterised by a whole body 
inflammatory ststae which can be due to the presence of bacteria) (Edbrooke et al., 
1999). Hence, the costs to the NHS is far higher if ICU patients gain HAIs and there is 
a great need to identify if the ward environment is acting as a source or reservoir for 
the organisms that cause HAIs.
1.4 Bacterial HAIs
1.4.1 Bacterial HAIs and risk factors
The majority of HAIs are caused by bacteria which are often members of our normal 
flora (WHO, 2002). Between 1985 and 1995 the number of bacteraemia and 
fungaemia HAI cases increased dramatically from 17.7 to 80.3 per 1000 admissions 
(Crowe et al., 1998). In the early 1990’s Gram-negative bacteria were the cause of 
high mortality but Gram-positive organisms were becoming increasingly important (Neu 
et al., 1993). MRSA, Stenotrophomonas maltophilia, P. aeruginosa and enterococci 
also became common pathogens among ICU patients (Neu etal., 1993).
Frequently reported in the literature now are bacterial nosocomial outbreaks, and 
common pathogens include S. aureus, E. coli, Enterobactercloacae, Klebsiella spp., P. 
aeruginosa, S. maltophilia, Acinetobacter baumannii and other commensal organisms 
including Staphylococcus epidermidis which can act as opportunistic pathogens 
(Crowe etal., 1998).
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To monitor the severity of HAIs, in 2001 the Department of Health made the 
surveillance of MRSA mandatory; this was extended in 2003 to include glycopeptide- 
resistant enterococci and in 2004 Clostridium difficle (HPA, 2006a).
Risk factors for HAIs are often similar and the same organism can present as 
numerous infections. For example Acinetobacter spp. can cause ventilator-associated 
pneumonia, skin and soft tissue infections, UTIs, bacteriaemia and wound infections in 
critically ill patients (Dijkshoorn et al., 2007). The majority of risk factors for these
infections are common in critically ill patients on ICUs. These include: -
• Mechanical ventilation
• Invasive procedures
• indwelling devices
• Previous stay and length on an ICU
• Exposure to contaminated medical equipment (Dijkshoorn et al., 2007;
Markogiannakis etal., 2009)
1.4.2 Prevention of bacterial HAIs
The Health Act 2006 introduced strict measures to help reduce and combat HAIs. One 
area of focus was upon the need to provide and maintain a clean and appropriate 
environment for healthcare (Department of Health, 2008). Eight guidelines were laid 
out in the health act: -
1 -  Effective communication to be made between infection control staff and facilities 
management
2 -  Designate a lead manager for cleaning and decontamination of medical equipment 
used for treatment
6
3 -  All areas of the ward involved in healthcare are kept clean and maintained in good 
physical condition and repair
4 -  The cleaning arrangements meet the standard of cleanliness required and the 
cleaning regimes are available to the public
5 -  Sufficient availability of handwash facilities and anti-bacterial handrubs 
8 -  Arrangements for effective decontamination of medical equipment
7 -  Linen and laundry supplies comply with the Health Service Guidance (95) 18
8 -  Ensure the staff uniform is clean and appropriate for the duties being carried out 
(Health Act, 2006).
Since these guidelines have been introduced there have been reductions in some HAIs, 
in particular MRSA. However, there is still extensive research into the effectiveness of 
routine cleaning (Danforth et a/., 1987; Dharan et a/., 1999; Wilcox et a/., 2003; 
Bhalla et al., 2004; Dancer, 2004; Denton et al., 2004; Kramer et aI., 2006; Dancer, 
2009; Whittington et al., 2009).
Some organisms including A. baumannii are able to survive in the ward environment 
due to multi-drug resistance and tolerance of drying (Denton et al., 2004). Additional 
cleaning was introduced after an outbreak of A. baumannii on a neurosurgical ICU and 
initially the number of A. baumannii positive environmental sites increased. When the 
outbreak occurred, several cleaning practices were revised on the ICU: one was to 
make the ward cleaning staff responsible for the cleaning of the ICU environment and 
the nursing staff responsible for cleaning patient equipment. Denton et al. (2004) 
demonstrated that when strict cleaning protocols were not followed the levels of A. 
baumannii in the environment correlated with patient infection and colonisation.
Dancer et al. (2009) investigated the impact an additional cleaner had on the presence 
of S. aureus (and MRSA). Overall a reduction was observed on the microbial
contamination of hand-touch sites. The areas of greatest contamination were areas
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closest to the patient (bedside locker and bed frame) as opposed to infusion pumps 
and computer keyboards. Molecular epidemiological evidence supported the 
conclusion that patients acquired MRSA from these particular environmental sites 
(Dancer et al., 2009).
Not only were the number of MRSA infections reduced but this also resulted in lowered 
hospital costs. Each MRSA infection costs on average £9000 and by introducing the 
enhanced cleaning the hospital saved between £30,000-70,000 (Dancer et al., 2009). 
Although this study showed the clear benefits of enhanced cleaning others have 
previously shown evidence that certain cleaning methods are not effective.
Comparison of detergent (cleaning aid which facilitates physical removal) and 
disinfectant (to kill micro-organisms) used for floor cleaning showed no difference in the 
levels of microbial floor contamination and the nosocomial infection rate did not alter 
(Danforth et al., 1987). Other studies to reduce infection rates by increasing cleaning 
have also failed (Dancer, 1999; Wilcox et al., 2003). Dharan et al. (1999) 
demonstrated the nosocomial infection rate did not alter over a four month period using 
various cleaning agents.
Organisms such as MRSA and C. difficile have been shown to persist in the 
environment even after general disinfection so other methods have been explored. 
The most effective cleaning reagent for the removal of persistent organisms such as C. 
difficle (which produces highly resistant endospores), MRSA and A. baumannl is 
hypochlorite on a large scale to disinfect the whole ward environment (Wilcox et al., 
2003), however, this reagent does require the evacuation of patients and ward shut 
down.
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1.4.3 Presence of bacteria in the ICU environment
The effectiveness of ward cleaning has been based upon controlling outbreak 
situations and little is known of the general microbial ecology of the ICU or any ward 
environment where these organisms may be surviving. Rather than trying to control an 
outbreak situation prevention would be better. It is acknowledged that the majority of 
infections are caused by patients own flora, however by investigating multiple 
environmental sites within the ICU for bacterial organisms more information and 
evidence would be provided on reservoirs of organisms.
The use of 16S rDNA sequences have become increasingly important in studying 
bacterial communities from environmental samples (Muyzer et al., 1993). Culture- 
independent methods are generally more reliable and rapid as they overcome the 
limitations of culture-dependent methods (Ercolini, 2004). There is limited knowledge 
of the exact conditions which bacteria require to grow in any given environment which 
can result in no isolation (Barer, 1997; Ercolini, 2004). This can however, lead to the 
question: are the bacterial cells viable?
A study based on microbial ecology in the environment can not solely rely on either 
method (culture dependent or independent). It is possible that bacteria could be 
detected via molecular methods but not be cultured.
This could be due to a number of factors: -
1. Bacterial cells are not viable
2. Bacterial cells are viable but non-culturable
3. Bacterial cells are in a dormant state (Barer, 1997)
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It could also be the case that bacteria are not detected by molecular methods but can 
be cultured, however, this would generally occur as molecular techniques cannot 
detect a single bacterial cell but under favourable growth conditions could form a single 
colony forming unit (Ware and Hawker, 1979). However, there are advantages to 
using culture techniques particularly in the clinical setting due to low cost, non- 
specialist training/equipment, rapid growth of organisms and detection. Therefore for 
studies observing microbial ecology both culture-dependent and independent methods 
should be used to gain the widest knowledge of that environment
Computer keyboards and taps are environmental sites common to all hospital wards 
and are in constant use and contact with the hands of hospital staff. Bures et al. (2000) 
using a culture-dependent method sampled the taps and computer keyboards of an 
ICU. The computer keyboards presented as the most contaminated site (24 %), with 
taps being 11 % and it was noted that the keyboards were contaminated regardless of 
patient proximity. Although not all the bacteria cultured were identified, MRSA was 
isolated from the tap and keyboard in a room with an MRSA positive patient (Bures et 
al., 2000). This study had significant limitations, in particular the samples were only 
taken on one sampling session and no repeats were carried out at another time.
Several studies showed similar findings; A. baumannii was identified on computer 
keyboard covers but not from other environmental sites within the patients' room 
(Neely et al., 1999). In a surgical ICU the computer keyboards were shown to have 
the highest levels of pathogenic organism colonisation compared to other 
environmental sites (Hartmann et al., 2004). A hospital which had high MRSA 
infection rates was shown to have high MRSA colonisation on computer keyboards 
(Devine etaI., 2001).
Conversely, a study based on computers in an ICU showed that the central unit of
computers did not act as a reservoir for nosocomial pathogens (Quinzio et al., 2005).
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Again this was culture-dependent which inevitably provides limitations to the study. No 
pathogenic bacteria or fungi were cultured from numerous sites around the computer 
(fan, ventilator and base) (Quinzio et a/., 2005).
All these studies show the potential for computer keyboards and taps to be a reservoir 
of pathogenic bacteria in the ICU setting. However, with only using culture-dependent 
methods it is possible that some organisms were missed if they could not be cultured 
on the pathogenic specific media used or were out competed by other organisms (on 
non-specific media).
Some of the most important pathogenic organisms able to survive in the environment 
are C. difficle, MRSA and VRE. Despite these pathogenic organisms and others 
identified in the ICU (and other ward) environments (Devine et al., 2001; Naas et al., 
2002; Shiomori et al., 2002; Wilcox et aI., 2003; French et al., 2004; Lemmen et at., 
2004; HPA, 2006b; Mammina eta!., 2007; HPA, 2008) it is unclear whether they are a 
source of patient colonisation/infection or a reservoir of these organisms (either from 
the environment or patients) (Hota, 2004). For example, by following VRE-colonised 
ICU patients, the environment was positive for VRE from 25 % of patient cases (Drees 
et at., 2008). The environment was not concluded to be acting as a reservoir but 
contaminated from the patient (Drees et al., 2008).
A previous study has also shown that nosocomial infection rates were unchanged 
when movement of a department to a new hospital led to a decrease in environmental 
contamination (Maki eta!., 1982).
Conclusions can be drawn from the current data available: -
1 -  Environmental surfaces can become contaminated from colonised patients
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2 -  Non-colonised patients can be at risk of developing HAIs from a contaminated 
room
3 -  Specific pathogenic micro-organisms may be dominant in the environment but are 
not colonising or infecting patients (Hota, 2004}
At present there is no conclusive evidence of the extent to which the ward environment 
is the source for HAIs. Available data supports the possibility that specific 
environmental sites may act as reservoirs for nosocomial pathogenic organisms (Neely 
etal., 1999; Devine etal., 2001; Naas et al., 2002; Hartmann eta l., 2004; Hota eta/., 
2009; Whittington et al., 2009). However, there are numerous environmental sites 
within an ICU ward including floors, bedside, ward sink plughole, computer keyboards, 
patient/staff chairs, curtains, trolleys, fans, sluice room sink plughole, pictures, door 
handles, ward sink taps and switches, but limited information is available to indicate 
whether any of these sites are reservoirs of nosocomial pathogens. Environmental 
sites are often tested if an outbreak situation has occurred (e.g. MRSA or A. baumannii 
infections) or one environmental site is tested just for bacterial contamination or to 
demonstrate effective cleaning methods.
The ward environment (particularly the ICU) needs to be sampled for a prolonged 
period of time to identify whether reservoirs of nosocomial pathogens are present and 
whether they persist in the environment
1.5 Fungal nosocomial infections
1.5.1 Fungal organisms that cause HAIs
Approximately 10% of the known 200 Candida species are able to cause human 
infections. Candida spp. are the most common cause of fungal nosocomial infections
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and over the past 20 years the incidence of yeast infections has risen dramatically 
(Verduyn-Lunel et al., 1999; Leone et al., 2003; Hobson, 2003; Bassetti et al., 
2006). C. albicans had been the most common cause of fungal hospital infections for 
many years but non-albicans Candida species are increasing in prevalence (Verduyn- 
Lunel et al., 1999; Hobson, 2003; Shelenz and Grandsen, 2003; Bassetti et al.,
2006). Candida parapsiolosis and Candida tropicalis have been isolated more 
frequently than C. albicans in some European and Latin American countries (Bassetti 
et al., 2006). It has been reported that Candida infections can result in an increased 
hospital stay of approximately 30 days and a 60 % crude mortality rate (Abi-Said et al., 
1997). Candida glabrata is the fourth most common Candida species isolated from 
blood samples and yet has a similar mortality rate to infections caused by C. albicans 
(Rentz etal., 1998; Leone etal., 2003).
1.5.2 Risk factors for fungal HAIs
The two main factors which predispose to invasive Candida species infections are 
immunosuppression and treatment on an ICU (Blumberg etal., 2001; Hobson, 2003). 
The majority of fungal nosocomial infections are blood-related and referred to as 
candidaemia (Hobson, 2003). The Candida spp. can cause a wide range of infections 
from superficial to invasive candidiasis (Rentz etal., 1998; Verduyn-Lunel etal., 1999; 
Blot and Vandewoude, 2004; Laverdiere et al., 2007), with the more extreme 
infections often seen in ICU patients.
The most common risk factors are mechanical ventilation, presence of CVCs and the
use of antibiotics (Laverdiere et al., 2007). Up to 80 % of hospitalised patients have
mucosal surfaces colonised with C. albicans (Verduyn-Lunel et al., 1999). This acts
as a high pre-disposing factor for critically ill patients’ developing disseminated
infections (Laverdiere et al., 2007). Fungal colonisation and infections have been high
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among ICU patients, with 71 % being colonised with yeasts and the remaining 29 % 
being infected (Verduyn-Lunel etal., 1999).
1.5.3 Prevention of fungal HAIs
Due to the high numbers of patients colonised with C. albicans, prevention of infections 
can be difficult especially in patients with numerous risk factors. The main focus has 
been on hand hygiene since it was reported that 80 % of general nosocomial infections 
are transmitted by the hands of hospital staff (Gniadek and Macura, 2007). One study 
showed 57-61 % of ICU staff to be hand carriers of Candida species (Brunetti et al., 
2008). They concluded that appropriate use of gloves could reduce the presence and 
spread of pathogenic yeasts from hospital staff hands to patients.
It has been suggested that patient screening may be of some benefit for certain patient 
groups (e.g. ICU patients) (Schelenz, 2008). The majority of ICUs already follow good 
operative techniques, selective antibiotic usage and good line care policies but there is 
also the possibility of anti-fungal prophylaxis (Schelenz, 2008). Using prophylaxis may 
lead to the increased risk of antifungal resistance development, but for those patients 
at the greatest risk of developing Candidiasis this preventative measure may be 
beneficial (Bolt and Vandewoude, 2004).
1.5.4 Presence of fungi and infected patients on ICUs
Limited research has been carried out on fungi in the hospital or ICU environment 
However, Gniadek and Macura (2007) identified Candida spp. from indoor air and walls 
of an ICU in a Polish hospital. A number of infections were shown to be non-albicans 
species, with the most common being C. parapsilosis, C. tropicalis and C. glabrata.
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The majority of research is based on patient infections, particularly reporting a shift 
from C. albicans infections to non-albicans infections (Nguyen et al., 1996; Hobson, 
2003; Bassetti et al., 2006). In Italy, a five year study showed a decrease in C. 
albicans infections but an increase in those caused by C. parapsilosis, C. tropicalis and 
C. glabrata (Bassetti et al., 2006). Generally C. tropicalis was the second most 
frequently isolated Candida spp. after C. albicans, followed by C. glabrata from patients 
(Kornshian et al., 1989; Nguyen et al., 1996) but some studies show C. parapsislosis 
to be the most common non-albicans Candida spp. isolated from ICU patients 
(Bassetti et al., 2006).
Although differences in the distribution of Candida spp. in patient infections has been 
observed between different ICUs, no difference has been seen between the ICU and 
conventional wards within the same hospital (Leone et al., 2003). The majority of 
patients were colonised with C. albicans (68 %) but a number were colonised with C, 
glabrata (9.4 %) (Leone et al., 2003). Similar results were seen from a Canadian ICU 
with 60.2 % of all patients being colonised with a fungal species; among which 72 % 
were C. albicans and 5 % C. glabrata (Laverdiere et al., 2007).
It is possible (although rare) for patients to be colonised with multiple Candida species. 
4.2 % of patients from a Texas cancer unit were colonised with >2 Candida species. 
The majority of these patients (90 %) were colonised with C. albicans and either C. 
glabrata, C. parapsilosis or C. tropicalis but two patients were colonised with two non- 
albicans species (C. tropicalis with C. glabrata or C. parapsilosis) exemplifying the shift 
towards non-albicansspecies (Abi-Said etal., 1997).
Not only is Candidemia a life-threatening yeast infection but there are significant
additional costs to the NHS as a direct result of such infections (Rentz et al., 1998),
The cost of a candidemia case in an ICU has been estimated at €16,000 (Schelenz,
2008). With the majority of risk factors common in ICU patients, the high mortality risk
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and the additional costs related to these infections, there is a need to observe the ICU 
environment for any potential reservoirs of fungal organisms to further reduce the risk 
of infection in this vulnerable group.
1.6 Antibiotic resistance
Antibiotic resistance is the term used when a bacterium or other micro-organism is 
permanently non-susceptible to a specific antibiotic (Walsh et al., 2004). There are 
several mechanisms which have evolved among bacteria to enable antibiotic 
resistance, for example, efflux pumps, antimicrobial target alteration, membrane 
permeability alteration, enzymatic modification and metabolic bypass (Smith & Jarvis, 
1999).
Bacteria can either acquire antimicrobial resistance or they are naturally resistant 
possessing the necessary resistance mechanism. Resistance can be acquired by 
horizontal gene transfer, from transmissible plasmids or transposons (Mims et al., 
1998b). Transposons which possess antibiotic resistance genes have the ability to 
integrate into plasmids or chromosomes. They also possess the ability to "jump" 
between plasmids i.e. from a non-transmissible plasmid to a transmissible one (Mims 
etal., 1998b).
Bacteria can acquire antimicrobial resistance in any of four ways; -
1. Mutation - resistance can arise from a mutation i.e. a single chromosomal 
mutation may result in the synthesis of an altered protein. Or a series of 
mutations can result in multiple changes i.e. in penicillin-binding proteins (Mims 
etal., 1998b)
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2. Conjugation - Gram-negative bacteria transfer plasmids containing resistance 
genes to adjacent bacteria via the pilus. With Gram-positive bacteria 
conjugation is initiated by the production of sex pheromones by the mating pair 
(Tenover, 2006}
3. Transduction - resistance genes are transferred between bacteria via 
bacteriophage (Tenover, 2006)
4. Transformation - bacteria are able to take up naked DNA. Bacteria can release 
DNA segments into the environment via cell lysis, and other bacteria are able to 
acquire and incorporate these DNA segments (Tenover, 2006)
The study described in this thesis focused on detecting the antibiotic resistance 
determinants meek, blact x -m, shv , tem  and tet{M, O, W) in the ICU and HDU ward 
environments. The following sections not only describe the mechanisms of resistance 
caused by these genes but also the associated organisms (including MRSA and 
common ESBL-producing organisms). Risk factors, infections, treatment and the 
presence of these organisms and genes in the ICU environment are also discussed.
1.7 Extended spectrum beta-lactamases
1.7.1 Overview of ESBLs
One of the most clinically significant resistance mechanisms to have emerged is the 
production of extended spectrum beta-lactamases (ESBLs). ESBLs have become a 
predominant feature in Gram-negative hospital infections over the last 25 years 
(Sturenburg and Mack, 2003), since the identification of the first ICU ESBL 
characterised back in 1985 from K. pneumoniae isolated from patients in France (Sirot 
et al.t 1987). Since then there has been extensive research into the detection of 
ESBL-producing bacteria and prevention and treatment of the diseases they cause.
17
ESBLs are plasmid-mediated bacterial enzymes that are able to hydrolyse a wide 
variety of (3-lactam antibiotics (Naiemi ef a/., 2005). They have evolved from native 
serine active-site, Ambler class A (3-lactamases i.e. TEM-1, TEM-2 and SHV-1 by 
genetic mutation (Pfaller & Segreti, 2006). The TEM-1 (3-lactamase is most commonly 
seen in ampicillin-resistant Gram-negative enteric organisms. However, the most 
common p-lactamase among the Klebsiella spp. is SHV-1 (Philippon et al., 1989). 
TEM-1, -2 and SHV-1 are able to hydrolyse ampicillin at a greater rate compared with 
oxacillin, cephalothin and carbenicillin. However, they show little or no activity against 
antibiotics such as cefotaxime or ceftazidime (Philippon etal., 1989).
ESBLs are more frequently found in P. aeruginosa, Serratia marcescens and 
Salmonella enterica (Pfaller & Segreti, 2006). Not only do these enzymes confer 
resistance to penicillins and first and second-generation cephalosporins, but also to the 
newer classes e.g. oxyimino cephalosporins (including cefotaxime and ceftazidime) 
and monobactams (including aztreonam) (Sturenburg & Mack, 2003).
UTIs are the main clinical manifestations of ESBL-producing organisms but 
bloodstream infections are also seen (Pessoa-Silva et al., 2003; Sturenburg and 
Mack, 2003; Tumbarello et al., 2007; Zahar ef al., 2009). Risk factors include 
increased age, previous UTIs, catheterisation, female sex, previous antibiotic usage 
and diabetes mellitus (Pessoa-Silva et at., 2003; Livermore and Woodford, 2006; 
Livermore et al., 2007; Falagas and Karageorgopoulos, 2009).
Patients with infections caused by ESBL-producing organisms have a high mortality
rate and for those with blood-stream infections the mortality rate is further increased
due to treatment failures. One study showed that after 21 days from infection onset the
mortality rate was 38 % (Tumbarello et al., 2007). These risk factors apply to all
hospitalised patients but ICU patients are more prone to these factors (particularly with
regard to catheterisation and antibiotic usage).
18
Serious infections caused by ESBL-producing organisms are treated with 
carbapenems (Rodriquez-Bano and Pascual, 2008). Inadequate initial treatment of 
these infections has been found as a predictor for mortality, with many ESBL-producing 
organisms being multi-drug resistant, treatment failures are high (Tumbarello et at.,
2007).
In some cases initial treatment is delayed because of a lack of rapid identification (up to 
72 hours after infection onset) (Song ef at., 2009; Trecarichi et at., 2009). Therefore 
there is a need for a quick and accurate identification technique for these organisms; 
the main method of identification is by culture and disk diffusion. Data from this 
present study contributed to the development of a simple disk diffusion overnight 
method to identify ESBL and AmpC-producing organisms (Derbyshire et at., 2009).
A variety of p-Iactamases have been classified into classes A, B, C and D according to 
their amino acid sequences. Class A enzymes are serine hydrolases with a serine 
active site which is acylated by the (3-lactam antibiotic (Fernandez-Varon et al., 2005). 
There are three pre-dominant groups of ESBLs blashv (class A), b/aTEM (class A) and 
bldcjx-M (class A).
CTX-M-type ESBLs are a new group of class A ESBLs (Brinas et at., 2005). The 
CTX-M (3-Iactamases have a potent hydrolytic activity against cefotaxime and some 
CTX-M-type ESBLs are able to hydrolyse ceftazidime (Paterson & Bonomo, 2005). 
These enzymes are not closely related to either TEM or SHV ESBLs, but they do share 
a high amino acid identity with chromosomal p-lactamases from Kluyvera georgiana, 
Kluyvera cryocrescens and Kluyvera ascorba. (Pitout et at., 2004).
SHV-type ESBLs are more commonly found in clinical isolates compared with other
ESBLs (Paterson & Bonomo, 2005). SHV stands for sulfhydryl variable, this is
because it was believed that inhibition of SHV activity was by p-chloromercuribenzoate
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and was substrate-related but was variable according to the substrate (Paterson & 
Bonomo, 2005). However, this has since never been confirmed but the name has 
remained. SHV-1 is a p-lactamase but not an ESBL. This is because it can only 
hydrolyse penicillin and cephalosporins but not extended-spectrum antibiotics (i.e. 
oxyimino cephalosporins) (Hammond et al., 2005). However, conversion to an ESBL 
can be caused by the single amino acid substitution G238S. The additional 
substitution E240K leads to further spectrum extension and increased enzyme activity 
(Hammond et a/., 2005). This enzyme has been denoted as SHV-2 and since its 
discovery within 15 years it has been identified across the world. SHV-type ESBLs 
have been detected in a wide range of Enterobacteriaceae and outbreaks of SHV- 
producing P. aeruginosa and Acinetobacter spp. are reported (Paterson & Bonomo,
2005).
TEM-type ESBLs are derived from TEM-1 and TEM-2. TEM-1 was initially reported in
1965 from an E. coli isolate of a patient named Temoniera (hence TEM) (Paterson &
Bonomo, 2005). Beginning in the early 1980s ESBLs derived from TEM-1 began
appearing in the clinical setting (Livermore, 1995). TEM-1 possesses the ability to
hydrolyse ampicillin at a higher rate than it hydrolyses carbenicillin, oxacillin or
cephalothrin and has a very low activity against extended spectrum cephalosporins
(Paterson & Bonomo, 2005). TEM-1, -2 and -13 are not classed as ESBLs due to this
low activity. However, certain K. pneumoniae isolates in 1987 possessed a novel
plasmid-mediated p-lactamase which is now referred to as TEM-3 (Paterson &
Bonomo, 2005). TEM-3 differs only in two amino acid substitutions compared with
TEM-2 and has an enhanced activity against the antibiotic cefotaxime (Paterson &
Bonomo, 2005). There have now been greater than one hundred TEM-type beta-
lactamases identified with the majority being ESBLs. Some TEM derivatives have
been identified which possess a lowered affinity for p-lactamase inhibitors (such as
clavulanic acid, which inhibits TEM-1 and many other beta-lactamases). However,
these enzymes tend to have no hydrolytic activity against the extended cephalosporins
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(Wu ef al., 1994). Although recently there has been the discovery of mutant TEM (3- 
lactamases that have inhibitor resistance but also maintain the ability to hydrolyse third 
generation cephalosporins (Paterson & Bonomo, 2005).
1.7.2 Presence of ESBL-producing organisms in the environment 
and transmission in ICUs
There is limited research into distribution and transmission of ESBL-producing 
organisms in the hospital environment; the majority of work focuses on clinical isolates 
and their spread between patients (Pena etal., 1998; Shannon etal., 1998; Coque et 
al., 2002; Naas et al., 2002; Naiemi et al., 2005; Zarnayova et al., 2005; Brinzio et 
al., 2006; Damjanova et al., 2007; Manzur et al., 2007) rather than identifying the 
source or reservoir of these infections from the environment. There have been 
numerous outbreaks of nosocomial infections caused by ESBL-producing organisms 
(Livermore, 1995; Naiemi etal., 2005; Brinzio etal., 2006; Damjanova etal., 2007; 
Manzur et al., 2007), particularly in ICUs and evidence shows that these organisms 
can persist in the hospital environment, particularly in sinks (Naas et al., 2002) so 
research is required to identify these potential reservoirs.
ESBL-producing organisms have been found to persist in the ICU environment after 
routine cleaning. An ESBL-producing Citrobacter freundii strain was identified on an 
ICU and a clonal outbreak was linked from the ICU to other medical wards. This 
organism produced the ESBL TEM-21 and was identified from the sinks in the ICU; 
after decontamination of this area the organism still remained (Naas et al., 2002). Only 
after the sinks were replaced was the spread of this ESBL-producing organism stopped, 
indicating that these organisms can persist in the ICU environment and the sink was 
able to act as a reservoir despite cleaning.
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Naiemi et al. (2005) showed two outbreaks in an ICU of multi-drug resistant 
Enterobacter cloacae and A. baumannii to possess the SHV-12 ESBL gene as well as 
the TEM-116 p-lactamase gene. Between June and November 2000 aminoglycoside- 
resistant and ESBL producing E. cloacae were isolated from ten patients. After the E. 
cloacae outbreak, infection control measures were taken including extra vigilance with 
hand hygiene, wearing gowns and gloves during patient care and isolating patients with 
multi-drug resistant (MDR) E. cloacae. However, these control measures did not 
prevent the multi-drug resistant A. baumannii outbreak in the ICU. These events 
suggest that by preventing the spread of resistant E. cloacae it was possible for other 
strains to become prevalent. Naiemi et al. (2005) showed that by further increasing the 
infection control measures it was possible to halt the outbreak of A. baumannii.
In 2004 a Spanish hospital saw only sporadic and non-related cases of ESBL- 
producing E. cloacae, however, an outbreak was observed in 2005 in the 
cardiothoracic ICU (CT-ICU) due to an epidemic strain (which caused infection in the 
majority of ICU patients) (Manzur et ah, 2007). Emergence of this strain was attributed 
to the application of an antibiotic cycling strategy, which led to an increased use of 
cefepime and quinolones (Manzur et al., 2007). As the infections were device­
associated it was assumed that cross-transmission was the cause of spread 
throughout the CT-ICU.
As previously mentioned ESBLs are mainly associated with E. coli and K. pneumoniae
and outbreaks are generally associated with high rates of intestinal carriage, however,
this is not often seen with E. cloacae (Pena et al., 1998). Of the E. cloacae strains
identified with this outbreak one was identified by gene sequencing to possess two
ESBLs (SHV and CTX-M-9) and the other possessed one (a TEM enzyme) (Manzur et
al., 2007). The initial outbreak was therefore believed to have started from a
transferable plasmid encoding ESBL production, isolated from other ESBL-producing
organisms from three patients (Manzur et al., 2007). This hospital had only
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experienced a handful of ESBL cases during the year before the outbreak. E. cloacae 
are not common ESBL producers but with ESBL genes found on transferable plasmids 
this suggests that any Gram-negative organism could potentially acquire a plasmid and 
produce an ESBL.
The emergence of ESBL-producing organisms on neonatal-ICUs (NICU) is usually due 
to antibiotic usage because of the restricted spectrum available. However, Mammina 
et al. (2007) showed a high percentage of ESBL isolates when observing the levels of 
multi-drug resistant Gram-negative (MDRGN) bacilli to be due to poor infection control 
compliance. It was shown that from one year surveillance, over 50% of patients were 
colonised with MDRGN and that a very high cross-transmission rate was observed 
(Mammina et al., 2007). Through molecular tracing using pulse-field gel 
electrophoresis (PFGE) they observed large cluster-related multi-drug resistant (MDR) 
organisms and identified the possibility of a common environmental reservoir 
interacting with healthcare workers. This study showed that not only can the use of 
antibiotics lead to the colonisation by MDR Gram-negatives but a lack of infection 
control measures can increase the risk of emergence of ESBLs enormously. Where 
Naiemi et al. (2005) had to quickly implement altered infection control measures (to halt 
outbreaks) Mammina et al. (2007) observed how easily cross-transmission can occur in 
NICUs if these measures are not strictly followed
However, other researchers have shown alternative hypotheses for ESBL transmission 
within and between ICUs. Studies in Spain and Slovakia suggest that SHV-2a ESBL 
distribution is not caused by plasmid dissemination and suggest independent evolution 
of variants from geographically wide spread broad-spectrum non-ESBL enzymes may 
be the reason for the identification of different ESBL variants found in various locations 
(Coque et al., 2002; Zamayova et al., 2005).
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Where many studies have shown that ESBL-producing organisms are the cause of 
epidemics (Naiemi et al., 2005; Manzur et al., 2007; Mammina et al., 2007) Coque et 
al. (2002) observed very little evidence of an epidemic (produced by a single bacterial 
clone) or even an endemic situation (a single clone maintained over a length of time). 
It is unknown why there is high clonal turnover however it is possible for clonal 
competition and those organisms possessing an ESBL maybe selected. With these 
ESBL genes being present in various bacterial populations, via antibiotic selective 
pressure these genes could enter a variety of K. pneumoniae and other bacterial 
clones (Coque et al., 2002).
1.8 Meticillin resistant Staphylococcus aureus
1.8.1 Overview of MRSA
S. aureus is a Gram-positive coccus which can often be found as part of the normal 
flora of the human skin and many individuals are nasal carriers (Berkeley, 1979). 
MRSA is a S. aureus organism which confers resistance to the widely used antibiotic 
meticillin.
MRSA has been identified in the hospital environment and is a frequent cause of 
infections seen on ICUs (French et al., 2004, Oztoprak et al., 2007). In 1999, 57% of 
all ICU-acquired S. aureus infections were meticillin resistant in Europe (Oztoprak et 
al., 2006). ICU patients who acquire an MRSA bacteraemia infection have a 22 % 
increased risk of death. This results in an additional 0.3 % to the overall mortality rate 
on the general ICU (Thompson et al., 2008). Vancomycin was initially the drug of 
choice to treat MRSA infections but resistance has been reported in America and 
Japan with reduced susceptibility observed in the UK, and so a combination of 
glycopeptide antibiotics is now used (Corey, 2009). However, the most effective
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treatment for decolonisation of the nasal cavity is the use of the antibiotic mupirocin 
which is prescribed as a nasal ointment (Crossley, 2009).
There is a need for a rapid detection method of MRSA and many researchers have 
developed a polymerase chain reaction (PCR) method (Murkami et al., 1991; Unal et 
al., 1992; Geha et al., 1994). However, with costs and technical ability/training 
required the methods used in the clinical microbiology laboratories are currently still 
culture based techniques on MRSA selective media (HPA, 2008).
1.8.2 Risk factors for MRSA infections
MRSA infections can result in high morbidity and mortality and some strains are 
classed as endemic in several American and European hospitals (Oztoprak et al.%
2006). S. aureus most commonly causes skin infections which result in abscesses and 
boils. In patients who have undergone invasive medical techniques, both S. aureus 
and MRSA can cause bloodstream infections (bacteraemia/sepsis) which is the 
majority of MRSA nosocomial infections, especially among ICU patients. (Gordon and 
Lowy, 2008).
Oztoprak et al. (2006) identified the following risk factors for ICU-acquired MRSA; -
• Long period of ICU hospitalisation
•  Presence of >1 MRSA positive patient on the ICU
• CVC insertion
• Previous antibiotic usage
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They also showed the need to study the ICU environment for MRSA, as some 
uncolonised patients acquired MRSA infections from another source, which could be 
hospital staff or the environment.
Weist et al. (2002) showed that where multiple patients were present in the same room,
11.1 % saw all the patients to have an MRSA infection or colonisation. This suggested 
the presence of mobile reservoirs, either hospital staff or medical devices. This 
indicates that there is a need to identify these mobile reservoirs and if they are present 
in the ICU environment.
1.8.3 Resistance mechanism of MRSA
MRSA organisms possess a mecA gene that encodes an altered penicillin binding 
protein (PBP2a), 78kDa in size (McKeegan et a/., 2002). PBP2a is a cell wall enzyme 
which unlike other PBPs has a lower affinity for {3-lactam antibiotics and enables cell 
wall formation despite the presence of drug concentrations which render other PBPs 
inactive. (Geha et al., 1994). PBPs include transpeptidases that are essential for 
cross-linking peptidoglycan (which is the essential strength-conferring component of 
the bacterial cell wall), and beta-lactam antibiotics inhibit these enzymes (as they are 
analogues of the natural peptide substrates of the enzymes). Inhibition occurs by 
acylating the active site serine of the PBPs and blocks the active site. The plasmid 
encoding the altered PBP often possesses other antibiotic resistance genes, rendering 
MRSA a multi-drug resistant organism. Other such resistance genes include those for 
rifampicin, erythromycin, tetracycline, aminoglycosides and clindamycin (Smith & 
Jarvis, 1999).
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1.8.4 Prevention of MRSA infections
Many patients (approximately 40 %) are colonised with S. aureus and approximately 1 % 
are colonised with MRSA making prevention difficult. In 2008/2009 the HPA introduced 
MRSA screening for all elective admissions and before 2011 this will include 
emergency admissions (however the logistics of 2011 MRSA screening is unclear). 
Routine screening was introduced to monitor community-acquired MRSA (CA-MRSA) 
so that patients could be isolated and decolonised to prevent spread of MRSA between 
patients. Infection control is required to prevent the spread of MRSA among patients 
and the ward, for example isolation of colonised patients, effective hand hygiene and 
the use of gloves and gowns (Furuno et al., 2008).
In ward areas of previously colonised or infected patients, MRSA has been detected on 
multiple environmental surfaces (French ef al., 2004). This suggests that beside staff 
to patient transmission, the ward environment is able to act as a reservoir for MRSA 
organisms (as described in Sections 1.4.2 and 1.4.3).
All hospital wards have routine cleaning carried out daily (often more than once per day) 
but questions have arisen as to whether this regime is sufficient to remove MRSA 
(Dancer, 1999; Dharan etal., 1999; Wilcox etal., 2003; Dancer, 2004; French etal., 
2004). In some studies cleaning did not significantly reduce the number of MRSA 
organisms in the environment. Before cleaning 74 % of environmental swabs were 
MRSA positive and routine cleaning only reduced this to 66 % (French et al., 2004). 
After cleaning, Blyth et al. (1998) showed that 41 % of the isolation rooms (from a total 
of 41) were still contaminated with MRSA. Hydrogen peroxide vapour decontamination 
showed a high reduction in MRSA from 72 % down to 1.2 % (French et al., 2004). 
However, for this method of cleaning the rooms/wards need to be evacuated first
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before decontamination can begin due to the high toxicity of hydrogen peroxide vapour, 
therefore more information is required on the environment and cleaning regimes.
1.8.5 Transmission of MRSA on the ICU
Reports of MRSA infections on ICUs have been frequent and outbreaks have been 
observed around the world (Devine et al., 2001; Wiicox et al., 2003; HPA, 2008; 
Thompson et al., 2008; Khan et al., 2009). One Canadian surgical ICU reported an 
outbreak when two MRSA cases were identified within a four week period (Khan et al.,
2009). Routine screening was not in action and after all patients were screened an 
additional two patients were found to be infected. Despite implementing specific 
infection control measures (education, increased surveillance and enhanced 
environmental cleaning) a further three cases appeared. Patients were placed into 
contact isolation and the hospital staff were screened. After a two week period another 
two cases appeared and decolonisation of all positive patients was implemented (Khan 
et al., 2009). This report shows the ability of MRSA to spread rapidly among patients 
despite initiating infection control measures and increasing environmental cleaning.
Bed occupancy has been shown to affect the incidence of MRSA infections on ICUs
(Howie and Ridley, 2008). One study from Hope hospital (in the UK) showed 7.8 % of
ICU admissions to be colonised with MRSA and a further 10.3 % acquired MRSA
infections during their hospitalisation. When bed occupancy was high, particularly in
cramped ICUs (where airborne and environmental MRSA contamination is more likely)
the number of MRSA cases increased (Howie and Ridley, 2008). Physical factors
including environmental contamination and patient proximity affect airborne
transmission (Shiomori et al., 2002) while MRSA contaminates the air and
environment around known MRSA positive patients (NHS Estates, 2003). It can be
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concluded therefore that the ward environment plays an important source in hospital 
cross-infection.
1.9 Tetracycline resistance
1.9.1 Overview of tetracycline
Tetracycline is a broad-spectrum antibiotic which has been used for many years to 
treat bacterial infections in both humans and animals (Villedieu et al., 2003). It can 
also be used as a growth promoter in animals and in humans as an immunosuppressor. 
Tetracycline is used to treat a number of Gram-positive and negative infections as well 
as those caused by intracellular pathogens and protozoa (Roberts, 2005).
The tetracyclines are a family of antibiotics with a common four-ring structure to which 
a variety of side chains are attached (Prescott et al., 2002). There are five members 
of this antibiotic family, tetracycline, chlortetracycline, oxytetracycline, doxycycline and 
minocycline.
The mode of action of the tetracyclines is to inhibit protein synthesis by stopping the 
attachment of aminoacyl-tRNA to the ribosomal acceptor (A) site (Chopra & Roberts, 
2001). Since their action is bacteriostatic the success/effectiveness of the treatment is 
also dependent upon the host defence mechanisms.
Due to extensive use of tetracyclines since their discovery in the 1940's resistance 
mechanisms have been identified (Chopra & Roberts, 2001). As mentioned 
tetracyclines can be used as a growth promoter in animal feeds (this mainly occurs in 
the USA), but this is a rather controversial issue. Many believe that this process may
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be significantly contributing to the emergence of resistance in human pathogens 
(Chee-Sanford et al., 2001; Chopra & Roberts, 2001; Roberts, 2005).
1.9.2 Tet genes in the environment
With tetracycline antibiotics having been used to treat humans and animals and in 
agriculture, tetracycline resistance genes are commonly found in the environment 
(Bryan et al., 2004). Several studies show the detection of tetracycline resistance 
genes from different environmental sources.
These genes have entered the environment as a direct result of agriculture and have 
been identified from groundwater samples, providing a possible source of antibiotic 
resistance in the human and animal food chain (Chee-Sanford et al., 2001). The 
majority of organisms associated with this resistance are of gastrointestinal origin, but 
by identifying these genes in organisms inhabiting soil this suggests that the vector is 
not limited and can spread between different bacterial classes (Chee-Sanford et al., 
2001).
The tetracycline genes can act as a common antibiotic resistance determinant known 
to be present in the environment (Anderson and Sandaa, 1994; Aminov et al., 2001; 
Roberts, 2005).
1.9.3 Mechanism of tetracyciine resistance
Bacteria have developed a number of resistance mechanisms against the tetracycline 
antibiotic class. At present there are 29 different known tetracycline resistance (tet) 
genes and 3 oxytetracycline resistance (oti) genes. There are three resistance
mechanisms against tetracyclines; efflux system, ribosome protection and tetracycline 
modification.
This present study focused on the detection of ribosome protection resistance tet 
genes. There are nine ribosomal protection proteins, named tet M, O, S, W, Q, T, 
otr{A), tetP(B) and one unnamed tet These are cytoplasmic proteins and confer a 
wider spectrum of tetracycline resistance compared with the efflux pumps. This 
method also enables resistance to doxycycline and minocycline (Chopra & Roberts, 
2001).
The action is to enable the aminoacyl-tRNA to bind to the acceptor site of the ribosome. 
These ribosomal protection proteins (RPP's) have sequence similarity to the elongation 
factors Tu and G. It is the N-terminal regions of these proteins that share the greatest 
similarity. The tet proteins compete with the elongation factors to bind to the ribosomes. 
The RPP's bind to the ribosome and alter the ribosomal conformation, the energy for 
this alteration is provided by GTP hydrolysis (Chopra and Roberts, 2001; Connell et 
al., 2003). So in the presence of GTP and either Tet(M) or Tet(O) protein the ability of 
tetracycline to bind to the ribosome is reduced. But also, by altering the conformation 
the antibiotics can not bind when the protein is released. Tet(M) has a greater affinity 
than the elongation factors for the ribosome binding site. Tet(M) binds to the ribosome 
and causes a conformational change. Elongation factor Tu can form the amino acid- 
tRNA-GTP-EF-Tu complex. The protein dissociates allowing the elongation factor 
complex to bind and enable protein synthesis to continue (Connell et al., 2003).
1.10 Aims and objectives of the present study
Extensive research has been carried out into the acquisition and transmission of HAIs
(particularly in outbreak situations) however; the role of the ward environment in HAIs
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has not been fully investigated. The overall aim of the study was to characterise the 
reservoir of microorganisms (bacterial and fungal) and resistance determinants in the 
ICU and HDU ward environment under a non-outbreak situation.
Before hospital sampling began an effective sampling regime was required and several 
methods were optimised to meet the aim of this present study (detailed in Chapter 3). 
Two hospitals were investigated throughout this study, the Royal Hallamshire Hospital 
(RHH) and Northern General Hospital (NGH) ICU/HDU departments. Samples were 
taken from both hospitals however the aim was not to compare the two hospitals; 
therefore the results have been separated into RHH and NGH. Similarities or contrasts 
in the results have however been highlighted where appropriate.
The objectives were to: -
•  detect bacteria and antibiotic resistance determinants in the ICU and HDU 
environment using a sensitive molecular method
• isolate bacteria and fungi in the ICU and HDU environment
• identify sites where bacteria and fungi were most frequently detected
• identify bacterial and fungal species
• compare bacterial and fungal species from environmental sites with clinical
isolates
• identify bacterial species carrying target genes ( b / a C T x -M ,  shv , te m , meek, tetM, O, 
W)
• assess the effect of routine ward cleaning
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2. Materials and methods
2.1 Ethical approval
Full ethical approval was granted by the National Research Ethics Service (REC 
reference number 08/H1310/2). Sheffield teaching hospitals provided the letter of 
authority for the study period 9th March 2007 to 21st December 2009, along with 
project authorisation granted on 20th February 2008. This approval enabled entry into 
the ICU environment at both the RHH and the NGH to collect samples from a variety of 
sites within the wards (Appendix 1).
2.2 Hospital sampling regime
The ICUs and HDUs of the Sheffield Teaching Hospitals Trust were sampled. At the 
start of the project (September 2006) there was one general ICU and HDU (six beds on 
each unit) located at the Royal Hallamshire Hospital (RHH), Glossop Road, Sheffield, 
S10 2JF. During the project several changes occurred, in March 2008 a new ICU/HDU 
(two four-bed wards and ten isolation rooms for each unit) was commissioned at the 
Northern General Hospital (NGH), Herries Road, Sheffield, S5 7AU. When sampling 
began in March 2008 both ICU and HDUs from the RHH and NGH were included. In 
July 2008 the RHH HDU moved floors within the hospital and included a larger HDU 
department (ten beds).
Hard surfaces (bedside, computer keyboard, fan, floor, computer stand, patient chair, 
picture, staff chair, ward sink plughole, ward sink taps, trolley, sluice room sink 
plughole, window ledge, door handle and machine handle) were sampled with a 
neutralising solution (1 ml -1.5  M NaCI and 1 M Tris base) moistened DACRON swab
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(FB57833 Thermo Fisher Scientific Inc). Swabs were taken of the same sample sites 
for each sampling session. Larger areas (including floors) were sampled using a 
20 cm x 15 cm disposable plastic grid, details of each sample site are provided in Table 
2.1a/b. Each sample was given a unique code number that specified the type of 
environment sampled, the hospital and unit from which the sample was taken and the 
date of the sampling (Appendix 2).
The DNA was extracted from each swab and stored at -20 °C in the 703/-20/2 freezer 
in room 703 BMRC labelled with the codes from Appendix 2. Microbial enumeration 
was performed by culturing on solid media (Section 2.4.1 Bacterial growth conditions 
and 2.4.2 Fungal growth conditions) (Figure 2.1).
Textured surfaces (chairs and curtains) were sampled (Appendix 2) by firmly placing a 
nutrient, blood (blood agar no2 and horse blood) and potato dextrose agar contact 
plate (Cherwell Laboratories cat no 101060,101050 and 101280) onto the sample area.
Nutrient agar dipslides (Cherwell Laboratories cat no CLO500) containing triphenyl 
tetrazolium chloride (TTC) were used to sample small hard surfaces (hand wash 
bottles, intercom buttons and switches) by being placed firmly on the sample area 
(Appendix 2). TTC is a dye used to enable easy enumeration of microorganisms. In 
the oxidised form TTC appears colourless but upon reduction by microorganisms 
appears red, this is due to the formation of formazan dye from tetrazolium salts (by 
dehydrogenase or reductase enzymes).
The results of DNA extraction and the detection of prokaryotic cells and antibiotic 
resistance determinants are described in Chapters 4 and 5. Microbial enumeration 
from culturing of swab samples, dipslides and contact plates are reported in Chapter 4. 
The results of fungal detection after culture from swab samples are described in
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Table 2.1a RHH sample sites and description
Sample site Number of 
sites sampled 
per session
Description
Bedside (ICU) 1 One side of the bed (plastic)
Computer keyboard 
(ICU)
1 The areas between the keys and 
the base of the keyboard
Fan (ICU) 1 Each plastic slat in the small fan 
located on the far wall of the ICU
Floor (ICU) 2 A 20 cm x 15 cm area immediately 
adjacent to the machine nearest 
the patient bed
HDU computer 
keyboard
1 The areas between the keys and 
the base of the keyboard
HDU computer stand 1 The base of the stand
HDU patient chair 3 A 20 cm x 15 cm area from the 
seat and back of the chair and the 
arm
HDU picture 1 Horizontal upward-facing surface 
of the frame
HDU staff chair 1 A 20 cm x 15 cm area from the 
back of the chair
Picture (ICU) 1 Horizontal upward-facing surface 
of the frame
Plughole (ICU ward 
sink)
2 Swab was inserted and turned 3 
to 4 times in the plughole
Taps (ICU ward sink) 2 Left and right tap handles of the 
ICU ward sink located on the far 
wall of the ICU
Trolley (ICU) 1 A 20 cm x 15 cm area of a 
supplies trolley surface
Sluice room sink 
plughole
2 Swab was inserted and turned 3 
to 4 times in the plughole
Window ledge (ICU) 1 Horizontal ledge at the joint of the 
glass with plastic frame
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Table 2.1b NGH sample sites and description
Sample site Number of 
sites sampled 
per session
Description
Computer keyboard 
(ICU)
1 The areas between the keys and 
the base of the keyboard
Door handle (ICU) 1 The whole of the sluice room door 
handle (metal)
Floor -  isolation room 
(ICU)
2 A 20 cm x 15 cm area immediately 
adjacent to the machine nearest 
the patient bed
F lo o r -w a r d  (ICU) 2 A 20 cm x 15 cm area immediately 
adjacent to the machine nearest 
the patient bed
HDU computer 
keyboard
1 The areas between the keys and 
the base of the keyboard
HDU door switch 1 A round electrical switch that is 
pressed to unlock the door of the 
HDU on the wall (plastic)
HDU floor 1 A 20 cm x 15 cm area immediately 
adjacent to the machine nearest 
the patient bed
HDU ward sink 
plughole
1 Swab was inserted and turned 3 
to 4 times in the plughole
Machine handles (ICU) 2 Left and right handles of the 
machine nearest the patient bed 
(patient monitoring equipment)
Patient chair (ICU) 4 A 20 cm x 15 cm area from the 
seat and back of the chair and the 
arms
Plughole (ICU ward 
sink)
2 Swab was inserted and turned 3 
to 4 times in the plughole
Sluice room sink 
plughole
2 Swab was inserted and turned 3 
to 4 times in the plughole
Window ledge (ICU) 1 Horizontal ledge at the joint of the 
glass with plastic frame between 
two rooms
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Swab environment -  bedside, computer keyboard, door handle, fan, floors, HDU 
computer keyboard, HDU computer stand, HDU door switch, HDU floor, HDU patient 
chair, HDU picture, HDU plughole, HDU staff chair, machine handle, patient chair, 
picture, plughole, tap, trolley, sluice plughole, window ledge
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Figure 2,1 Methods for each environmental swab sample
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Chapter 6. A period of intensive sampling was carried out to report on the effect of 
routine ward cleaning and details of the extra sampling regime are laid out in Chapter 7.
2.3 Identification and subculturing of clinical isolates from ICU 
patients
RHH and NGH microbiology departments have an intercalated database (providing 
access to clinical isolate information from both ICU sites) of all clinical isolates. A 
database search was established to locate all clinical isolates from both RHH and NGH 
ICU and HDU. Clinical samples were screened routinely by the hospital staff, ICU and 
HDU clinical isolates were collected weekly from storage on nutrient agar (NA) plates.
The bacteria were streaked out to yield single colonies and grown on nutrient agar (NA) 
(cat no 70148 Sigma) plates overnight at 37 °C. Pure cultures were sub-cultured 
overnight in nutrient broth (cat no 70123 Sigma) at 37 °C with shaking at 200 rpm.
Glycerol stocks were made from 900 pi bacterial suspension and 100 pi 80 % glycerol 
(cat no G5516), then gently mixed and stored at -80 °C.
2.4 Microbiological growth conditions
2.4.1 Bacterial growth conditions
Dipslides and contact plates were incubated aerobically at room temperature 20-25 °C 
(RT) (in a laminar flow hood -  Heraeus) for 48 h and also at 37 °C (in a static incubator 
-  Heraeus). All contact plates and dipslides were stored at 4 °C after incubation for
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further analysis and any colonies grown in liquid culture (nutrient broth) were stored at 
-80 °C as glycerol stocks (including antibiotic gene-carrying organisms).
All ICU/HDU clinical isolates throughout this study were grown aerobically in 5 ml 
nutrient broth at 37 °C with shaking at 200 rpm in an orbital incubator S1 50 (Stuart 
Scientific).
All environmental swab samples were plated out in duplicate (NA, blood and cysteine 
lactose electrolyte deficient agar) and incubated aerobically at RT (48 hours) and 37 °C 
(overnight) (Table 2.2).
2.4.2 Fungal growth conditions
Throughout this study all fungal cultures were grown using the following standard 
conditions; aerobic incubation at 30 °C with shaking at 200 rpm in an orbital incubator 
(Gallenkamp) in 9 ml YPD broth (1 L 20 g peptone, 20 g dextrose and 10 g yeast 
extract - Sigma) for up to 5 days.
Throughout this study environmental fungal contact plates were grown aerobically at 
30 °C in a static incubator (Heraeus) on potato dextrose glucose (PDG) (cat no 70139 
Sigma) agar plates for up to 5 days.
All environmental swab samples were tested for fungal species by inoculating on PDG 
agar plates and incubated aerobically at 30 °C in a static incubator (Heraeus) for up to 
5 days.
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Table 2.2: Growth conditions for cultivation of bacteria from swab samples
Agar Volume spread (pi) Temperature
Blood 50 RT
Blood 50 37°C
CLED 50 RT
CLED 50 37°C
Nutrient agar 50 RT
Nutrient agar 50 37°C
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2.5 DNA extraction
All DNA extractions from swabs and cultures were performed to isolate genomic 
bacterial DNA or fungal DNA via a Qiagen spin column method (QIAamp® DNA mini kit 
cat no 51304 Qiagen Ltd).
Whilst chemical treatment alone can release DNA from Gram-negative bacteria, 
treatment of whole cells with a peptidoglycan-digesting enzyme is necessary for 
effective release of DNA from Gram-positive bacterial cells. This may be because the 
Gram-positive cell wall contains substantially more of the strength-conferring 
peptidoglycan, compared with the outer membrane of Gram-negative cells. Therefore 
the enzymes lysozyme and lysostaphin are required to enable better lysis of Gram- 
positives. Lysozyme hydrolyses 1,4 p-linkages between N-acetylmuramic acid and N- 
acetyl D-glucosamine residues in peptidoglycan. However, lysozyme is inactive 
against certain Gram-positive organisms, notably Staphylococci including S. aureus. 
To enable lysis of staphylococcal cells, lysostaphin was added to the cell pellet or to 
the tip of the swab that was used for taking the sample. Like lysozyme, lysostaphin 
disrupts the peptidoglycan, but differs from lysozyme in that it cleaves the polyglycine 
cross-links. Lysozyme and lysostaphin were used in combination because lysostaphin 
is inactive against the majority of micro-organisms where the peptidoglycan lacks the 
pentaglycine bridge between the peptide moieties.
Yeast cell walls can form capsules or resistant spores so lyticase was added to aid in 
fungal DNA extraction from cultures. Lyticase is a lysing enzyme that hydrolyses poly- 
p(1-3)-glucose which is present in the cell wall compound glucan. This enzyme 
enables the partial formation of spheroplasts which can then be easily lysed to release 
DNA.
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2.5.1 DNA extraction from swab samples
DNA was extracted from swab samples following the Qiagen QIAamp DNA mini kit, 
buccal swab spin protocol adapted by Lee et al. (2007). After swabbing, the DACRON 
swab tip was placed into a 2 ml Eppendorf tube and 200 pi of lysozyme extraction mix 
(20 M Tris, 2 mM EDTA pH 8.0, 1.2 % [vol/vol] P40 detergent [which causes cellular 
membrane breakdown], 20 mg/ml lysozyme, 20 pg/ml lysostaphin) was added and 
incubated for 30 min at 37 °C. Proteinase K (20 pi -  cat no 19131 Qiagen) was added 
(in order to digest protein cellular components) and 400 pi of buffer AL (lysis buffer) 
was added and incubated for 10 min at 70 °C. Samples were vortexed with 400 pi of 
100 % ethanol and 700 pi of mixture was applied to the spin column and centrifuged 
(micro centrifuge 5415D -  Eppendorf UK Limited) at 8000 rpm for 1 min, and the flow­
through was discarded. The DACRON swab tip was removed from the mixture and the 
remaining solution was applied to the spin column, and re-centrifuged at 8000 rpm for 1 
min. The flow-through was discarded and 500 pi of buffer AW1 was applied and 
centrifuged at 8000 rpm for 1 min. The flow-through was discarded, and 500 pi of 
buffer AW2 was added and the column re-centrifuged at 13000 rpm for 3 min. The 
flow-through was discarded and the column re-centrifuged for 1 min. The spin column 
was placed in a clean 2 ml Eppendorf and 150 pi of buffer AE was added to the column 
and incubated at RT for 1 min then the column was re-centrifuged at 8000 rpm for 
1 min. The spin column was discarded and extracted DNA was stored at -20 °C.
2.5.2 DNA extraction from bacterial cultures
DNA was purified from Gram-positive cultures using the QIAamp® DNA mini kit (cat no
51304 Qiagen Ltd). The manufacturer’s instructions were followed from protocol D -
isolation of genomic DNA from Gram-positive bacteria. Briefly, 1 ml of bacterial culture
was pelleted and 200 pg/ml of lysostaphin (cat no L0761 Sigma) was added to the
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pellet of S. aureus cultures and 20 mg/ml of lysozyme (cat no L6876 Sigma) was 
added to other Gram-positive species. The tissue protocol was followed from step 4 as 
instucted, and 200 pi of buffer AE was added to the column and incubated at RT for 5 
min, and the eluted DNA was stored at -20 °C.
DNA was purified from Gram-negative cultures using the QIAamp® DNA mini kit (cat 
no 51304 Qiagen Ltd). The manufacturer’s instructions were followed from protocol Cb 
- isolation of genomic DNA from bacterial cultures. Briefly, 1 ml of bacterial culture was 
pelleted and 180 pi of lysis buffer ATL was added to the pellet. The tissue protocol was 
followed from step 4 as instructed, 200 pi of buffer AE was added to the column and 
incubated at RT for 5 min, and the eluted DNA was stored at -20 °C.
2.5.3 DNA extraction from fungal cultures
Fungal genomic DNA was extracted using the Qiagen QIAamp DNA (Qiagen Ltd) mini 
kit, by following the manufacturer’s protocol for yeast followed by the tissue protocol 
from step 2. Briefly, the yeast culture was grown in YPD media to an O D 6oo= 10. 3 ml 
of fungal culture was centrifuged for 10 min at 7500 rpm. The pellet was resuspended 
in 600 pi of sorbital buffer with 200 U of lyticase (cat no G5516 Sigma) and incubated 
for 30 min at 30 °C. The sample was centrifuged at 7500 rpm for 5 min (to pellet 
spheroplasts). The spheroplasts were resuspended in 180 pi of buffer ATL. 
Proteinase K (20 pi -  cat no 19131 Qiagen) was added (to digest protein cellular 
components), and incubated at 56 °C until the cells were completely lysed 
(approximately 2 hours). Buffer AL (200 pi) was added (lysis buffer) and incubated at 
70 °C for 10 min, 200 pi of 100 % ethanol was added to the sample, then applied to the 
QIAamp spin column and centrifuged at 8000 rpm for 1 min. The flow-through was 
discarded and 500 pi of buffer AW1 was added and the column re-centrifuged at 
8000 rpm for 1 min. The flow-through was discarded and 500 pi of buffer AW2 was
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added and the column re-centrifuged at 13000 rpm for 3 min. The flow-through was 
discarded and the column re-centrifuged at 13000 rpm for 1 min. Buffer AE (200 pi) 
was added to the column and incubated at RT for 5 min. The column was centrifuged 
at 8000 rpm for 1 min and extracted DNA was stored at -20 °C.
2.6 Polymerase chain reaction
Polymerase chain reaction (PCR) was used frequently throughout this project in order 
to detect the presence of specific genes e.g. bacterial 16S rRNA genes and antibiotic 
resistance determinants. The technique of PCR involves three main steps: -
1. Denaturation - DNA was heated to separate double stranded DNA molecules to 
single strands
2. Annealing - the temperature was reduced to the optimum for annealing of the 
oligonucleotide primers to the complementary sequence of the DNA template
3. Amplification - Thermoprime Taq DNA polymerase amplified the primed DNA 
sequence using the dNTPs provided to create a copy of the original DNA
This process was cycled to enable multiple strand amplification which could 
subsequently be visualised using agarose gel electrophoresis (Section 2.8 Agarose Gel 
Electrophoresis).
All PCRs were carried out using 2x master mix (cat no AB-0575-DC ABgene Ltd), 
which in a 25 pi total reaction volume consisted of the following final concentrations: -
0.625 U ThermoPrime Taq DNA polymerase 
75 mM Tris-HCI (pH 8.8 at 25 °C)
20 mM (NH4)2S04
1.5 mM MgCI2 
0.01 %(v/v) Tween 20 
0.2 mM each of dATP, dCTP, dGTP, dTTP
The constituents of the master mix have a specific role in the PCR reaction. MgCI2was 
a source of magnesium required for the activity of DNA polymerases (a lack of free 
magnesium results in the inactivity of Taq and other DNA polymerase). Tween 20 is a 
non-ionic detergent which also stabilises Taq polymerase and can suppress the 
formation of unwanted DNA secondary structures. Tris-HCI maintains the pH of the 
reaction and ammonium sulphate precipitates DNA resulting in a reduction in non­
specific binding.
Reagents were added to the tube in the following order: -
7.5 pi sterile water
12.5 pi master mix (x2)
1 pi 30 pmol forward primer 
1 pi 30 pmol reverse primer 
3 pi template (>6 ng/pl)
Negative control - the template was replaced with 3 pi sterile water.
Positive control - the template was replaced with DNA known to possess the target 
gene.
PCR cycle:
[95 °C 5 min, annealing temperature (AT) °C 30 s, 68 °C 1 min] x 1;
[95 °C 30 s, AT °C 30 s, 68 °C 1 min] x 25;
[95 °C 30 s, AT °C 30 s, 68 °C 10 min] x 1
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All primers were custom synthesised by Invitrogen.
2.6.1 Antibiotic resistance determinant PCR
Primers were identified from the literature to amplify highly conserved regions of the 
mecA, blact x -m, sh v ,tem  and tet(M, O and W) genes (Table 2.3). All primers were tested 
against known positive and negative controls to optimise the amplification parameters 
(detailed in Chapter 3).
2.6.2 Bacterial 16S rRNA gene PCR
Primers were identified from the literature to enable the amplification of the highly 
conserved 16S rRNA gene for the detection of prokaryotic cells (all known eubacteria, 
Gram-positive and Gram-negative bacteria) (Table 2.4). The primers were optimised 
using S. aureus SH1000 and E. coli XL1 to determine the optimum amplification 
parameters (detailed in Chapter 3).
2.6.3 PCR-DGGE
Universal primers were identified from the literature to enable the amplification of the 
variable nt 341-926 16S rDNA fragments for the detection and identification of bacterial 
species (Table 2.5), and optimum amplification was established using CNS and 
Klebsiella spp (detailed in Chapter 3).
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Table 2.3: Primers for antibiotic resistance determinant detection
Gene Primer sequence (5'-3') Annealing 
temp (AT) 
(°C)
Expected 
amplicon 
size (bp)
Reference
b l a j E M TEM-F1
AT GAGTATT CAACATTT CCG 
TEM-R1
G ACAGTTACCAAT GCTTAAT CA
50 862 Naiemi et 
al., 2005
tet{ o) TETO-F
ACGGARAGTTTATTGTATACC
TETO-R
TGGCGTATCTATAATGTTGAC
52 171 Aminov et 
al., 2001
blasw SHV-F1
CTTTACTCGCCTTTATCG
SHV-R1
T CCCGCAGAT AAAT CACC
55 827 Naiemi et 
al., 2005
blaCjx-
M
CTX-M F1
GCGT GATACCACTT CACCT C 
CTX-M R1 
T GAAGTAAGT GACCAGAAT C
55 540 Weill et al., 
2004
tef(w) TETW-F
GAGAGCCT GCT AT ATGCCAGC 
TETW-R 
GGGCGT AT CCACAAT GTTAAC
60 168 Aminov et 
al., 2001
mecA MECA-1
AAAAT CGAT GGTAAAGGTT GGC 
MECA-2 
AGTT CTGCAGTACCGGATTT
60 533 Geha et 
al., 1994
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Table 2.4: Primers for bacterial 16S rRNA gene detection
Gene Primer sequence (5'-3') Annealing 
temp (AT) 
(°C)
Expected 
amplicon 
size (bp)
Reference
16S
rRNA
1651
AGAGTTT GATCMT GGCT CAG
1652
TACGG YTACCTT GTT ACG ACTT
50 1500 Bodrossy 
et al., 1999
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Table 2.5: Primers for amplification of 16S rDNA fragments for DGGE
Gene Primer sequence (5’-3’) Annealing 
temp (AT)
(X )
Expected 
amplicon 
size (bp)
Reference
16S rDNA 
fragments
926R(907R)
CCGT CAATT CMTTT GAGTTT 
341F-GC
CGCCCGCCGCGCCCCGCGCCC
GTCCCGCCGCCCCCGCCCGCCT
ACGGGAGGCAGCAG
55 600 Brinkhoff 
et al., 1998 
Muyzer et 
al., 1993
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2.6.4 Fungal PCR
Primers were identified from the literature to enable the amplification of the 18S-25/28S 
rDNA fragments for the detection of medically relevant yeasts (Table 2.6). These 
primers target a sequence which contains an intergenic region that varies in length 
between fungal species. The length of the PCR product provides information about the 
species identity of the yeast.
2.7 PCR-Restriction Fragment Length Polymorphism
Fungal PCR products were digested with Mwo\ (cat no R0573S New England Biolabs) 
at 60 °C for 2 hours.
Reaction: -
1 pi Mwo\ enzyme 
5 pi buffer 3 
10 pi PCR product 
34 pi sterile water 
50 pi total reaction volume
To enable the differentiation of C. tropicalis and C. parapsilosis and C. guillermondii 
and C. membranaefaciens a second digestion of the PCR product was required with 
Bs/I (cat no R0555S New England Biolabs) at 55 °C for 2 hours (Table 2.7).
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Table 2.6: Primers for amplification of fungal 18S-25/28S rDNA fragments for 
species identification
Gene Primer sequence 
(5 -3 ’)
Annealing 
temp (AT) 
(°C)
Expected 
amplicon size 
(bp)
Reference
18S-
25/28S
rDNA
fragments
Primer 1
GTCAAACTTGGTCA 
TTTA 
Primer 3 
TTCTTTTCCTCCGC 
TTATTGA
50 C. albicans 
586
C. dubliniensis 
589 
C. glabrata 
925
Trost et al., 
2004
C. krusei 
560 
C. tropicalis 
576
C. parapsilosis 
570
C. guillermondii 
657 
C.
membranaefacien
s
686
S. cerevisiae 
891
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Table 2.7: Fragment sizes for fungal species identification after restriction 
digestion
Species Fragment sizes after 
Mivol digestion (bp)
Fragment sizes after Bsl\ 
digestion (bp)
C. albicans 261, 184, 141
C. dubliniensis 325, 264
C. glabrata 414, 174, 171, 86, 80
C. krusei 289, 134, 83, 49, 5
C. tropicalis 325, 154, 97 326, 187, 63
C. parapsilosis 336, 146, 88 413, 94, 63
C. guillermondii 355, 302 356, 238, 63
C. membranaefaciens 387, 299 623, 63
S. cerevisiae 343, 207, 173, 168
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2.8 Agarose gel electrophoresis
Agarose gel electrophoresis is used to separate DNA fragments by size using the fact 
that DNA is negatively charged (due to phosphate moieties present in the DNA 
backbone) and migrates towards the positively charged electrode upon application of 
an electric field across the agarose gel (polysaccharide matrix). The agarose provides 
a cross-linked matrix which enables smaller DNA molecules to migrate further through 
the gel at a higher rate compared with larger DNA molecules. PCR products were run 
on agarose gels to enable approximate size quantification.
In order to visualise the products, the gel requires staining and during this project two 
stains were used for various samples; ethidium bromide (cat no E-8751 Sigma) and 
Sybr Green 1 (cat no 86205 Sigma). Both of these stains intercalate with the DNA to 
enable visualisation under UV light. Ethidium bromide was used to stain all gels and 
provides a 25-fold increase in fluorescence when bound to ds-DNA and generally does 
not require de-staining and is added directly to the gel prior to setting. SybrGreen 1 
was used as an ultra sensitive stain compared to ethidium bromide, in order to 
visualise smaller quantities of ds-DNA (as low as 1-2 ng). For all PCR products run 
from environmental samples the gel was initially stained with EtBr followed by staining 
with SybrGreen 1 solution (4 pi SybrGreen 1 in 40 ml TE buffer).
When analysing amplicons (DNA fragments <1 kb), 0.8 % agarose (cat no 15510-019 
Invitrogen) gels were used, when analysing fungal restriction digestion products 2 % 
agarose gels were used. When pouring the agarose gel (50 ml) 2 pi of 10 mg/ml 
ethidium bromide was added. A total of 10 pi of sample and 2 pi of 6x loading dye (cat 
no R0611 Fermentas), were vortexed to mix and centrifuged briefly to collect the full 
volume. A total of 12 pi was loaded onto the gel along with the corresponding DNA 
ladder. When identifying amplicons >500 bp a 1 kb DNA ladder (cat no SM0311
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Fermentas) was used, to identify fungal restriction digestion products and amplicons 
<500 bp a 100bp DNA ladder (cat no N3231L New England BioLabs) was used. DNA 
was visualised using a light box or UVP camera (Epi Chemi 11 darkroom -  UVP).
2.9 Denaturing gradient gel electrophoresis
Denaturing gel electrophoresis (DGGE) is a technique for separating PCR fragments of 
the same size but different sequences. During DGGE the DNA product is subjected to 
increasing concentrations of a chemical denaturant (urea and formamide) as they 
migrate through a polyacrylamide gel, resulting in separation based on their differential 
denaturation (melting) profile defined by the DNA sequence. DGGE is a very sensitive 
technique to the sequence composition and is able to resolve even single nucleotide 
differences. DNA is run through the gel of increasing denaturant concentration driven 
by an electric field, resulting in DNA denaturation.
The PCR primer is designed to include a GC-clamp at the 5' end in order to alter the 
denaturation pattern of the DNA fragments (as detailed in Section 2.6.3 PCR-DGGE). 
The GC clamp regions remain annealed at a particular formamide concentration which 
prevents further migration through the polyacrylamide gel. The PCR was carried out as 
detailed in Section 2.6 Polymerase chain reaction.
To set up the parallel gradient gel sandwich, the manufacturer's instructions were
followed from BIO-RAD the DCode universal mutation detection system (cat no
170/9080-9104), as follows. The glass plates were cleaned thoroughly using soap
(dish washing liquid) and water, followed by 100 % ethanol (cat no M/4450/17 Thermo
Fisher Scientific), then acetone (cat no A/0560/17 Thermo Fisher Scientific). The
edges of the spacers were greased with petroleum jelly and placed on the larger glass
plate; the small glass plate was placed on top. The clamps were attached onto the gel
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sandwich and tightened. The sandwich assembly was placed in the alignment slot of 
the casting stand, and the alignment card placed between the glass plates and the 
plates were aligned (ensuring the glass plates were sat flush). The sponge was placed 
onto the front casting slot and the gel sandwich assembly was attached. Two 30 ml 
syringes were labelled low and high: - 
High density solution (8% polyacrylamide gel)
15 ml 70% denaturant solution (see below)
300 pi 6x loading dye (cat no R0611 Fermentas)
120 pi 10 % (w/v) APS (cat no A3678 Sigma)
12 pi TEMED (cat no T9281 Sigma)
Low density solution (8% polyacrylamide gel)
15 ml 30% denaturant solution (see below)
120 pi 10 % (w/v) APS 
12 pi TEMED
70% denaturing solution
20 ml 40% N,N'-methylene bis-acrylamide (37:1 wt/wt) (cat no 154563 Sigma)
2 ml 50x TAE buffer 
28 ml formamide (cat no F9037 Sigma)
29.4 g urea (cat no U6504 Sigma)
50 ml distilled water
30% denaturing solution
20 ml 40% N.N'-methylene bis-acrylamide (37:1 wt/wt)
2 ml 50x TAE buffer
12 ml formamide
12.6 g urea
66 ml distilled water 
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The solutions were drawn into the syringes and the high density solution filled syringe 
was attached to the bottom filling side of the gradient delivery system and the low 
density solution filled syringe to the top filling side. The cam wheel was rotated slowly 
and steadily to deliver the gel solution. The comb was inserted and the polyacrylamide 
gel left to set (Figure 2.2). Water was run back through the delivery system to remove 
any traces of unpolymerised acrylamide. 7 L of 1x TAE was prepared and heated to 
60 °C using the electrophoresis tank and temperature control module (power turned on). 
To load the gel 10 pi of PCR product and 2 pi of 6x loading dye was used. The power 
was turned off and left for 15 s, then the temperature control module was removed and 
samples loaded. The temperature control module was replaced and power restored, 
when the temperature reached 60 ‘C the gel was run at 20 V for 15 min to run the 
samples into the gel. The gel was run overnight at 60 V for 16 hours (960 min). The 
power was turned off and left for 15 s, then the gel sandwich was removed and the 
polyacrylamide gel was stained with SybrGold for 40 min in the dark then visualised 
using the UVP imager (Epi Chemi 11 darkroom -  UVP). The amplicons were 
visualised during this project using SybrGold, which is a highly sensitive nucleic acid 
stain and provides a >1000 fold increase in fluorescence when bound to ds- or ss-DNA.
2.10 DIG-labelled probe and colony blotting
This method was used to enable easy detection of antibiotic resistance determinants 
from colonies blotted onto hybridisation membranes. Digoxigenin-11-dUTP was 
incorporated into the PCR products for the detection of tetracycline resistance genes 
tet O, W and M using Taq DNA polymerase to create a digoxigenin-labelled 
oligonucleotide probe. All chemicals were purchased from Roche Products Limited 
unless otherwise stated.
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In brief PCR reactions were carried out using the cycles stipulated in Section 2.6.1 and 
were amplified using the following reaction: -
4 pi 30 pmol forward primer 
4 pi 30 pmoi reverse primer 
1 pi Taq DNA polymerase (5 U/pl)
5.2 pi MgCI2 (50 mM)
10 pi PCR buffer (x10)
10 pi PCR DIGmix (2 mM dNTP, 1.3 mM dTTP, 0.7 mM digdUTP)
53.8 pi sterile water
The reaction was mixed and aliquoted into 4 x 22 pi and 3 pi DNA template (>6 ng/pl) 
was added.
Solutions were prepared fresh on the day of use and included (details provided by 
Roche Products Limited): -
Denaturation solution (0.5 M NaOH, 1.5 M NaCI, 0.1% SDS)
Neutralisation solution (1.0 M Tris-HCI, 1.5 M NaCI)
20x SSC stock solution (3 M NaCI, 0.3 M sodium citrate)
Washing buffer x1 
Blocking solution 
Detection buffer 
Antibody solution 
BCIP/NBT colorimetric detection tablets
The nylon membrane was placed over the whole contact plate (avoiding any air 
bubbles) and left for 1 min. Filter paper was soaked in denaturation, neutralisation and
2x SSC solutions. The filter paper soaked in denaturation solution was placed on the
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membrane and incubated at RT for 15 min. The same was carried out using the 
neutralisation then the 2x SSC soaked filter papers (for 15 min and 10 min 
respectively). The membrane was placed on a UV transilluminator for 1 min in order to 
cross-link the DNA. To digest any potential interfering proteins the membranes were 
incubated at 37 °C for 1 hour with 2 mg/ml Proteinase K.
To prepare the hyb-probe solution, the dig-easy hyb solution was incubated at 42 °C for 
1 hour and the probe denatured at 100 °C for 5 min. The hyb-probe was added to the 
pre-warmed dig-easy hyb solution and poured over the membrane and re-incubated at 
42 °C for 2 hours. The dig-probe solution was poured off and stored at -20 °C for up to 
1 year. The membrane was washed twice with 2x SSC and 0.1 % SDS for 5 min at RT, 
followed by two washes with 0.5x SSC and 0.1 % SDS for 15 min at 68 °C. In order for 
colorimetric detection, the membrane was equilibrated in washing buffer for 1 min, then 
blocked with blocking buffer for 1 hour at RT with gentle agitation. The antibody 
solution (anti-digoxigenin-AP Fab fragments) was added and incubated for 30 min at 
RT. Membranes were washed twice with washing buffer for 15 min, followed by the 
detection buffer for 2 min. The BCIP/NBT colour substrate solution was added and the 
samples were placed in the dark overnight and the reaction stopped by washing the 
membrane in water. Positive reactions were initially seen by purple colouration after 
approximately 30-60 min.
2.11 PCR purification
PCR purification was used to purify ds-DNA products via a spin column method similar 
to that used for DNA extraction for sequencing. Buffer PBI enables efficient binding of 
ds- and ss- PCR products (>100 bp) onto the silica spin column. PBI also acts as a pH 
indicator to ensure the maintenance of an optimum pH <7.5 for DNA binding. 
Impurities and unwanted primers in the PCR reaction do not bind to the column during
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DNA adsorption and salts are removed by the addition of buffer PE containing ethanol. 
Elution buffer EB (10 mM Tris-Cal pH8.5) was used to elute the DNA from the column 
at optimum salt concentration and pH conditions and to enable storage at -20 °C with 
minimal DNA degradation.
PCR products were purified following the manufacturers instructions from QIAquick 
spin handbook (cat no 28104 Qiagen Ltd), QIAquick PCR purification kit protocol, as 
follows; 5 volumes of PBI buffer was added to 1 volume of PCR sample and mixed. 
The sample was applied to the column and centrifuged at 13000 rpm for 1 min, and the 
flow-through discarded, 0.75 ml of buffer PE was added to the column and re­
centrifuged at 13000 rpm for 1 min, and the flow-through discarded. The column was 
placed in a sterile 1.5 ml eppendorf and 30 pi of elution buffer was added, and the 
column incubated at RT for 1 min, and re-centrifuged at 13000 rpm for 1 min. The 
purified PCR products were stored at -20 °C.
2.12 DNA sequencing
PCR products were purified following the methods laid out in Section 2.11 PCR 
purification. 20 pi of the PCR products (>5 ng/pl) were sent to Euro Fins Genetic 
Services Ltd for DNA sequencing.
After DNA sequencing of purified DNA from isolated bacteria, organisms were 
identified from GenBank database searches. Retrieved sequences from PCR-DGGE 
were sequenced and GenBank database searches used to generate percentage 
identity/similarity to bacterial sequences. Chromatograms were studied to check 
sample purity and unresolved residues.
For manufacturer details please refer to Appendix 3
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3. Method optimisation
3.1 Background and aims
The aim of the work described in this chapter was to create a robust sampling regime 
and down-stream sample processing for molecular and cultural analysis of 
environmental samples. Before sampling began in the hospital environment, the 
sampling methodology was developed by using samples from the environment of the 
research laboratory and by sampling pieces of flooring material, some of which were 
deliberately contaminated with microbial cultures.
The objectives were to: -
•  identify a variety of solid media to enable the isolation of a wide range of 
bacteria and fungi from environmental swab samples
• establish a DNA extraction method for the isolation of Gram-negative and
Gram-positive bacterial DNA from environmental sites
•  identify a method to detect and characterise fungi of clinical significance
• optimise the use of DGGE to identify bacterial diversity and enable the
resolution and retrieval of bacterial sequences
• optimise PCR conditions for the detection of eubacterial DNA and antibiotic 
resistance determinants {mecA, blaCjx-M, shv , tem  and tetO, M, W genes)
3.2 Culturing on solid media
Culturing techniques were used to enable the isolation of most clinically relevant and
commensal bacteria and fungi. The solid media selected was blood, CLED and NA for
culturing bacteria and potato dextrose agar for fungi. Blood agar was used to select for
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fastidious organisms and show haemolytic activity (i.e. Staphylococcus species). 
CLED was used to select for urinary tract bacteria (e.g. E. coli). NA was used to 
enable the growth of most bacteria and some fungal species. PDG agar was used to 
enable the growth of fungi.
3.3 Bacterial identification
3.3.1 DNA extraction directly from swab samples
Initially the swab DNA extraction method was followed directly from the Qiagen 
QIAamp DNA extraction kit. After carrying out the extraction from a dry swab of S. 
aureus SH1000 and a separate PBS soaked swab from a molecular laboratory bench, 
eubacterial DNA was amplified from the S. aureus SH1000 sample but no product was 
amplified from the laboratory bench sample (data not shown). This was perhaps due to 
the low yield of the extraction as the DNA concentration in environmental sites could 
have been very low or the swab was too dry to pick up sufficient prokaryotic cells.
In order to improve the removal of cells from the surfaces sampled and to promote their 
adhesion to the swab, it was decided to investigate pre-wetting of the swab by adding 
sterile neutralising solution (see Section 2.2 hospital sampling regime) to the swab 
holder to wet the swab before use, as described by Lee et at. (2007). Extraction of 
DNA from an unused swab dipped in neutralising solution confirmed neither were 
sources of prokaryotic contamination (Figure 3.1).
To test the sensitivity of the DNA extraction method a small piece (10.5 cm x 8 cm) of 
plastic cushioned flooring was spiked with 100 pi and 500 pi of S. aureus SH1000 
overnight broth cultures (approximately 107 cells). Positive amplification of 16S rRNA
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1 2  3 4
Size marker (bp)
2000
1500
1000
750
500
250
Figure 3.1 Evaluation of the swab wetting method for contamination from the
neutralising solution
Lane 1 marker, lane 2 positive control, lane 3 no DNA template control, lane 4 blank
swab extraction
(Using the eubacterial 16S rRNA gene specific primers detailed in the materials and
methods)
1500bp 
-16S rRNA 
gene
62
gene was seen from both samples (Figure 3.2). This demonstrated that the method 
was sufficient to detect pure cultures from a floor piece.
In order to perform a more relevant test, a piece of used ICU flooring was obtained 
during replacement of the ICU floor at the RHH. After swabbing, DNA extraction and 
PCR (directly from the floor piece with no bacterial spiking), no DNA or 16S rRNA gene 
product could be visualised, indicating the levels of bacteria were extremely low or 
absent. This was confirmed as only ten colonies were cultured from 100 pi of swab 
solution on NA incubated aerobically at 37 °C overnight
According to a modification proposed by Lee et al. (2007), recovery of bacterial DNA 
can be improved by incubation of the swab at 37 °C for 30 min with a lysozyme 
reaction mixture to improve extraction of bacterial DNA by digesting the bacterial cell 
wall
To test this method, an area of the molecular biology laboratory floor was swabbed and 
DNA was purified by using the altered version of the kit extraction method described by 
Lee et al. (2007) (Section 2.5.1 in Materials and Methods). Subsequent PCR and gel 
analysis showed a visible 16S rRNA gene product (Figure 3.3). The kit was sensitive 
enough to detect prokaryotic cells from relevant environmental sites such as linoleum- 
covered floors. A Gram-specific PCR reaction was used to determine whether both 
Gram-positive and Gram-negative DNA could be extracted using this method (Figure 
3.4). However, when the first ICU sampling began some sites yielded high colony 
numbers of Staphylococci species on blood agar, but no visible product following 16S 
rRNA gene amplification. To rectify this, lysostaphin was also added to the lysozyme 
reaction mix to ensure the extraction of S. aureus DNA from the swab samples.
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1 2 3 4 5
Size marker (bp)
2000  ^
1500 ------ ►
1000  ►
750 ►
500
250 ------ ►
Figure 3.2 Amplification of 16S rRNA genes from a floor piece inoculated with S.
aureus
Lane 1 marker, lane 2 positive control, lane 3 no DNA template control, lane 4 100 pi S. 
aureus culture, lane 5 500 pi S. aureus culture 
(Using the eubacterial 16S rRNA gene specific primers detailed in the materials and
methods)
1500bp 
— <--------- 16S rRNA
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Size marker (bp)
2000
1500
1000
750
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Figure 3.3 PCR detection of bacterial 16S rRNA genes from molecular biology
laboratory floor samples
Lane 1 marker, lane 2 positive control, lane 3 no DNA template control, lane 4 
molecular laboratory floor swab sample 
(Using the eubacterial 16S rRNA gene specific primers detailed in the materials and
methods)
1500bp 
16S rRNA 
gene
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1 2  3 4 5 6 7
Gram specific 16S 
rRNA gene fragment 
350bp
(a) (b)
Figure 3.4 (a) Amplification of Gram-positive specific DNA
Lane 1 marker, lane 2 S. aureus SH1000 Gram-positive control, lane 3 no DNA 
template control, lane 4 positive Gram +ve PCR product from template DNA purified
from environmental tap swab samples 
Figure 3.4 (b) Amplification of Gram-negative specific DNA 
Lane 5 no DNA template control, lane 6 E. coliXL1 Gram-negative control, lane 7 no 
DNA template control, lane 8 positive Gram -ve PCR product from template DNA 
purified from environmental tap swab samples
Size marker (bp)
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3.3.2 Selection of staining technique
With most of the methods requiring agarose gel electrophoresis, a staining technique 
was required to enable the visualisation of faint PCR products. Ethidium bromide had 
been used widely for many years to visualise DNA on agarose gels. However, recently 
new stains have been identified which are more sensitive. As it was possible there 
could be extremely low DNA yields from the ICU environment, a stain was required to 
enable the visualisation of DNA and PCR products at low concentrations. Ethidium 
bromide enabled visualisation down to 0.6 ng of plasmid DNA (Figure 3.5); however 
SybrGreen enabled visualisation down to 0.07 ng (Figure 3.6). Throughout this study a 
sequential staining with ethidium bromide and then SybrGreen was established for the 
study,
3.3.3 Use of PCR for the detection of prokaryotic cells
The 16S rRNA gene sequence can be used to detect and identify bacteria to the 
species level (Woese et al., 1983; Bodrossy et al., 1999), and it was decided to use 
16S rRNA gene primers 16S1 and 16S2 (Bodrossy et al., 1999) to amplify the whole 
1500bp gene fragment which is specific to prokaryotic cells and is highly conserved.
Eubacterial 16S rRNA gene PCR was optimised using pure cultures followed by 
environmental samples to show a single sized amplicon that could be used to identify 
the presence of prokaryotic cells in a given sample. Positive amplification was 
achieved for S. aureus SH1000, E. coli XL1 and an environmental DNA sample (from 
sink slime in the trap in the waste pipe) at the expected size of 1500 bp (Figure 3.7).
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1 2 3 4 5 6 7 8 9 10 11 12
Size marker (bp) 
10000
1000
Figure 3.5 Visualisation of plasmid DNA using ethidium bromide staining
Lane 1 marker, lane 2 4.6 ng DNA, lane 3 2.3 ng DNA, lane 4 1.15 ng DNA, lane 5 
0.575 ng DNA, lane 6 0.288 ng DNA, lane 7 0.144 ng DNA, lane 8 0.07 ng DNA, lane 9 
0.04 ng DNA, lane 10 0.02 ng DNA, lane 11 0.01 ng DNA, lane 12 0.005 ng DNA
Size marker (bp)
10000
1000
Figure 3.6 Visualisation of plasmid DNA using SybrGreen staining
Lane 1 marker, lane 2 4.6 ng DNA, lane 3 2.3 ng DNA, lane 4 1.15 ng DNA, lane 5 
0.575 ng DNA, lane 6 0.288 ng DNA, lane 7 0.144 ng DNA, lane 8 0.07 ng DNA, lane 9 
0.04 ng DNA, lane 10 0.02 ng DNA, lane 11 0.01 ng DNA, lane 12 0.005 ng DNA
1 2 3 4 5 6 7 8 9 10 11 12
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Size marker (bp) 16S rRNA
1500------ ►  . --------- gene
1000------ ► -  " 1500bp
750
500____
250
Figure 3.7 Validation of 16S rRNA gene PCR
Lane 1 marker, lane 2 S. aureus SH1000, lane 3 E. coliXL1, lane 4 purified DNA from 
environmental sample (plughole slime in the trap on the waste pipe), lane 5 no DNA
template control
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Amplification of 16S rRNA genes only indicates the presence of eubacterial DNA 
(prokaryotic cells), therefore DGGE technology was also used to resolve specific GC- 
clamped nt 341-926 16S rDNA fragments based on the sequence rather than size.
3.3.4 Optimisation of PCR-DGGE
Universal DGGE primers 341F-GC and 901R (Muyzer et a l 1993; Brinkhoff et a/.,
1998) were used to amplify the 341-901 region of 16S rRNA genes, which is conserved 
in size (600 bp) among prokaryotic cells but varies in sequence. The PCR cycle was 
optimised using pure cultures of a coagulase-negative Staphylococcus (CNS) and K. 
oxytoca (from ICU clinical strains) and a mix of the two. After PCR the products were 
run on a 0.8 % agarose gel to observe the expected 600 bp amplicon (Figure 3.8). 
Products were then run on 8 % acrylamide 30-70 % denaturant gels at 60 V for 16 h. 
Products from mixed template PCR resolved/migrated separately on the gel (Figure 
3.9).
3.4 Fungal identification
With the incidence of fungal nosocomial infections rising, it was necessary to detect 
environmental fungal isolates by culture followed by further analysis to identify 
medically relevant yeasts.
3.4.1 Detection offungai organisms
All fungal species possess internal transcribed spacer regions (ITS) 1 and 2 between 
the DNA sequences encoding the mature forms of the 18S and 25-28S subunits o?
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1 2  3 4
Size marker (bp)
1000 — ►
750----- ►
500 ------ ►
250----- ►
Figure 3.8 Optimisation of DGGE PCR
Lane 1 marker, lane 2 purified clinical CNS DNA, lane 3 purified clinical K. oxytoca
DNA, lane 4 no DNA template control
1 2  3 4
< Clinical CNS
< Clinical K. pneumoniae
Figure 3.9 Representative DGGE gel
Lane 1 marker, Lane 2 purified clinical CNS DNA, lane 3 purified clinical K. 
pneumoniae DNA, lane 4 mix purified clinical CNS and K. pneumoniae DNA
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rDNA. Primers were used from Trost et al. (2004) to amplify this region and the 5.8S 
rDNA of the most common human fungal pathogens (Trost et al., 2004). The PCR 
products resulted in altered sizes for different Candida species. The PCR was 
optimised using RHH ICU clinical fungal strains of C. glabrata, C. guillermondii, C. 
parapsilosis, C. tropicalis and S. cerevisiae (data not shown). The optimum annealing 
temperature was 50 °C (Figure 3.10). This PCR was used to identify medically 
relevant yeasts from environmental isolates, however further analysis was required to 
identify to species level.
3.4.2 Identification of fungai species
To identify the species of medically relevant yeasts detected, Trost et al. (2004) 
established a restriction digest using Mwo\, which involved each yeast amplicon 
possessing at least one cleavage site (Trost ef al., 2004). Using C. glabrata and C. 
parapsilosis the digests were run using the method by Trost et al., 2004 (Figure 3.11).
It was confirmed using known Candida species that the digest could be used to identify 
the species of several medically relevant yeasts and a further digest with Bsl\ enabled 
the differentiation of C. parapsilosis and C. tropicalis.
3.5 Antibiotic resistance determinants
3.5.1 mecA gene detection
PCR for the meek gene was optimised using a clinical strain of MRSA. Primers mecA1 
and mecA2 (Geha ef al., 1994) were used to amplify the 533 bp conserved region of 
the meek gene. PCR cycles were performed at 55, 60 and 65 °C annealing
1 2 3 4 5 6 7
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Figure 3.10 Identification of medically relevant yeasts by PCR
Lane 1 marker, lane 2 no DNA template control, lane 3 C. parapsilosis, lane 4 C, 
glabrata, lane 5 C. guillermondii, lane 6 S. cerevisiae, lane 7 C. tropicalis 
(Using 18S-25/28S rDNA fragment specific primers detailed in materials and methods. 
All templates were purified DNA from clinical fungal isolates)
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Figure 3.11 Mwo1 restriction digestion
Lane 1-2 markers, lane 3 1 U Mwo'\ enzyme, lane 4 1/5 dilution, lane 5 1/10
dilution, lane 6 1/100 dilution 
(PCR products from the amplification of 18S-25/28S rDNA fragments were 
digested with Mwo\. The enzyme was diluted and lanes 3-4 were C. 
parapsilosis and lanes 5-6 were C. glabrata)
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temperatures. Products were generated at 533 bp for 60 °C annealing temperature, 
but not for 55 and 65 °C (Figure 3.12). The optimum annealing temperature was 60 °C.
3.5.2 blaCTx-M gene detection
b la c T x -M - s p e c i f ic  PCR was optimised using E. coli strains which possessed blactx -m  
genes fof CTX-M (-2, 14, 15, 26). CTX-M-F and CTX-M-R primers (Weill et al., 2004) 
were used to amplify the 540 bp conserved fragment of the blactx -m  gene. The PCR 
cycle was run at:
[10min 94°C] x1 [30s 94°C, 30s 55°C, 1min 72°C] x35 [10min 72°C] x1 
This yielded a band of approximately 540 bp which was the expected size (Figure 3.13).
3.5.3 blaSHv gene detection
b/asHv-specific PCR was optimised using E. coli which possessed the SHV-2 ESBL 
gene. SHV-F and SHV-R primers (Naiemi et al., 2005) were used to amplify the 
827 bp fragment of the b/aSHv gene. The PCR cycle was run at 50, 55 and 60 °C 
annealing temperature and positive amplification was seen at 827 bp for 50 and 55 °C 
cycle (Figure 3.14). The optimum annealing temperature for blashv genes was 55 °C.
3.5.4 blaTEM gene detection
b/aTEM-specific PCR was optimised using the plasmid pTJS140 (Smith et al., 2002) 
known to possess a TEM beta-lactamase gene. TEM-F and TEM-R primers (Naiemi 
et al., 2005) were used to amplify the highly conserved 862 bp fragment of the blajEM 
gene. The PCR cycle was run at 50 and 55 °C annealing temperatures and positive
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Figure 3.12 Optimisation of mecA gene PCR
Lane 1 marker, lane 2 no DNA template control, lanes 3-5 PCR products from template 
DNA purified from an RHH ICU clinical MRSA strain at 55°C, 60°C and 65°C AT 
(Using mecA gene specific primers detailed in the materials and methods)
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500
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Figure 3.13 blactx -m  gene detection
Lane 1 marker, lane 2 PCR product from template DNA purified from cultured E. coli 
clinical isolate, Lane 3 no DNA template control, lane 4 PCR product from template 
DNA purified from E. coli CTX-M-2, lane 5 PCR product from template DNA purified 
from E. coli CTX-M-14, Lane 6 PCR product from template DNA purified from E. coli
CTX-M-15
(Using blactx -m  gene specific primers detailed in the materials and methods)
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Figure 3.14 blash v  gene detection
Lane 1 marker, lane 2 no DNA template control, lanes 3-4 PCR products from template 
DNA purified from E. coli SHV-2 at 50°C AT, lane 5 negative control, lanes 6-7 PCR 
products from template DNA from E. coli SHV-2 at 55°C AT 
(Using blash v  gene specific primers detailed in materials and methods)
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amplification was seen at 862bp for the 50 °C cycle (Figure 3.15). The optimum 
annealing temperature for blaTEM genes was 50 °C.
An environmental DNA sample obtained by swabbing slime from the trap of the waste 
pipe (from the molecular biology laboratory) was used as template for bla gene-specific 
PCR. No products were visualised except a faint positive result for b/ajEM- The 
environmental DNA sample was spiked with 1, 0.1 and 0.01 ng of plasmid pTJS140 
DNA to check whether low concentrations of DNA template could be amplified from a 
mixed background. From this PCR 0.01 ng of DNA template could be detected from 
spiked samples by PCR (Figure 3.16).
3.5.5 Detection of tet genes
A Bacillus subtilis strain known to possess the tet{M) gene and E  coli strains known to 
possess the tet{O) and fef(W) genes were provided by Dr P Mullany. The PCR 
annealing temperatures were tested at 45, 50, 52, 55 and 60 °C. The optimum AT was 
determined as 52 °C for fef(M)/te/(0) and 60 °C for fef(W) (data not shown).
3.6 Detection levels of ESBL-producing organisms
Since it was possible that no environmental sites would yield ESBL-producing 
organisms it was required to know the detection rates of the methods used. In order 
for bacteria to survive in the environment they have evolved complex starvation 
survival patterns to enable persistence (Clements et al., 1999). E. coli SHV-2 and E. 
coli CTX-M-2 were cultured in reduced nutrient broth (1/10 dilution) to create long-term 
starved cells. Microscopy enabled cell enumeration and dilutions were carried out to 
provide 25 pi aliquots containing 1, 10, 100 and 1000 cells. The ICU floor piece was
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Figure 3.15 b/aTEm gene detection
Lane 1 marker, lane 2 no DNA template control, lane 3-4 PCR products from template 
DNA purified from E. coli clinical isolate at 50°C and 55°C AT 
(Using blaTEM gene specific primers detailed in materials and methods)
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Figure 3.16 Threshold of detection of blaTEM gene in environmental samples
Lane 1 marker, lane 2 PCR product from template DNA purified from environmental 
plughole sample, lane 3-5 PCR products from template DNA from environmental 
plughole sample spiked with 1, 0.1 and 0.01 ng blaTEM positive DNA, lane 6 negative
control
(Using blaTEM gene-specifc primers detailed in materials and methods)
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cleaned with bactericidal wipes and domestic washing liquid to simulate ward cleaning. 
Aliquots of cells were spread onto the floor piece, allowed to dry and the area was 
swabbed. DNA was extracted directly from the swab samples and used as the 
template for blactx -m  and blashv gene specific PCRs (as described in Chapter 2).
After PCR, amplicons of blactx -m  and blash v  genes were recovered from approximately 
1x103 SHV and CTX-M-producing cells. No amplicons were obtained when less than 
1000 cells were added (Figure 3.17). If efficiency of DNA recovery and PCR 
amplification of beta-lactamase genes from the hospital environment are similar to 
those observed from this laboratory study, this result would mean that if no ESBL or 
native (3-lactamase genes were detected from a particular environmental site, then 
there were possibly 1x103 ESBL-producing cells present and therefore would not cause 
a significant clinical infection threat.
3.7 Results summary
After extensive method optimisation a robust sampling regime was established, which 
included sample areas, a swabbing technique, DNA extraction, detection of 
eubacterial-specific genes, detection of medically relevant yeasts, bacterial and fungal 
species identification and the detection of antibiotic resistance determinants.
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Figure 3.17 Detection levels of b/aCTx-M andSHv producing organisms
Lane 1 marker, lane 2 E. coli SHV-2 positive control, lane 3 no DNA template control, 
lane 4-7 PCR products from purified template DNA representing 1000, 100, 10 and 1 
individual SHV-producing cells, lane 8 E. coli CTX-M positive control, lane 9 no DNA 
template control, lane 10-13 PCR products from purified template DNA representing 
1000,100,10 and 1 individual CTX-M producing cells 
(Using b/aSHv and blact x -m  gene specific primers detailed in the materials and methods)
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4. Distribution of bacteria in the /CU and HDU environment
4.1 Background and aims
The aim of this chapter was to determine the distribution of bacteria in the ICU and 
HDU environment. In order to determine the presence of and identify bacteria in the 
environment a molecular approach was used. PCR was used to detect bacterial 16S 
rRNA genes in the environment and PCR-DGGE enabled bacterial species 
identification on the basis of 16S rRNA gene fragment mobility. Parallel isolation of 
culturable bacteria was also performed.
The objectives were to: *
•  detect bacteria in the ICU and HDU environment from swab samples by PCR 
using eubacterial 16S rRNA gene-specific primers (as detailed in materials and 
methods)
• isolate bacteria from the ICU and HDU environment by cultivation from swab, 
dipslide and contact plate samples
•  determine environmental sites where bacteria could most frequently be 
detected
• identify species present and diversity using PCR-DGGE (as detailed in 
materials and methods)
• compare bacterial species from environmental sites with those isolated from 
clinical samples
4.2 Overview of materials and methods
The ICU and HDU departments were sampled over 12 sessions from the RHH
(12/05/08 -  15/12/08) and the NGH (11/03/08 -  09/12/08). In total 252 environmental
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swab samples were taken from both the RHH and NGH (Table 2.2a/b). At the RHH, 15 
environmental sites were sampled and 13 environmental sites at the NGH. After 
sampling, DNA was extracted from each swab sample and the remaining swab solution 
was plated out onto various solid media (NA, blood and CLED) for the isolation of 
culturable bacteria. Contact plates were used to sample and culture bacteria from two 
textured surfaces at the RHH (HDU patient chair and ICU curtain) and two similar 
surfaces at the NGH (ICU patient chair and ICU curtain) (Table 2.3a/b). Dipslides were 
used to sample and culture bacteria from four small hard surfaces at the RHH and six 
at the NGH (Table 2.4a/b) (full details of the sampling regime are provided in Section
2.2 Materials and Methods).
4.3 Results 
SCU and HDU at the Royal Hallamshire Hospital
4.3.1 Detection of prokaryotic celis from RHH environment
in total, eubacterial DNA was detected in 42.1% (106/252) of swab samples (Table 4.1 
and representative gels are shown in Figure 4.1 a/b).
Bacteria were isolated from swab, contact plate and dipslide samples (Table 4.1, 4.2 
and 4.3). In total bacteria were isolated from 43.7% (110/252) of swab samples (Table 
4.1), 100% (36/36) of contact plate samples (Table 4.2) and 60.4% (29/48) of dipslide 
samples (Table 4.3).
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Table 4.1 Proportion of ICU and HDU swab samples positive for eubacterial 16S 
rRNA genes and culturable bacteria per sample session at RHH1
Sample session Proportion of 
swabs positive for 
eubacterial 16S 
rRNA gene
<%)(n = 252)*
Proportion of 
swabs that 
yielded culturable 
bacteria
(%)(n = 252)'
1 (12/05/08) 61.9 76.2
2 (02/06/08) 9.5 38.1
3 (30/06/08) 4.8 28.6
4 (14/07/08) 19.0 33.3
5 (15/09/08) 47.6 28.6
6 (29/09/08) 57.1 61.9
7(13/10/08) 66.7 61.9
8(03/11/08) 19.0 47.6
9(17/11/08) 71.4 33.3
10(01/12/08) 47.6 38.1
11 (08/12/08) 38.1 14.3
12(15/12/08) 61.9 61.9
Average (%) 42.1 43.7
1 The data was obtained from molecular and cultural studies from ICU and HDU 
environmental swab samples 
* n = 21 per sampie session
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Figure 4.1 Amplification of eubacterial DNA from RHH environmental swab 
samples
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Size marker (bp)
2000—
1500—
1000 —
750 —
500—
250—
(a)
Lane 1 marker, lane 2 E. coliXL1 positive control, lane 3 no DNA template control, 
ianes 4-5, 7-13, 15 PCR products from template DNA purified from environmental swab 
samples (sites -  ICU floor, ICU bedside, ICU window ledge from 01/12/08 session 10, 
sites -  ICU trolley, ICU ward sink plughole, ICU computer keyboard, ICU ward sink tap 
from 13/10/08 session 7, site -  ICU picture from 12/05/08 session 1 and site -  ICU fan
from 13/10/08 session 7 respectively)
(Using the eubacterial 16S rRNA gene-specific primers detailed in the materials and
methods)
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Size marker (bp)
2000  ►
1500------ ►
1000 ►
750------►
500 *
250------►
fb)Lane 1 marker, lane 2 E. coliXL1 positive control, lane 3 no DNA template control,
lanes 8-9, 12-14 PCR products from template DNA purified from environmental swab
samples (sites -  ICU ward sink plughole, ICU computer keyboard, ICU ward sink tap,
ICU picture from 12/05/08 session 1 and site - fan from 29/09/08 session 6 respectively)
(Using the eubacterial 16S rRNA gene-specific primers detailed in the materials and
methods)
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Table 4.2 Number of bacterial colonies cultured from RHH ICU and HDU contact plate samples
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Eubacterial DNA was most frequently detected in swab samples from the ICU ward 
sink plughole (70.8% of samples), HDU patient chair (52.1%) and ICU floor (50%) 
(Figure 4.2). Bacteria were most frequently isolated from HDU patient chair contact 
plate samples (Table 4.2) and ICU/HDU handwash bottle dipslides (Table 4.3).
Eubacterial DNA was much less frequently detected in swab samples from the sluice 
room sink plughole, hard surfaces (ICU bedside, ICU computer keyboard, ICU fan, 
HDU computer keyboard, HDU computer stand, ICU ward sink taps, ICU trolley and 
ICU window ledge) and pictures (ICU and HDU) (Figure 4.2). Bacteria were detected 
with only very low frequency from ICU curtain contact plates compared to HDU patient 
contact plates (Table 4.2). The majority of dipslide samples from the ICU door handle 
(58.3%) and ICU light switch (83.3%) did not yield culturable bacteria (Table 4.3).
All (36) contact plate samples (HDU patient chair and ICU curtain) and ICU handwash 
bottle dipslide samples yielded at least one bacterial colony (Table 4.2 and 4.3). The 
total number of bacterial colonies from the sites of most frequent isolation, varied 
between sample sessions; HDU patient chair contact plates yielded 1 to 152 colonies 
(Table 4.2), ICU handwash bottle dipslides yielded 1 to 48 colonies and HDU 
handwash bottle dipslides yielded 0 to 46 colonies (Table 4.3). Interestingly the 
majority (75%) of ICU handwash bottle dipslides yielded <10 colonies, however on 
sessions 6 (29/09/08) and 7 (13/10/08) the number of colonies increased more than 
fourfold (41 and 48 colonies respectively) (Table 4.3).
Bacterial sequences of the nt 341-926 16S rRNA gene fragment were retrieved from 
environmental swab samples of the RHH ICU ward sink plughole, ICU floor and HDU 
paitent chair by PCR-DGGE, excised and sequenced. Each sequence was obtained 
from a single representative band (Table 4.4a/b/c and representative gel shown in 
Figure 4.3) where the number of samples with persistant sequence refers to the
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Figure 4.2 Proportion of swab samples positive for eubacterial 16S rRNA genes 
from RHH ICU and HDU environmental sites 
(number) = total number of swab samples taken 
1 The data were obtained from PCR of 16S rRNA gene in DNA from ICU and HDU
environmental swab samples 
z Hard surfaces -  ICU bedside, ICU computer keyboard, ICU fan, HDU computer 
keyboard, HDU computer stand, ICU ward sink taps, ICU trolley and ICU window ledge
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Table 4.4 Retrieval of sequences from RHH environmental swab samples (ICU 
ward sink plughole, ICU floor and HDU patient chair) generated after PCR-DGGE 
from representative DGGE bands: -
(a) ICU ward sink plughole
Sequences 
similar to
Number of 
samples with 
persistant 
sequence
Percentage 
identity (%)
Number of 
aligned 
residues 
(max 600)
Accession
number
Luteibacter spp. 9 99 432" AM930508
Soil bacterium 9 97 432 DQ490030
Lactobacillus
salivarius
9 99 411' GU357500
Ralstonia
metallidurans
9 98 384 CP000352
Burkholderia
cepacia
8 99 405’ NR029209
Burkholderia
cenocepacia
8 97 414’ FJ947055
Pseudomonas
aeruginosa
8 86 294” DQ864493
Cupriavidus
metallidurans
5 97 390’ CP000353
Cupriavidus
gilardii
3 96 432” EF114428
Ralstonia spp. 3 96 450’ GQ417782
FR2_C116 
Ralstonia spp.
3 84
84
420”
366”
EU888560
FJ774001
Clearly defined DNA sequence
”  Sequence interrupted due to unassigned residues
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(b) ICU floor
Sequences 
similar to
Number of 
samples with 
persistant 
sequence
Percentage 
identity (%)
Number of 
aligned 
residues 
(max 600)
Accession
number
Staphylococcus
epidermidis
4 50 168" EF558734
Ralstonia spp. 3 100 477* GQ417854
nbw555e03cl 1 99 417" GQ107864
Trochodendron 99 327" DQ629469
aralioides
nbw402g08cl 
Ralstonia spp.
1 70
68
420
273*
GQ098212
EU440055
Burkholderia 1 96 393’ AF097530
cepacia
Leifsonia spp. 1 99 476* FJ872398
Clearly defined DNA sequence
"  Sequence interrupted due to unassigned residues
(c) HDU patient chair
Sequences 
similar to
Number of 
samples with 
persistant 
sequence
Percentage 
identity (%)
Number of 
aligned 
residues 
(max 600)
Accession
number
Leifsonia spp. 6 89 330" FJ872398
Variovorax spp. 3 98 414 GQ332345
Burkholderia
cepacia
2 100 474 NR029209
TSPBJ37 2 39 255" FJ213492
Gamma
proteobacterium
43 126” EF111071
Clearly defined DNA sequence
"  Sequence interrupted due to unassigned residues
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Figure 4.3 DGGE gel showing bacterial diversity and community from RHH ICU
ward sink plughole swab samples
Lanes 1-13 PCR products from template DNA purified from RHH environmental ICU 
ward sink plughole swab samples (from 12/05/08 session 1 to 17/11/08 session 9) 
(Using nt 341-926 16S rDNA fragment-specific primers detailed in the materials and
methods)
94
DGGE bands that have migrated the same distance from multiple swab samples. A 
number of samples had clearly defined chromatograms resulting in a high percentage 
identity against other sequences in the GenBank database. However, after sequencing 
several samples did not contain enough clear sequence of the 16S rRNA gene that 
could be unambiguously assigned to enable a clear identification of the organism, 
resulting in lower percentage identity values against sequences in the GenBank 
database. A number of chromatograms showed mixed samples or conceivably 
bleeding from neighbouring lanes after loading of sequencing gel,
Bacterial diversity was greatest in ICU ward sink plughole swab samples compared to 
the ICU floor and HDU patient chair swab samples (Table 4.4a/b/c). From ICU ward 
sink plughole swab samples 11 different DGGE bands were retrieved. From ICU floor 
and HDU patient chair swab samples six and four different DGGE bands were retrieved 
respectively.
The number of representative DGGE bands indicates the presence of the same or 
similar organism from the same site on different sample sessions. The ICU ward sink 
plughole swab samples contained the highest number of similar DGGE bands from 
multiple samples compared to ICU floor and HDU patient chair swab samples (Table 
4.4a/b/c). From nine ICU ward sink plughole swab samples, four similar DGGE bands 
were retrieved and from seven ICU ward sink plughole swab samples three similar 
DGGE bands were retrieved. From six HDU patients chair swab samples, one similar 
DGGE band was retrieved and from four ICU floor swab samples, 1 DGGE band was 
retrieved.
The explanation of types of bacteria present is speculative because precise
identification was not possible from all sequencing data. In some cases as indicated in
Table 4.4a/b/c the fact that sequences can not be identified precisely may be due at
least in part to inaccuracies and ambiguity in the sequences. In the majority of cases
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however, analysis of the sequencing gel chromatograms showed that the sequence is 
accurate and there are closely matching sequences in the GenBank database. Despite 
a number of low percentage identities all retrieved sequences had e values ranging 
from 0.0 to 9e-12. This suggests that although the organism identification could not 
always be precise the sequence must be closely related and not a completely different 
organism. The PCR-DGGE results presented do provide complementary information 
from other techniques of organisms present in the ICU environment.
Sequences most frequently retrieved were similar to common environmental or 
commensal organisms; Luteibacter spp., Lactobacillus salivarius and Ralstonia 
metallidurans from ICU ward sink plughole swab samples (Table 4.4a). 
Staphylococcus epidermidis and Ralstonia spp. from ICU floor swab samples (Table 
4.4b) and Leifsonia spp. from HDU patient chair swab samples (Table 4.4c). 
Sequences with relatively high similarity to the opportunistic pathogen P. aeruginosa 
were frequently retrieved from ICU ward sink plughole swab samples.
Sequences that were less frequently retrieved include those with high similarity to 
opportunistic organisms, for example members of the genus Burkholderia (B. cepacia 
and B. cenocepacia). However, representative Burkholdena spp. sequences were 
retrieved from each of the three environmental sites (ICU ward sink plughole, ICU floor 
and HDU patient chair) suggesting a wide environmental distribution of Burkholderia 
spp.
Occassionally sequences were retrieved with relative similarity to organisms
associated with human skin and blood (according to the annotation of the GenBank
database entry); nbw555e03cl (Trochodendron aralioides) and nbw402g08cl (Ralstonia
spp.) from ICU floor swab samples and TSPB_37 (Gamma proteobacterium) from HDU
patient chair swab samples. Sequences were also retrieved similar to environmental
organisms; Cupriavidus gilardii, Ralstonia spp., Cupriavidus metallidurans and
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FR2_C116 (Ralstonia spp.) from ICU ward sink plughole swab samples and Leifsonia 
spp., and Ralstonia spp. from ICU floor swab samples.
From environmental HDU patient chair and ICU curtain contact plate samples, isolated 
organisms were identified by PCR of the eubacterial 16S rRNA gene from purified DNA 
(Table 4.5). After representative colony picks, S. epidermidis and Micrococcus spp. 
were identified from ICU curtain and HDU patient chair.
Only one organism, S. epidermidis was detected using both molecular and cultural 
methods. S. epidermidis was isolated from ICU curtain and HDU patient chair contact 
plate samples and sequences were retrieved from ICU floor swab samples that had low 
percentage identity to S. epidermidis.
4.3.2 RHH ICU bacterial clinical isolates
All clinical samples were routinely taken by medical staff and culturable 
microorganisms identified by routine laboratory analysis. A total of 24 bacterial species 
were identified from clinical samples during the period that environmental sampling was 
taking place (12/05/08-15/12/08) (Table 4.6). Multiple samples were taken from 
patients, resulting in more positive cultures and isolates than the number of infected or 
colonised patients. The most commonly isolated organisms were CNS, E. coli and S. 
aureus. From 403 clinical isolates 55% were Gram-negative pathogens.
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Table 4.5 Identification of bacterial species from RHH contact plates (HDU patient 
chair and ICU curtain) after representative colony picks, from DNA sequences 
generated after PCR of the eubacterial 16S rRNA gene1
Sample site Organism
identified
Percentage 
identity (%)
Number of 
aligned 
residues 
(max 1500)
Accession
number
Curtain (ICU) Micrococcus 99 820 EU196531
luteus
Staphylococcus
epidermidis 99 1433 FN393820
HDU patient Micrococcus 99 1035 FJ357605
chair spp.
Staphylococcus
epidermidis 98 819 DQ870761
1 The data were obtained from cultured organisms from ICU and HDU contact plate 
samples after molecular sequencing
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Table 4.6 Diversity of RHH bacterial clinical isolates and frequency of infected 
patients
Organism Number of clinical 
isolates
Number of 
infected/colonised 
patients
Coagulase-negative 85 73
Staphylococci (CNS)
Escherichia coli 53 46
Staphylococcus aureus 51 43
Pseudomonas aeruginosa 37 27
Klebsiella pneumonia 31 24
Enterococcus spp. 30 24
Klebsiella oxytoca 18 17
Enterobacter cloacae 16 16
Proteus mirabilis 15 11
MRSA 14 8
Stenotrophomonas 13 10
maltophilia
Pseudomonas spp. 12 12
Enterobacter aerogenes 5 4
Serratia spp. 4 4
Acinetobacter baumanii 3 3
Citrobacter freundii 3 3
Serratia liquefaciens 3 2
Citrobacter koseri 2
Enterobacter agglomerans 2 2
Proteus vulgaris 2 2
Enterococcus faecium “T ~ 1
Morganella morganii 1 1
Pantoea agglomerans T ~
Providencia rettgeri 1 1
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ICU and HDU at the Northern General Hospital
4.3.3 Detection of prokaryotic cells from NGH environment
Similar to the RHH, 40.1% (101/252) of swab samples were positive for eubacterial 
16S rRNA genes (Table 4.7 and representative gels are shown in Figure 4.4a/b).
Bacteria were isolated from 37.7% (95/252) of swab samples (Table 4.7). All (36) 
contact plate samples (ICU curtain and ICU patient chair) yielded culturable bacteria 
(Table 4.8), similar to the RHH, and bacteria were isolated from 38.9% (28/72) of 
dipslide samples (Table 4.9).
Similarly to the RHH data, eubacterial 16S rRNA genes were most frequently detected 
in swab samples from the ICU ward sink plughole (62.5%), sluice room sink plughole 
(58.3%) and ICU floor (52.1%) (Figure 4.5). Again, similar to the RHH, bacteria were 
most frequently isolated from ICU patient chair contact plates (Table 4.8) and ICU 
handwash bottle dipslides (Table 4.9),
The number of sample sessions when bacteria were isolated from ICU handwash 
bottle dipslides was much lower at the NGH than RHH. Handwash bottles were 
sampled an equal number of times (12) at both sites, however no bacteria could be 
isolated from 66.7% (8/12) of sample sessions at the NGH (Table 4.9),
Eubacterial DNA was infrequently detected from hard surfaces (ICU computer 
keyboard, HDU computer keyboard and ICU window ledge) and switches (ICU door 
handle, HDU door handle and ICU machine handles). In contrast to the RHH, 
eubacterial DNA was least frequently detected from ICU patient chair swab samples 
(Figure 4.5).
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Table 4.7 Proportion of ICU and HDU swab samples positive for eubacterial 16S 
rRNA genes and culturable bacteria per NGH sample session1
Sample session Proportion of 
swabs positive for 
eubacterial 16S 
rRNA gene
(%)(n = 252)'
Proportion of 
swabs that 
yielded culturable 
bacteria
(%)
(n = 252)’
1 (11/03/08) 23.8 33.3
2 (08/04/08) 42.9 38.1
3 (15/05/08) 81.0 61.9
4 (03/06/08) 14.3 28.6
5 (01/07/08) 23.8 33.3
6 (15/07/080 42.9 33.3
7 (16/09/08) 19.0 19.0
8 (30/09/08) 47.6 38.1
9(14/10/08) 38.1 38.1
10(04/11/08) 42.9 47.6
~ T i (18/11/08) 38.1 28.6
12 (09/12/08) 66.7 52.4
Average (%) 40.1 37.7
1 The data were obtained from molecular and cultural studies from ICU and HDU 
environmental swab samples 
* n = 21 per sample session
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Figure 4.4 Amplification of eubacterial DNA from NGH environmental swab 
samples
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Size marker (bp)
2000 _ 
1500- 
1000 -  
750- 
500" 
250“
(a)
Lane 1 marker, lane 2 E. coli XL1 positive control, lane 3 no DNA template control, 
lanes 4, 5, 9, 12 PCR products from template DNA purified from environmental swab 
samples (sites -  ICU machine handle x2, ICU computer keyboard, and ICU floor-ward
respectively from 15/05/08 session 3)
(Using the eubacterial 16S rRNA gene-specific primers detailed in the materials and
methods)
1500bp 
16S rRNA 
gene
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Size marker (bp)
2000
1500
1000
750
5 0 0 -
2 5 0 '
1500bp 
16S rRNA 
gene
(b)
Lane 1 marker, lane 2 E. coli XL1 positive control, lane 3 no DNA template control, 
lanes 5-6, 8, 11 PCR products from template DNA purified from environmental swab 
samples (sites - HDU floor, HDU computer keyboard, ICU floor, ICU ward sink plughole
respectively from 08/04/08 session 2)
(Using the eubacterial 16S rRNA gene-specific primers detailed in the materials and
methods)
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Table 4.8 Number of bacterial colonies cultured from NGH ICU contact plate samples
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Figure 4.5 Proportion of swab samples positive for eubacterial 16S rRNA genes 
from NGH ICU and HDU environmental sites1
(number) = total number of swabs taken
1 The data were obtained from PCR of eubacterial 16S rRNA gene in DNA from ICU
and HDU environmental swab samples
2 Hard surfaces -  ICU computer keyboard, HDU computer keyboard and ICU window
ledge
5 Switches -  ICU door handle, HDU door handle and ICU machine handles
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Similar to the RHH data, bacteria were least frequently isolated from ICU curtain 
contact plates compared to ICU patient chair contact plates (Table 4.8) and 75% of ICU 
light switch dipslides yielded no culturable bacteria (Table 4.9). In addition, the majority 
of other dipslide samples from the ICU blind switch (66.7%), ICU inner window switch 
(83.3%) and intercom button (75%) also yielded no culturable bacteria (Table 4.9).
Bacterial sequences were retrieved using the same technique as the RHH from 
environmental swab samples of the NGH ICU ward sink plughole, ICU floor and ICU 
patient chair (Table 4.10a/b/c and representative gel shown in Figure 4.6). Similar to 
the RHH, precise identification of bacteria was not always possible from the 
sequencing data however, the results do provide information about the microbial 
ecology and diversity in sites harbouring bacteria,
ICU ward sink plughole swab samples had the greatest bacterial diversity (17 different 
DGGE bands were retrieved) and ICU patient chair swab samples had the lowest 
(three different DGGE bands were retrieved). However in contrast to the RHH, the 
NGH ICU floor swab samples had a greater bacterial diversity (10 different DGGE 
bands were retrieved) (Table 4.10a/b/c).
The number of similar DGGE bands present in multiple ICU ward sink plughole swab 
samples was higher at the NGH compared to the RHH. From ten, eight and seven ICU 
ward sink plughole swab samples two, one and four similar DGGE bands were 
retrieved respectively (Table 4.10a). From eight and five ICU floor swab samples one 
and two similar DGGE bands were retrieved respectively (Table 4.10b).
Similar to the RHH, the most prevalent DGGE bands had sequence similarity to
environmental or commensal organisms. Sequences retrieved from ICU ward sink
plughole swab samples were similar to Pseudomonas putida, Aquabacterium spp.,
Variovorax spp. and nbw533b03cl (Beta-proteobacterium) (associated with human skin
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Table 4.10 Retrieval of sequences from NGH environmental swab samples (ICU 
ward sink plughole, ICU floor and ICU patient chair) generated after PCR-DGGE 
from representative DGGE bands: -
(a) ICU ward sink plughole
Sequences similar 
to
Number of 
samples with 
persistant 
sequence
Percentage 
identity (%)
Number of 
aligned 
residues 
(max 600)
Accession
number
Serratia marcescens 10 38 201" FJ919562
nbw533b03cl
Beta-
proteobacterium
10 80
80
225"
222"
GQ106160
AB252912
Pseudomonas
putida
8 87 312" DQ313383
Burkholderia
cepacia
7 98 453' GQ359110
Peptostreptococcus
spp.
7 95 495’ GU401462
Aquabacterium spp. 7 98 417' AF523022
Klebsiella spp. 7 50 303" EU360123
Variovorax spp. 6 97 399* EU593268
Enterobacter spp. 5 45 252" CP000653
Stenotrophomonas
maltophilia
4 100 511* GU391033
Alcaligenes spp. 4 94 408’ AB046605
Pseudomonas spp. 4 99 324* GU198110
Delftia spp. 4 99 384' GQ205102
T529_a01f06 
Coriobacterium spp.
3 79
79
396"
369”
FJ367280 
AJ131150
Beta-
proteobacterium
2 99 462’ AB252902
Burkholderia
pyrrocinia
2 99 450* NR029210
Soil bacterium 2 65 378" EU515500
* Clearly defined DNA sequence
"  Sequence interrupted due to unassigned residues
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(b) ICU floor
Sequences similar 
to
Number of 
samples with 
persistant 
sequence
Percentage 
identity (%)
Number of 
aligned 
residues 
(max 600)
Accession
number
Variovorax 8 100 468* GQ332345
paradoxus
Proteus mirabilis 5 94 282* AM942759
Staphylococcus
epidermidis
5 50 180** AJ581947
Delftia spp. 4 99 444* AB451538
Burkholderia spp. 4 98 450* GQ465226
nbw1222e02cl 3 59 297** GQ059064
Cupriavidus
metallidurans
58 234** FJ644635
Stenotrophomonas
maltophilia
3 82 330’* FJ393299
Burkholderia 2 95 420* GQ383907
cepacia
nbw775b04cl 1 79 426* GQ009331
Wautersiella falsenii 79 429’ FM162560
nbt171c11 1 61 369** EU535130
Empedobacter spp. 61 156” EU276091
* Clearly defined DNA sequence
”  Sequence interrupted due to unassigned residues
(c) ICU patient chair
Sequences similar 
to
Number of 
samples with 
persistant 
sequence
Percentage 
identity (%)
Number of 
aligned 
residues 
(max 600)
Accession
number
Delftia spp. ~ 3 ~ 98 465* GQ329375
Stenotrophomonas
maltophilia
2 98 480* EF114176
Delftia spp. 2 100 485* AB451538
Clearly defined DNA sequence
”  Sequence interrupted due to unassigned residues
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1 2 3 4 5 6 7 8 9 10 11 12 13
Figure 4.6 DGGE gel showing bacterial diversity and community from NGH ICU
ward sink plughole swab samples
Lanes 1-13 PCR products from template DNA purified from NGH environmental ICU 
ward sink plughole swab samples (from 15/07/08 session 6 to 09/12/08 session 12) 
(Using nt 341-926 16S rDNA fragment-specific primers detailed in the materials and
methods)
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and blood) (Table 4.10a) and from ICU floor swab samples were similar to Variovorax 
paradoxus and S. epidermidis (Table 4.10b).
Sequences retrieved from ICU ward sink plughole swab samples had the highest 
similarity to opportunistic species; Serratia marcescens, Peptostreplococcus spp., 
Klebsiella spp. and Burkholderia cepacia (Table 4.10a) and from ICU floor swab 
samples sequences were relativley similar to Proteus mirabilis (Table 4.10b).
It is interesting that, as in the ICU at the RHH, swab samples from the ward sink 
plughole and floor in the ICU at the NGH contained sequences similar to Burkholderia 
spp. (B. cepacia and B. cenocepacia). In addition, at the NGH sequences similar to 
Stenotrophomonas maltophilia and Delftia spp. were also retrieved from all 
environmental sites (ICU ward sink plughole, ICU floor and ICU patient chair), 
suggesting a wide distribution of these sequences in the NGH ICU environment
Sequences retrieved infrequently were similar to environmental organisms; 
Bacteroidetes, beta-proteobacterium, Burkholderia pyrrocinia, T529_a01f06 
(Coriobactenum spp.), Alcaligenes spp, Pseudomonas spp., soil bacterium and 
Enterobacter spp. retrieved from ICU ward sink plughole swab samples (Table 4.10a)* 
Sequences retrieved relatively similar to nbw775b04cl (Wautersiella falsenii), 
nbt171c11 (Empedobacter spp.) and nbw1222e02cl (Cupriavidus metallidurans) (from 
samples associated with human blood and skin as detailed in the annotation on 
GenBank database) from ICU floor swab samples (Table 4.10b),
Micrococcus spp. were also identified after representative colony picks from NGH ICU 
curtain and ICU patient chair contact plate samples, similar to the RHH (Table 4.11). 
However, none of the representative DGGE bands that were sequenced yielded 
sequences similar to Micrococcus spp,
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Table 4.11 Identification of bacterial species from NGH ICU contact plates (ICU 
patient chair and ICU curtain) after representative colony picks, from DNA 
sequences generated after PCR of the eubacterial 16S rRNA gene1
Sample site Organism Percentage Number of Accession
identified identity (%) aligned 
residues 
(max 1500)
number
Curtain (ICU) Micrococcus 99 1463 FJ999947
luteus
Patient chair Bacillus spp. 98 888 EU58537
(ICU) Micrococcus 99 828 AM990824
spp.
1 The data were obtained from cultured organisms from ICU and HDU contact plate 
samples after molecular sequencing
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4.3.4 NGH ICU bacterial clinical isolates
A total of 22 bacterial species were identified from clinical samples during the period of 
environmental sampling (11/03/08 -  09/12/08) (Table 4.12). The most common 
organisms isolated were the same as the RHH (CNS, E. coli and S. aureus). However, 
in comparison from 360 clinical isolates 47.8% were Gram-negative pathogens.
4.4 Discussion
HAIs are a continual cause for concern due to high mortality rates and costs to the 
NHS (Edbrooke et al., 1999; Dean ef a/., 2002; Wilcox, 2003; HPA, 2008). 
Extensive research has previously relied upon analysis of clinical isolates to reveal 
cross-transmission events (Naiemi et al., 2005; Mammina et al., 2007; Manzur et al.f 
2007; Khan et al., 2009) and cultural studies to identify environmental sites harbouring 
organisms during infection outbreaks (Bures et al., 2000; Devine et al., 2001; Drees 
et al., 2008). This chapter has investigated the bacterial ecology of the ICU 
environment during a non-outbreak situation, using a combination of cultural and 
molecular ecology techniques. To the authors knowledge this is the first example of 
PCR-DGGE being used in the hospital environment.
In this present study, a number of environmental sites yielded bacteria. Areas of 
highest bacterial detection were: ICU handwash bottles, ICU ward sink plugholes, ICU 
floors, HDU patient chairs and sluice room sink plugholes. The same sites had the 
highest bacterial detection at both the RHH and NGH, indicating that these sites 
commonly yield bacteria in hospitals. It is widely acknowledged that plugholes and 
sinks have been associated with outbreak situations (Bures et al., 2000; Naas et al., 
2002; Hota ef al., 2009) (as detailed in Chapter 8).
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Table 4.12 Diversity of NGH clinical bacterial isolates and frequency of infected 
patients
Organism Number of clinical 
isolates
Number of 
infected/colonised 
patients
Coagulase-negative 108 57
Staphylococci (CNS)
Escherichia coli 48 33
Staphylococcus aureus 36 21
Enterococcus spp. 29 23
Pseudomonas aeruginosa 27 13
Enterobacter cloacae 16 11
Klebsiella pneumoniae 15 7
Enterobacter aerogenes 11 6
Stenotrophomonas 10 5
maltophilia
MRSA 9 8
Proteus mirabilis 9 7
Acinetobacter baumanii 6 2
Klebsiella oxytoca 6 4
Citrobacter freundii 4 4
Citrobacter koseri 4 2
Proteus spp. 4 2
Serratia spp. 4 “1 “
Klebsiella spp. 3 3
Micrococcus spp. 3 2
Peptostreptococcus spp. 3 2
Serratia liquefaciens 3 2
Serratia marcescens 2 2
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It is extensively reported that Gram-positive organisms (e.g. CNS) are present in the 
environment particularly due to hand contact and skin shedding (Andersson et al., 
1999; Kampfer et a!., 1999; Tsai and Macher, 2005; Lee et al., 2007; Rintala et ah, 
2008). In the present study, S. epidermidis and Micrococcus spp. were frequently 
isolated. However, PCR-DGGE yielded sequences that could be classified as Gram- 
negative more frequently than those which were clearly Gram-positive.
During this present study a limitation was the inability to precisely identify bacterial 
species from all DNA sequencing after PCR-DGGE. This was due to unclear 
sequences and not mis-alignment against bacterial sequences in the GenBank 
database.
There are also general limitations to PCR-DGGE and primer bias has been well 
documented (Muyzer ef al., 1993; Muyzer and Smalla, 1998; Ishii and Fukui, 2001),
There are different types of primer bias, especially from multi-template PCRs: -
• The PCR products to bacterial cells ratio in multi-template PCRs often differ due 
to the different copy numbers of rDNA in organisms (Farrelly et al., 1995; 
Fogel etah, 1999; Klappenbach etah, 2000)
•  Difference in primer binding energies (Polz et al., 1998)
• Frequent cycling of template re-annealing (Suzuki et al., 1996)
• High GC rich sequences may not be amplified due to low efficiency of template 
dissociation (Reysenbach etal., 1992; Muyzer and Smalla, 1998)
Other limitations to PCR-DGGE are the formation of multiple bands from single 
genomes after gene amplification (Brosius ef ah, 1981; Nubel ef ah, 1996; Ercolinl, 
2004), co-migration of DNA in the same DGGE band from different species (Sekiguchi 
etah, 2001; Speksnijder etah, 2001; Gafan and Spratt, 2005) and reproducable and
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efficient DNA extraction from environmental samples (Muyzer and Smalla, 1998; 
Niemi ef al., 2001).
Recent research by Araujo and Schneider (2008) showed the ability of PCR-DGGE for 
the identification of important community members from a three member consortium (E  
coli, B. cepacia and S. maltophilia) but could not identify the most dominant organisms. 
It was concluded that PCR-DGGE from template genomic DNA was not appropriate for 
identifying dominant organisms (and was only marginally improved using template 16S 
rDNA) but was extremely useful for demonstrating bacterial diversity. Inefficiencies in 
the PCR reaction are most likely to effect the identification of dominant organisms.
Despite these limitations, PCR-DGGE using genomic DNA as template was necessary 
to provide knowledge of the bacterial diversity and ecology where samples yielded no 
culturable bacteria. Using universal PCR-DGGE primers (Muyzer ef al., 1993; 
Brinkhoff ef al., 1998) enabled a wide variety of bacterial sequences to be retrieved 
from samples,
During this present study, results from PCR-DGGE identified hospital sinks and floors 
to have a high bacterial diversity. Particular bacterial communities were shown to 
persist in hospital sinks and floors over a prolonged period of time. An explanation for 
this observation could be the presence of biofilms which are commonly associated with 
sinks (Davies ef al., 1998; Costerton ef al., 1999; Conway ef al., 2002). Alternatively, 
it could be due to the effect of routine ICU ward cleaning on the bacterial species 
present in the hospital sinks and on the floor (as detailed in Chapter 7).
The results from PCR-DGGE indicate the potential presence of opportunistic and
environmental spp. Several opportunistic spp. (Enterobacter spp., Klebsiella spp.,
Peptostreptococcus spp., Pseudomonas aeruginosa, Serratia marcescens and
Stenotrophomonas maltophilia) which are causative agents of infections, have been
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isolated from clinical samples during this study. This implies that ICU environmental 
sites can harbour organisms that cause disease, however further investigation would 
be required to isolate these organisms using selective media to identify any potential 
transmission routes and confirm sequences from the environment
Burkholderia spp. are common environmental organisms which frequently persist in 
biofilms (Conway et al., 2002). While their association with sinks has been 
established in previous work (O’Toole et al., 2000; Conway ef al., 2002; Yoshida et 
al., 2009) their association with hard surfaces has not previously been reported in the 
literature.
There was also a widespread distribution of S. maltophilia in the NGH ICU environment. 
S. maltophilia has recently been described as a new ‘superbug’ (Batty, 2008) and is a 
common cause of nosocomial pneumonia and bacteraemia (Denton et al., 1998; 
Micozzi ef al., 2000; Hanes ef al., 2002) thus detection of S. maltophilia is of 
potentially great clinical significance. S. maltophilia was isolated from clinical samples 
throughout this study (at both the RHH and NGH).
Identification of Burkholderia spp. and S. maltophilia in all environmental sites implies 
the possibility of transmission. Recent research has established the spread of P. 
aeruginosa from hospital sinks onto nearby medical equipment and hospital staff hands 
(Brooke, 2008; Hota ef al., 2009). Burkholdena spp. and S. maltophilia may have 
been transferred from the ICU ward sink onto patient chairs and floors during this 
present study. However, further work would be necessary to determine if the same 
organism is present in these sites which would require isolation of these organisms and 
clonal studies (e.g. using PFGE).
Throughout this study samples were taken to establish the microbial ecology of the ICU
and HDU environments and care was taken not to influence the normal operation of the
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wards. In an effort to remove any potential ‘Hawthorne effect’, whereby staff may alter 
their cleaning pattern, samples were taken at different times of the day.
After a review of the data across the 12 sample sessions it was revealed that the 
detection of eubacterial DNA varied at both the RHH and NGH ICU/HDU between 
sample sessions. In order to determine whether this routine ICU ward cleaning regime 
Could account for these differences, a study was designed to compare the detection of 
eubacterial DNA on occasions before and after routine ICU ward cleaning (detailed in 
Chapter 7).
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5. Detection of antibiotic resistance determinants in the iCU
and HDU environment
5.1 Background and aims
The aim of this chapter was to characterise environmental reservoirs of antibiotic 
resistance determinants in the ICU and HDU. Initially MRSA and ESBL-producing 
organisms were chosen as the focus of this study, because these two resistance 
determinants represent two of the major molecular mechanisms of resistance in 
organisms causing HAIs. Although of less clinical significance, tetracycline resistance 
genes were included in this study to act as markers of antibiotic resistance, as they are 
commonly detected in the environment
The objectives were to: -
•  detect antibiotic resistance determinants in the ICU and HDU environment by 
PCR using gene-specific primers for meek, blaCjx i^, s h v , t e m  and tet O, M, W  
genes (as detailed in materials and methods)
• characterise native and ESBL genes from ICU and HDU environmental swab 
samples and clinical isolates
•  identify bacterial species carrying target genes
• identify the sites of antibiotic resistance determinant detection
• relate the distribution of MRSA and ESBL infected patients and rate of MRSA 
isolation from clinical samples
118
5.2 Overview of materials and methods
The RHH and NGH ICU/HDU departments were sampled over 12 sessions (RHH 
12/05/08 -  15/12/08 and NGH 11/03/08 -  09/12/08). Only samples which were 
positive for eubacterial DNA by PCR were tested for antibiotic resistance determinants 
(RHH = 106 swab samples, NGH = 101 swab samples) (full details of the sampling 
regimes are provided in Section 2.2 Materials and Methods, swab samples were 
screened by molecular methods and dipslide samples by cultural methods).
5.3 Results
iCU and HDU at the Royal Hallamshire Hospital 
5.3.1 Detection of mecA and bla genes in the RHH environment
No b/actx-m or biashv genes were detected in DNA from environmental swab samples 
from the RHH wards (a selection of these negative results are shown in Figure 5.1 and 
5.2).
However, blaTEM genes were identified from 11.3% (12/106) of swab samples screened. 
The sites of detection included the ICU floor, ICU ward sink plughole, HDU ward sink 
plughole, HDU patient chair and ICU ward sink taps, which had previously shown the 
highest detection of eubacterial 16S rRNA genes. b/aTe m  genes were also detected on 
hard surfaces of low bacterial detection (ICU bedside, ICU computer keyboard and ICU 
window ledge) (Figure 5.3a/b/c).
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1 2 3 4 56  7 8 9 1011 12 13
Size marker (bp)
1000-------► 540bp
750 ► .4--------- b/acTx-M
500 ► gene
250------ ►
Figure 5.1 b/aCTx-Mgene detection from RHH environmental swab samples
Lane 1 marker, lane 2 E. coli CTX-M positive control, lane 3 no DNA template control, 
lanes 4-13 PCRs from template DNA purified from swab samples (sites -  ICU floor, 
ICU trolley, ICU ward sink plughole, ICU floor, ICU computer keyboard, ICU ward sink 
taps, ICU fan and HDU poster respectively)
(Using blact x -m  gene-specific primers as detailed in the materials and methods)
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1 2 3 4 5 6  7 8 9 1011 12 13
Size marker (bp)
1500___ ^
1000 *
750----- >  f
500 *
250-----
827bp
■4-------------blasm
gene
Figure 5.2 b/aSHvgene detection from RHH environmental swab samples
Lane 1 marker, lane 2 E. coli SHV-2 positive control, lane 3 no DNA template contra), 
lanes 4-13 PCRs from template DNA purified from swab samples (sites -  ICU 
computer keyboard, ICU ward sink taps, sluice room sink plughole, HDU ward sink 
plughole, HDU poster, HDU computer stand and HDU patient chair x2 respectively) 
(Using blash v  gene-specific primers as detailed in the materials and methods)
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Figure 5.3 Amplification of blaTEM from RHH environmental swab samples
1 2 3 4 5 6
Size marker (bp)
1500------ ►
1000------- ►
750------ ►
500 f
250------ ►
mm
862bp
b id  JEMgene
(a)
Lane 1 marker, lane 2 E. coli TEM positive control, lane 3 no DNA template control, 
lanes 4-6 PCR products from template DNA purified from swab samples (sites -  ICU 
bedside, ICU ward sink plughole and ICU computer keyboard respectively) 
(Using blaTEM gene-specific primers detailed in the materials and methods)
1 2 3 4 5 6 7
Size marker (bp)
1500
1000
750
500
250
J
-mm
862bp
bid TEM
gene
(b)
Lane 1 marker, lane 2 E. coli TEM positive control, lane 3 no DNA template control, 
lanes 4-7 PCR products from template DNA purified from swab samples (sites -  ICU 
ward sink taps, HDU ward sink plughole and HDU chair respectively)
(Using bldjEM gene-specific primers as detailed in the materials and methods)
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1 2 3 4 5 6 7
Size marker (bp)
1500-------► mm 862bp
1000 ------► I t / f  ? a: i? j$ -4--------- bldjEM
750  ► ™  T gene
500  ► ^
250 ------►
(c)
Lane 1 marker, lane 2 E. coli TEM positive control, lane 3 no DNA template control, 
lanes 4-7 PCR products from template DNA purified from swab samples (sites -  ICU 
floor, ICU bedside, ICU window ledge and ICU computer keyboard respectively) 
(Using blaTEM gene-specific primers as detailed in the materials and methods)
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interestingly, b/aTEM genes were detected on five consecutive sampling sessions 
(13/10/08 - 08/12/08) although from different sites. However, b/aTEM genes were only 
detected from one site (ICU ward sink taps) on consecutive sampling sessions (Table 
5.1).
DNA sequencing was used to characterise native and ESBL TEM genes amplified 
directly from environmental samples. All positive amplicons were identified as native 
TEM beta-lactamases and not ESBLs (Table 5.1).
No organisms carrying blaTm genes could be identified from bacterial isolates from 
blajm  positive swab samples.
One of 106 DNA samples (from the ICU ward sink plughole) was positive for meek 
(0.94%) (Figure 5.4). No meek gene-carrying organisms could be identified from 
bacterial isolates from the ICU ward sink plughole swab sample.
A meek positive coagulase-negative Staphylococcus was cultured (confirmed by Gram 
stain, coagulase test and culturing on MRSA selective media) from the ICU handwash 
bottle (previously identified as a site of high bacterial isolation) using dipslides (Figure 
5.5).
To confirm the amplified products were meek, they were sequenced. Both amplicons 
were confirmed to be altered PBP, PBP2a (meek gene) commonly associated with 
MRSA (Table 5.1). Interestingly, MRSA infected patients were present on the ward 
during the sampling sessions positive for meek gene detection (02/06/08 and 13/10/08) 
(Table 5.1).
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1 2 3 4 5
Size marker (bp)
750 — 
500 _
250 —
m.
533bp
m meek
gene
Figure 5.4 Amplification of mecA gene from swab sample of ICU ward sink
plughole RHH
Lane 1 marker, lane 2 no DNA template control, lane 3 MRSA positive control, lane 4 
no DNA template control, lane 5 PCR product from template DNA purified from swab
sample of ICU ward sink plughole 
(Using meek gene-specific primers as detailed in the materials and methods)
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1 2  3 4
Size marker (bp)
533bp
mecA
gene
300------- ► -:& l&
200 ---------► m
Figure 5.5 Amplification of mecA gene from cultured bacterium of ICU handwash
bottle dipslide sample RHH
Lane 1 marker, lane 2 MRSA positive control, lane 3 no DNA template control, lane 4 
PCR product from template DNA purified from cultured bacterium of ICU handwash
bottle dipslide sample 
(Using mecA gene-specific primers as detailed in the materials and methods)
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5.3.2 Rate of MRSA and ESBL isolation from clinical samples at RHH
From 181 Gram-positive clinical isolates cultured from routine patient samples on the 
ICU by the clinical microbiology staff, only 14 MRSA isolates were identified. Only 
eight individual patients had an MRSA infection, totalling 40 patient days. MRSA 
infected patients were present on the ward during sampling sessions 2-3 (02/06/08 -  
30/06/08), 6-7 (29/09/08-13/10/08), 10 (01/12/08) and 12 (15/12/08) (Table 5.1).
Routinely, Gram-negative clinical isolates are screened for ESBLs phenotypically at the 
RHH (Derbyshire et al., 2009); during this study, there were 222 Gram-negative 
clinical isolates. Using gene-specific PCR, blactx-m genes were detected from two 
ESBL-producing clinical isolates (E. coli and K. pneumoniae) (Figure 5.6) from two 
separate patients. These patients were not on the ward on the date of sampling.
Following the detection of native b/aTe m  genes in the RHH environment, all (20) 
Klebsiella spp. and E. coli clinical isolates were screened for the presence of native 
blaTEM genes. Native h/ara/i genes were identified from eight clinical isolates (Figure 
5.7a/b). These organisms were isolated during sampling sessions 1-4 (12/05/08 -  
14/07/08), 7 (13/10/08) and 10 (01/12/08) (Table 5.1).
5.3.3 Tet gene detection in the RHH environment
PCR was used to amplify tet(O, M and W) genes directly from environmental swab 
samples. From the first four sample sessions (12/05/08 -  14/07/08), only tet O was 
detected on one occasion from the sluice room sink plughole swab sample by PCR 
(Figure 5.8). No tet M or W genes were detected from any environmental swab 
samples by PCR (a few of these negative results are shown in Figure 5.9 and 5.10).
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1 2 3 4 5
540bp
bla CTX-M
gene
Figure 5.6 Detection of CTX-M ESBL from two RHH clinical isolates
Lane 1 marker, lane 2 E. coli CTX-M positive control, lane 3 no DNA template control, 
lane 4 PCR product from template DNA purified from cultured Escherichia coli clinical 
isolate, lane 5 positive PCR product from template DNA purified from cultured 
Klebsiella pneumoniae clinical isolate 
(Using blactx-m gene-specific primers as detailed in materials and methods}
Size marker (bp)
1000 ►
750------ *
500------ *
250------►
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Figure 5.7 blaJEM gene detection from RHH clinical isolates
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Size marker (bp)
1500___ ^  862bp
1000 ► » «m Ml • +----------blaTem
750  ►  ^ I | gene
500 ►
250------►
(a)
Lane 1 marker, lane 2 E. coli TEM positive control, lane 3 no DNA template control, 
lanes 4, 6-9, 12 PCR products from template DNA purified from cultured Klebsielia spp.
and E. coli clinical isolates 
(Using blaTEM gene-specific primers as detailed in the materials and methods)
1 2 3 4 5 6  7 8 9  10 11
Size marker (bp)
1500----------------------------------------------------------------------- 862bp
1000 ► j  “  bla tem
(b)
Lane 1 marker, lane 2 E. coli TEM positive control, lane 3 no DNA template control, 
lanes 6, 8 PCR products from template DNA purified from cultured Klebsiella spp. and
E. coli clinical isolates 
(Using blaTEM gene-specific primers as detailed in the materials and methods)
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Size marker (bp)
500___ ► 171 bp 
tet( O)250------►100 gene
Figure 5.8 tet{O) gene detection from RHH environmental swab samples
Lane 1-2 markers, lane 3 E. coli tet O positive control, lane 4 no DNA template control, 
lanes 5-9 PCRs from template DNA purified from swab samples (sites -  ICU floor, ICU 
computer keyboard, ICU ward sink tap and ICU picture respectively), lane 10 PCR 
product from template DNA purified from swab sample of sluice room sink plughole 
(Using tetO gene-specific primers as detailed in the materials and methods)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
100
Size marker (bp)
300___ ^  W 171 bp
200------► * --------- tet{ M)
gene
Figure 5.9 fef(M) gene detection from RHH environmental swab samples
Lane 1 marker, lane 2 Bacillus subtilis tet M positive control, lane 3 no DNA template 
control, lanes 4-15 PCRs products from colony picks from environmental dipslide and 
contact plate samples (HDU handwash bottle x2, ICU handwash bottle x4, ICU door 
handle, HDU patient chair x2, ICU curtain x3 and HDU curtain respectively) 
(Using tetM gene-specific primers as detailed in the materials and methods)
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1 2 3 4 5 6 7
Size marker (bp) I 168bp tetON) 
gene
Figure 5.10 tet{\N) gene detection from RHH environmental swab samples
Lane 1 marker, lane 2 E. coli tet\N  positive control, lane 3 no DNA template control, 
lanes 4-7 PCRs from template DNA purified from swab samples (sites -  ICU ward sink 
plughole, HDU patient chair, ICU ward sink plughole x2 and ICU floor respectively) 
(Using teA/V gene-specific primers as detailed in the materials and methods)
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Due to the low detection of tet genes by PCR, a cultural method was introduced during 
the last eight sessions (15/09/08 -  15/12/08), during which period 49 tetracycline 
resistant colonies were cultured from swab samples. Tetracyline resistant colonies 
were cultured most frequently from the ICU ward sink plughole, ICU floor and ICU 
bedside trolley (Table 5.1). tet(M) was identified from three tetracycline resistant 
colonies, tet[O) from two and fef(W) from two. There were 42 tetracycline resistant 
colonies that did not possess any of the tet genes tested for, and so were presumed to 
carry other tet resistance determinants (Table 5.1).
ICU and HDU at the Northern General Hospital
5.3.4 Detection of mecA and bla genes in the NGH environment
Similar to the RHH, no blactx-m or blashv genes were detected in DNA from 
environmental swab samples, however, no meek genes were identified from either 
swab or dipslide samples (a small number of these negative results are shown in 
Figure 5.11, 5.12, 5.13).
A similar proportion of swab samples yielded b/ajEM genes (10.9%). The sites of 
detection were similar to the RHH; the ICU floor-ward, ICU ward sink plughole, sluice 
room sink plughole and ICU patient chair. Other sites were hard surfaces of low 
bacterial detection; the ICU computer keyboard, ICU machine handle, ICU door handie 
and ICU window ledge (Figure 5.14a/b).
In contrast to the RHH, bIaTEM genes were detected on two non-consecutive sessions 
(15/07/08 and 04/11/08). Interestingly, on session 10 (04/11/08) b/aTEm genes were 
detected in swab samples from five different sites; the ICU floor, two from the sluice
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1 2 3 4 5 6 7 8 9 10 11 12
Size marker (bp)
1000 ► *750-------*  533bp
500------------9  l  mecA
250-------► gene
Figure 5.11 mecA gene detection from NGH environmental swab samples
Lane 1 marker, lane 2 MRSA positive control, lane 3 no DNA template control, lanes 4- 
12 PCRs from template DNA purified from swab samples (sites -  ICU machine handle, 
ICU computer keyboard, ICU window ledge, ICU door handle, ICU floor and sluice
room sink plughole respectively)
(Using mecA gene-specific primers as detailed in the materials and methods)
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1 2 3 4 5 6 7 8 9 10 11 12
Size marker (bp)
1000------► m
750------ ►
500 ►
250------►
540bp
< blaCjx-M
gene
Figure 5.12 blact x -m  gene detection from NGH environmental swab samples
Lane 1 marker, lane 2 E. coli CTX-M positive control, lane 3 no DNA template control, 
lanes 4-12 PCRs from template DNA purified from swab samples (sites -  ICU machine 
handle, ICU computer keyboard, ICU window ledge, ICU door handle, ICU floor and
sluice room sink plughole respectively)
(Using blaCjx-w\ gene-specific primers as detailed in the materials and methods)
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1 2 3 4 5 6 7
i
Size marker (bp)
1500
1000
750
500
250
Figure 5.13 b/aSHvgene detection from NGH environmental swab samples
Lane 1 marker, lane 2 E. coli SHV-2 positive control, lane 3 no DNA template control, 
lanes 4-7 PCRs from template DNA purified from swab samples (site -  ICU patient 
chair, ICU floors and sluice room sink plughole respectively)
(Using blashv gene-specific primers as detailed in the materials and methods)
827bp 
bias hv 
gene
138
Figure 5.14 blaTEm gene detection from NGH environmental swab samples
1 2 3 4 5 6
Size marker (bp)
1500 
1000 
750 
500 
250
(a)
Lane 1 marker, lane 2 E. coli TEM positive control, lane 3 no DNA template control, 
lanes 4-6 PCR products from template DNA purified from swab samples (ICU ward 
sink plughole and ICU patient chairs respectively)
(Using blaTEM gene-specific primers as detailed in the materials and methods)
S 862bp -blaj em gene
1 2 3 4 5 6 7 8 9 10 11 12
Size marker (bp) 1
1500 ---► mm1000 — ► mm750 ---► mm
500
250 ---►
862bp
blajEM
gene
(b)
Lane 1 marker, lane 2 E. coli TEM positive control, lane 3 no DNA template control, 
lanes 4-12 PCR products from template DNA purified from swab samples (sites -  ICU 
machine handles, ICU computer keyboard, ICU window ledge, ICU door handle, ICU 
floors-ward, ICU ward sink plughole respectively)
(Using blaTEm gene-specific primers as detailed in the materials and methods)
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room plughole, left and right ICU machine handles, ICU computer keyboard and ICU 
window ledge (Table 5.2).
Characterisation of native and ESBL blaJEM genes amplified during all 12 sampling 
sessions revealed that 10 out of 11 amplicons were native blaTEm and one was a TEM- 
116 ESBL (from session 10 04/11/08) (Table 5.2). No blaTEM gene-carrying organisms 
were identified from isolated bacteria cultured from swab samples.
5.3.5 Rate of MRS A and ESBL isolation from clinical samples at NGH
The rate of MRSA isolation from clinical samples was similar to the RHH. From 188 
Gram-positive clinical isolates (cultured routinely by clinical microbiologists), only nine 
MRSA isolates were identified. In total five MRSA infected patients were present on 
the ward during sampling; sessions 5 (01/07/08), 7-8 (16/09/08 -  30/09/08) and 10 
(04/11/08) (Table 5.2).
A similarly low proportion of ESBL-producing Gram-negatives were identified from 
NGH clinical isolates (1/172). The ESBL-producing E. coli was identified as a CTX-M 
ESBL by gene-specific PCR (Figure 5.15). This patient was on the ward for one day 
(02/11/08) and was present two days prior to sampling session 10 (04/11/08).
After detecting native blaTEm genes in the NGH environment, similar to the RHH, three 
clinical isolates were carrying native blaTEM genes (from 11 Klebsiella spp. and E. coli 
clinical isolates) (Figure 5.16). They were isolated during sampling sessions 7-8 
(16/09/08 - 30/09/08) and 10 (04/11/08) (Table 5.2).
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1 2  3 4
Size marker (bp)
1000—— ►
750
500
250—— ►
540bp
bla CTX-M
gene
Figure 5.15 Detection of CTX-M ESBL from NGH E. coli clinical isolate
Lane 1 marker, lane 2 E. coli CTX-M positive control, lane 3 no DNA template control, 
lane 4 PCR product from template DNA purified from cultured E. coli clinical isolate 
(Using blactx-m gene-specific primers as detailed in the materials and methods)
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1 2 3 4 5 6 7 8 9 1011 12
Size marker (bp)
1500
1000
750
500
* *
862bp
blajEM
gene
250
Figure 5.16 b/ajEM gene detection from NGH clinical isolates
Lane 1 marker, lane 2 E. coli TEM positive control, lane 3 no DNA template control, 
lanes 6, 8,12 PCR products from template DNA purified from cultured Klebsiella spp.
and E. coli clinical isolates 
(Using blaTEM gene-specific primers as detailed in the materials and methods)
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5.3.6 Detection of tet genes in the NGH environment
In contrast to the RHH, from the first seven sessions (11/03/08 -  16/09/08) no tet M, O 
or W genes were identified from environmental swab samples by PCR (some of these 
negative results are shown in Figure 5.17, 5.18 and 5.19).
From the last five sampling sessions (30/09/08 -  09/12/08) 13 tetracycline resistant 
colonies were cultured from swab samples, which was much lower than the RHH. 
However, the tetracycline resistant colonies were most frequently cultured from the 
same environmental sites; ICU floors (isolation rooms and main bed ward). tef(W) was 
identified from two tetracycline resistant colonies and tet(M) from one; similar to the 
RHH, a proportion of colonies (10) were carrying different tet resistance genes (Table 
5.2).
5.4 Discussion
The impact of nosocomial infections caused by antibiotic resistant organisms has been 
high on the political and public agenda. Previous culturing studies have identified 
MRSA and ESBL-producing organisms in clinical samples and the ICU environment 
during infection outbreaks (Naas et a t 2002; Naiemi et a/., 2005; Manzur et at., 2007; 
Khan et at., 2009). In this present study, antibiotic resistance determinants were 
detected in the ICU and HDU environments at a low frequency.
Antibiotics are extensively used to treat patients on ICUs. It is known that antibiotic 
resistance determinants (particularly tet genes) are commonly found in the environment 
due to the extensive use of antibiotics in human/animal therapy and agriculture 
(Aminov et at., 2001; Chee-Sanford et a t 2001; Bryan et at., 2004; Borjesson et
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1 2 3 4 5 6 7 8 9  10
Size marker (bp)
300
200
100 -►
171 bp 
tef(M) 
gene
Figure 5.17 tet{M) gene detection from NGH environmental swab samples
Lane 1 marker, lane 2 and 3 Bacillus subtilis tet M positive control, lane 4 no DNA 
template control, lane 5-10 PCRs from template DNA purified from swab samples (site 
-  ICU ward sink plughole, ICU patient chair, ICU computer keyboard, ICU floor-ward 
and sluice room sink plughole x2 respectively)
(Using teM  gene-specific primers as detailed in the materials and methods)
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1 2 3 4 5 6 7 8 9
Size marker (bp) «■*
500------ ► «► I
250------ ► L *  171 bp
,1---------- tet{ O)
100 ► gene
Figure 5.18 fef(0) gene detection from NGH environmental swab samples
Lane 1-2 markers, lane 3 E. coli tet O positive control, lane 4 no DNA template control, 
lanes 5-9 PCRs from template DNA purified from swab samples (site -  ICU ward sink 
plughole, ICU floor-ward x2 and sluice room sink plughole x2 respectively) 
(Using tetO gene-specific primers as detailed in the materials and methods)
14?
1 2 3 4 5 6  7 8 9
Size marker (bp)
300
200
100  ►
168bp
tet(\N)
gene
Figure 5.19 tet{W) gene detection from NGH environmental swab samples
Lane 1 marker, lane 2 E. coli tet\N  positive control, lane 3 no DNA template control, 
lanes 4-9 PCRs from template DNA purified from swab samples (site -  ICU ward sink 
plughole, ICU patient chair, ICU computer keyboard, ICU floor-ward, sluice room sink
plughole x2 respectively)
(Using telSN gene-specific primers as detailed in the materials and methods)
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al., 2009; Martinez, 2009). Previous research using culture methods has shown the 
detection of MRSA and ESBL-producing organisms in the ICU environment (Naas et 
al., 2002; Naiemi et al., 2005; Manzur et al., 2007; Khan et al., 2009). However, 
from this present study meek and blaTEm genes were detected in low numbers from the 
ICU and HDU environments.
During this study, PCR was used to detect antibiotic resistance determinants. There 
are limitations to the use of molecular techniques for detecting antibiotic resistance 
determinants. Single bacterial cells or single copies of antibiotic resistance genes can 
not be harvested from swab samples and thus the determinants would not be amplified 
by PCR (Bartlett and Stirling, 2003). However, in this present study a PCR approach 
enabled antibiotic resistance determinants to be detected in the absence of the host 
organism. This was of great importance when samples did not yield culturable bacteria.
fn contrast to culture-based studies (Shiomori et al., 2002; NHS Estates, 2003; 
Howie and Ridley, 2008; Khan et al., 2009) there was a low frequency of meek 
genes detected in the ICU environment even in the presence of MRSA infected 
patients during this present study. Although the meek gene is commonly associated 
with S. aureus (McKeegan et al., 2002), in this present study the two mecA-gene 
carrying organisms were CNS. Methicillin resistant CNS have been reported in the 
literature and are common commensal organisms (Suzuki et al., 1992; Hussain et al., 
2000; Schulin and Voss, 2001; Tee et al., 2003). Although during this present study 
the frequency of meek gene detection was low, CNS were isolated by culturing.
There is a wide distribution of the meek gene among CNS species (Suzuki ef al., 1992; 
Kobayashi et al., 1994; Hanssen et al., 2004). Previously two hypotheses have been 
put forward for why CNS carry the meek gene:-
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1 -  The meek gene has been inherited by CNS and S. aureus from a common 
ancestor cell
2 -  The meek gene has been transferred between Staphylococci species (Suzuki et 
al., 1992)
Only 17 ICU and HDU patients were found to be colonised or infected with MRSA 
during this study and the Sheffield Teaching Hospitals NHS Foundation Trust as a 
whole have seen only low numbers of MRSA bacteraemias compared with other 
specialist trusts (HPA, 2006a). The Sheffield Trust had 103 MRSA bacteraemias in a 
one year period between April 2004 and March 2005, which when compared with the 
Leeds Trust (200 cases), Brighton and Sussex Trust (129) and Cambridge Trust (123), 
is relatively low (HPA, 2006a). These data suggest that MRSA is seldom found in the 
ICU and HDU ward environments at the Sheffield Teaching Hospitals and this may 
account for the low numbers of MRSA infected patients.
Interestingly, all blajm  genes detected in the ICU and HDU environment were native 
beta-lactamases not ESBLs, except one (TEM-116 from the NGH ICU). The number of 
ESBL-producing organisms isolated from clinical samples was low, however they were 
ail CTX-M, the most common ESBL in the general hospital setting (Bonnedahl et al., 
2009). The low rate of ESBLs and MRSA may in part be due to the high standard of 
infection control in operation within these two ICU departments. Strict control 
measures have been shown in other studies to halt the spread of ESBL-producing 
organisms (Naiemi et al., 2005; Mammina et al., 2007).
To the author’s knowledge, this is the only study to report native b/a-ro/i genes in the
ICU environment and clinical isolates during the same time period. The possibility
cannot be excluded that wild-type blaTEM genes were detected in previous studies but
were not reported since they may not have been perceived as a clinical priority.
Although the frequency of antibiotic resistance determinant detection was low, there
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was a widespread distribution with blaTEm genes being detected in various samples. 
Gram-negative organisms (including Enterobacteriaceae) frequently carry beta-lactam 
resistance genes (e.g. native blaTem genes, TEM-1 and TEM-2) (Tristram et al., 2005). 
However, detection of native blaTEM in clinical isolates is of clinical significance as 
organisms are not routinely screened for native beta-lactamases and there is the 
potential for ESBL conversion under antibiotic selective pressure (Hammond et al., 
2005; Paterson and Bonomo, 2005; Pfaller and Segreti, 2006).
During this present study Klebsiella spp. and E. coli ICU clinical isolates were screened 
for blaJBm genes. Future work could be carried out to screen other Gram-negative 
clinical isolates for blajm genes and isolate blatem gene-carrying organisms from the 
ICU environment. This would enable clonal work to be carried out to identify if the 
same b/aTEM gene-carrying organism is present in the ICU environment and clinical 
isolates, which could indicate transmission between the environment and patients (or 
vice versa).
Tetracycline resistance genes are commonly found in the environment e.g. in soil and 
water (Aminov etal., 2001; Chee-Sanford eta I., 2001; Bryan eta I., 2004), therefore 
they were used in this present study as an environmental marker for antibiotic 
resistance. During this study a number of tetracycline resistant colonies were cultured, 
indicating the ICU and HDU environment does yield common antibiotic resistance 
determinants.
The detection of antibiotic resistance determinants in the ICU and HDU environment 
was investigated. Low frequencies of b/aTem and meek genes were detected in the ICU 
and HDU environments. However, there is a potential for gene transfer among 
bacteria in areas of high density. The detection of b/ajEM genes in clinical isolates is of 
clinical significance due to the potential for mutation to give ESBLs under particular 
antibiotic selective pressure.
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All blaTEM genes were detected in the absence of culturable organisms. However, no 
culturable organisms does not mean no viable organisms. It may be that the medium 
used did not enable organism growth, the ICU environmental site was not sufficient to 
enable the organisms’ survival or the bacterial cells are in a dormant state (Barer, 
1997). From the data presented in Chapter 4, it is known that viable organisms are 
present in the ICU environment. Therefore the absence of culturable gene-carrying 
organisms could be due to the effect of routine ICU ward cleaning. Cell lysis after 
cleaning could enable the detection of the antibiotic resistance determinant in the 
absence of culturable organisms. To investigate this possibility and persistence of 
antibiotic resistance in the ICU environment, swab samples were taken on occasions 
before and after routine ICU ward cleaning (detailed in Chapter 7).
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6. Identification of environmentai fungal reservoirs in the ICU
and HDU departments
6.1 Background and aims
The aim of this chapter was to identify environmental reservoirs of fungi in the ICU and 
HDU departments. In order to detect environmental fungi a culture method was used. 
A molecular approach was used to identify yeasts amongst fungal isolates. Candida 
spp. and S. cerevisiae were identified by PCR of yeast-specific 18S-25S/28S rDNA 
gene fragments. Restriction digestion of amplified products enabled identification to 
species level.
The objectives were to: -
• isolate fungi from the ICU and HDU environment
•  identify the sites where fungi were most frequently detected
• quantify the level of fungal growth
• identify yeasts to species level, including C. albicans, C. glabrata, C. 
guillermondii, C. tropicalis and C. parapsilosis
•  compare fungal species from environmental sites with clinical isolates from 
patients in the RHH
6.2 Overview of materials and methods
The ICU and HDU departments were sampled over 12 sessions from the RHH
(12/05/08 -  15/12/08) and the NGH (11/03/08 -  09/12/08). Fungi were cultured from
swab samples positive for eubacterial DNA. Samples were taken from 17 sites in the
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RHH (Table 6.1); and from 13 sites in the NGH (Table 6.4) (full details of the sampling 
regime are provided in Section 2.2 Materials and Methods).
6.3 Results
ICU and HDU at the Royal Hallamshire Hospital
6.3.1 Isolation of fungi from the RHH environment
Medically relevant yeasts (Candida spp. and S. cerevisiae) were isolated from 46.8% of 
95 RHH environmental swab samples (representative gels used for identification of 
cultured organisms are shown in Figure 6.1a/b).
Fungi were isolated from samples from 16 environmental sites (Table 6.1). At least 
one sample from each environmental site was positive for fungal growth except the 
sluice room sink plughole, where no fungi could be isolated (Table 6.1). Each of the 
sampling sites except the HDU bedside trolley yielded culturable yeasts on at least one 
occasion (Figure 6.2). All samples from the ICU ward sink plughole yielded fungal 
isolates; the majority were members of the Candida spp. (66.7%).
Candida spp. were most frequently cultured from samples of the ICU ward sink 
plughole, ICU ward sink taps and ICU floors. However, fungi were much less 
frequently cultured from all other sites (the ICU bedside, ICU bedside trolley, ICU 
computer keyboard, HDU bedside trolley, HDU patient chair, HDU computer stand, 
HDU floor, HDU picture, HDU plughole, HDU window ledge, ICU picture, ICU staff 
chair and ICU window ledge) (Figure 6.3).
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Figure 6.1 Amplification of the yeast-specific 18S-25/28S rRNA gene fragment
from medically relevant yeasts isolated from RHH environment
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lanes 4-9 PCR products from template DNA purified from fungal isolates (sites - HDU 
computer stand, HDU chair, HDU picture, HDU computer stand from 14/07/08 session 
4, sites -  ICU bedside, ICU bedside trolley from 03/11/08 session 8 and site -  ICU 
computer keyboard from 30/06/08 session 3 respectively)
(Using yeast specific 18S-25/28S rRNA gene fragment primers as detailed in materials
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Figure 6.2 Sites of detection for medically relevant yeasts from the RHH1
(number) = total number of swab samples taken 
1 The data was obtained from PCRs using DNA extracted from the cultured strains 
Each sample was spread on PDG and incubated at 30°C for a maximum of five days. 
One colony of each colony type from each PDG plate was subcultured and identified by 
18S-25/28S rRNA PCR. The reported number of yeasts identified from each site is the 
total number of subcultured yeast strains from that site.
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Figure 6.3 Environmental sites of fungal isolation from the RHH1
(number) = total number of swab samples taken 
1 This data was obtained from cultural studies from ICU environmental swab samples
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The amount of fungal growth on the plate inoculated with each sample differed 
between environmental sites and sampling sessions (Table 6.1). The majority of fungi 
isolated formed a confluence of fungal growth on the agar plate (from the ICU floor, 
HDU window ledge, ICU picture, ICU ward sink plughole, ICU ward sink taps and ICU 
window ledge). Other fungi isolated were single colonies (from the ICU bedside trolley, 
HDU chair and HDU picture).
All fungal isolates were identified by 18S-25S/28S rRNA gene fragment specific-PCR 
as non-albicans Candida species (Table 6.2). The majority of these were identified as 
C. parapsilosis (59.1%). C. guillermondii (20.5%), C. tropicalis (18.2%) and C. 
dublinensis (2.3%) were also identified (Table 6.2). No C. albicans were isolated from 
the ward environment
6.3.2 Clinical fungal isolates from the RHH ICU
Fungi were cultured from patient samples as part of the standard monitoring and 
diagnosis performed by clinical staff. During the period of this study (January-May 
2008) routine clinical monitoring of patients yielded 119 fungal isolates. The majority of 
Candida positive patients were colonised with C. albicans (78.2%). Patients were also 
colonised with non-albicans species; C. glabrata (10.9%), C. parapsilosis (2.5%), G. 
guillermondii (1.7%), C. tropicalis (0.8%) and C. krusei (0.8%) (Table 6.3).
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Table 6.2 Medically relevant yeasts identified from the RHH ICU environment
Fungal species Number of environmental 
isolates
Percentage observed 
(%)(total 44 samples)
C. parapsilosis 26 59.1
C. guillermondii 9 20.5
C. tropicalis 8 18.2
C. dublinensis 1 2.3
C. albicans 0 0.0
C. glabrata 0 0.0
C. krusei 0 0.0
S. cerevisiae 0 0.0
161
Table 6.3 Fungal species colonising ICU patients in the RHH ICU
Fungal species Percentage patient isolates
<%)(total 119)
C. albicans 78.2
C. glabrata 10.9
S. cerevisiae 5.0
C. parapsilosis 2.5
C. guillermondii 1.7
C. tropicalis 0.8
C. krusei 0.8
C. dubliniensis 0.0
C. membranefaciens 0.0
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ICU and HDU at the Northern General Hospital
6.3.3 Isolation of fungi from the NGH environment
In contrast to the RHH, the proportion of isolates of medically relevant yeasts (Candida 
spp. and S. cerevisiae) was higher; 66.2% of 65 NGH environmental swab samples 
yielded yeasts (a representative gel used for identification of cultured organisms is 
shown in Figure 6.4).
Fungi were cultured from samples from all (13) ICU and HDU environmental sites at 
the NGH (Table 6.4). At least one sample from all ICU sites yielded fungi (Figure 6.5). 
However, in contrast to the results from the RHH HDU, no medically relevant yeasts 
were isolated from the NGH HDU environment (Figure 6.6),
Candida spp. were most frequently isolated from similar sites to the RHH; from 
samples of the ICU floor (the ward and isolation room), ICU patient chair and plugholes 
(ICU ward and sluice room sinks). Candida spp. were much less frequently isolated 
from all other sites (the ICU bedside, ICU computer keyboard, ICU door handle, HDU 
computer keyboard, HDU door switch, HDU floor, HDU ward sink plughole and ICU 
window ledge) similar to the RHH (Figure 6.6).
Interestingly, compared to the RHH, fungal isolation from only one sample site (ICU 
computer keyboard) was consistently an overgrowth on the agar plate (Table 6.4), 
From the HDU floor and ICU door handle samples fungal growth was consistently low 
(2-10 colonies and a single colony respectively) (Table 6.4).
The same non-albicans Candidia species were identified from fungal isolates at the 
NGH compared to the RHH; C. parapsilosis (39.5%), C. tropicalis (20.9%) and
163
1 2 3 4  5 6 7 8
Size marker (bp) |
1500 Mi
1000
750 — —► B
500 -►
250
Figure 6.4 Amplification of the yeast-specific 18S-25/28S rRNA gene fragment 
from medically relevant yeasts isolated from NGH environment
Lane 1 marker, lane 2 C. glabrata positive control, lane 3 no DNA template control, 
lanes 6-8 PCR products from template DNA purified from fungal isolates (sites -  ICU 
ward sink plughole x2, ICU floor, ICU computer keyboard from 08/04/08 session 2 and 
site - sluice room sink plughole from 03/06/08 session 4 respectively)
(Using yeast specific 18S-25-28S rDNA gene fragment primers as detailed in materials
and methods)
164
Table 6.4 Distribution and growth of fungal isolates from NGH environment (samples detailed in Table 2.2b)1 (continued over page)
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Figure 6.5 Environmental sites of fungal isolation from NGH1
(number) = total number of swab samples taken 
1 This data was obtained from cultural studies from ICU environmental swab samples
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Figure 6.6 Detection of medically relevant yeasts from the NGH environment1
(number) = total number of swab samples taken 
1 The data was obtained from PCRs using DNA extracted from the cultured strains 
Each sample was spread on PDG and incubated at 30°C for a maximum of five days. 
One colony of each colony type from each PDG plate was subcultured and identified by 
18S-25/28S rRNA PCR. The reported number of yeasts identified from each site is the 
total number of subcultured yeast strains from that site.
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C. guillermondii (16.3%) (Table 6.5). However in addition C. glabrata (20.9%) was also 
identified from the NGH environment (Table 6.5).
Fungal clinical isolate data was not obtained during this study from the NGH, the focus 
was on the ICU and HDU environment. Patient data was only obtained for fungal 
clinical isolates at the RHH.
6.4 Discussfon
The incidence of nosocomial yeast infections has risen dramatically, particularly 
amongst ICU patients (Verduyn-Lunel eta!., 1999; Leone ef a/., 2003; Bassetti etal., 
2006). There is limited research on fungal species in the ICU and HDU environment. 
In this present study the ICU and HDU environment was investigated for the presence 
of fungal species and Candida spp. in particular. Interestingly, the sites of highest 
fungal isolation were the same as those yielding the highest bacterial detection and 
where antibiotic resistance determinants were detected (detailed in Chapter 4 and 5).
During this present study the environmental results show the trend towards non- 
albicans Candida spp. which has previously been reported in clinical samples in the 
literature. For many years C. albicans was the most common cause of fungal 
nosocomial infections, however there is a current switch towards non-albicans Candida 
infections in ICUs (Nguyen et a!., 1996; Hobson, 2003; Bassetti ef a/., 2006; Shorr 
et at., 2007). This may potentially be due to the extensive use of fluconazole in the 
1990’s (Trick et al., 2002; Hobson, 2003) which has led to an increase in non-albicans 
Candida infections (especially C. glabrata) due to their lower susceptibility to azole anti* 
fungals (Nguyen eta/., 1998; Fidel eta/., 1999; Hobson, 2003).
169
Table 6.5 Medically relevant yeasts identified from the NGH ICU environment
Fungal species Number of 
environmental isolates
Percentage observed 
(%)(total 43 samples)
C. parapsilosis 17 39.5
C. glabrata 9 20.9
C. tropicalis 9 20.9
C. guillermondii 7 16.3
S. cerevisae ~ r~ 2.3
C. albicans 0 0.0
C. dubliniensis 0 0.0
C. krusei 0 0.0
C. membranefaciens 0 0.0
170
Non-albicans Candida spp. were present in various sample sites within the ICU and 
HDU environment during this present study. Previous research has demonstrated the 
presence of Candida spp. in the indoor air and on walls in ICUs (Gniadek and Macura, 
2007; Krajewska-Kulak et al., 2007). Commensal fungal organisms are typically 
found on the skin of 10-20% of healthy individuals (Sullivan et al., 1996). The most 
common environmental yeast isolates (from RHH and NGH) were C. parapsilosis 
which has previously been shown to persist on environmental surfaces for 14 days 
(Kramer et a!., 2006). From the NGH ICU, C. glabrata was present which has 
previously been shown to persist for five months on environmental surfaces (Kramer et 
al., 2006). This implies that non -albicans Candida spp. could persist in the ICU 
environment on hard surfaces (and sinks).
C. albicans was not isolated in the ICU environment which appears to rule out the 
possibility of a link between the environment and C. albicans infected patients. The 
reason why no C. albicans was present in the ICU environment may be because C. 
albicans is a common commensal of the mouth and gastrointestinal tract (Cannon and 
Chaffin, 1999; Hobson, 2003) in contrast to the most common environmental yeast 
isolated (C. parapsilosis), which is a commensal of the skin (particularly hands) 
(Sullivan et al., 1996; Gacser et al., 2007). Therefore the lack of C. albicans in the 
ICU environment may be due to good infection control policies around patients infected 
with C. albicans. Insufficient hand hygiene may explain the wide distribution of non- 
albicans Candida spp. due to hand contact with various sites in the ICU environment.
Interestingly, a wider range of Candida spp. was isolated from the environment of the
NGH than the RHH. Whilst it is not possible to assign the reason for this with certainty*
it is possible that the ward design and number of patients/hospital staff could be the
cause. There are a greater number of patients and staff on the NGH ICU compared to
the RHH ICU. This could explain why more Candida spp. were isolated from the NGH.
The greater number of patients and hospital staff could result in more Candida spp. in
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the environment from commensal fungal organisms due to hand contact and skin 
shedding (Lee eta!., 2007; Rintala eta!., 2008).
There was a larger number of CFUs per sample at the RHH ICU compared to the NGH 
ICU. A possible explanation for this observation could be due to patient proximity and 
ward design. Previous research has shown how patient proximity can contribute to the 
transmission of MRSA and an increase in environmental contamination (Howie and 
Ridley, 2008). Besides the NGH ICU having a greater patient intake and number of 
hospital staff, the ward itself is approminately three times the size (in terms of floor 
space) compared to the RHH ICU. Therefore, approximately the same number of 
microorganisms could be present in a larger space, so they are less frequently 
detected by culturing.
Other differences which could exlplain the larger number of CFUs per sample at the 
RHH ICU include the age of the ward. The NGH ICU was newly commissioned during 
this present study therefore a possibility could be that there has not been as much 
fungal build-up in the NGH ICU environment compared to the RHH ICU. The NGH ICU 
ward design is also different compared to the RHH ICU. For example the sinks on the 
NGH ICU have a larger splash guard and no tap handles compared to the RHH ICU. 
This could limit organism backsplash from the plughole onto hospital staff hands and 
nearby medical equipment which has previously been reported in the literature (Doring 
et al., 1996; Lango et al., 2007; Brooke, 2008; Hota et al., 2009) (as detailed in 
Chapter 8).
Non-albicans Candida spp. are widely distributed in the ICU environment. There was a 
wide variation in the number of fungal CFUs isolated over the 12 sample sessions. It 
was suspected that this variation may be due to routine ICU ward cleaning, therefore 
the study to compare the samples taken from the ICU environment before and after
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cleaning was expanded to include culture media for the isolation of fungal species (as 
detailed in Chapter 7).
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7. Comparison of the microbial ecology and presence of 
antibiotic resistance determinants before and after routine ICU
ward cleaning
7.1 Background and aims
This chapter aims to compare the effect of routine ward cleaning on the detection of 
prokaryotic and fungal microorganisms and specific antibiotic resistance markers. For 
a three week period, intensive sampling was carried out on the sites of highest 
eubacterial DNA detection and fungal isolation (the ICU patient chair, ICU floor, ICU 
ward sink plughole and sluice room sink plughole).
The objective was to sample on occasions before and after routine ICU ward cleaning 
and compare the effect on the -
•  detection of eubacterial DNA from ICU environmental swab samples 
9  presence of bacterial sequences by PCR-DGGE
• isolation of fungi from ICU environmental swab samples
• persistence of antibiotic resistance determinants in the ICU environment by 
PCR using gene-specific primers for mecA and blact x -m , s h v , t e m
9  isolation and identification of target gene-carrying {mecA and blaTEm) bacterial 
species
7.2 Sampling regime
A total of 180 swab samples were taken over a three week sampling period (02/03/09 -
20/03/09 Monday-Friday) (Table 7.1a/b). Four sample sites were tested; the ICU
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Table 7.1a Environmental swab samples tested for eubacterial DNA from the ICU
at the RHH
Sample site Floor
(ICU)
Patient chair 
(ICU)
Plughole 
(ICU ward 
sink)
Sluice room 
sink plughole
Sample 
session 1 
02/03/09
R1M #1/2 R1M #5/6 R1M #3 R1M #4
03/03/09 R1T #1/2 R1T #5/6 R1T #3 R1T #4
04/03/09 R1W #1/2 R1W #5/6 R1W #3 R1W #4
05/03/09 R1Th #1/2 R1Th #5/6 R1Th #3 R1Th #4
06/03/09 R1F #1/2 R1F #5/6 R1F #3 R1F #4
Sample 
session 2 
09/03/09
R2M #1/2 R2M #5/6 R2M #3 R2M #4
10/03/09 R2T #1/2 R2T #5/6 R2T #3 R2T #4
11/03/09 R2W #1/2 R2W #5/6 R2W #3 R2W #4
12/03/09 R2Th #1/2 R2Th #5/6 R2Th #3 R2Th #4
13/03/09 R2F #1/2 R2F #5/6 R2F #3 R2F #4
Sample 
session 3 
16/03/09
R3M #1/2 R3M #5/6 R3M #3 R3M #4
17/03/09 R3T #1/2 R3T #5/6 R3T #3 R3T #4
18/03/09 R3W #1/2 R3W #5/6 R3W #3 R3W #4
19/03/09 R3Th #1/2 R3Th #5/6 R3Th #3 R3Th #4
20/03/09 R3F #1/2 R3F #5/6 R3F #3 R3F #4
Code: -
R [sampling session] [day of the week] # [code number representing site]
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Table 7.1b Environmental swab samples tested for eubacterial DNA from the ICU
at the NGH
Sample site Floor
(ICU)
Patient chair 
(ICU)
Plughole 
(ICU ward 
sink)
Sluice room 
sink plughole
Sample 
session 1 
02/03/09
N1M #1/2 N1M #5/6 N1M #3 N1M #4
03/03/09 N1T #1/2 N1T #5/6 N1T#3 N1T #4
04/03/09 N1W #1/2 N1W #5/6 N1W #3 N1W #4
05/03/09 N1Th #1/2 N1Th #5/6 N1Th #3 N1Th #4
06/03/09 N1F #1/2 N1F #5/6 N1F #3 N1F #4
Sample 
session 2 
09/03/09
N2M #1/2 N2M #5/6 N2M #3 N2M #4
10/03/09 2T #1/2 N2T #5/6 ironmenN2T N2T #4
11/03/09 N2W #1/2 N2W #5/6 N2W #3 N2W #4
12/03/09 N2Th #1/2 N2Th #5/6 N2Th #3 N2Th #4
13/03/09 N2F #1/2 N2F #5/6 N2F #3 N2F #4
Sample 
session 3 
16/03/09
N3M #1/2 N3M #5/6 N3M #3 N3M #4
17/03/09 N3T #1/2 N3T #5/6 N3T #3 N3T #4
18/03/09 N3W #1/2 N3W #5/6 N3W #3 N3W #4
19/03/09 N3Th #1/2 N3Th #5/6 N3Th #3 N3Th #4
20/03/09 N3F #1/2 1  3F #5/6 N3F #3 N3F #4
Code: -
N [sampling session] [day of the week] # [code number representing sits]
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patient chair, ICU floor, ICU ward sink plughole and sluice room sink plughole. These 
sites had previously shown the highest detection and isolation of bacteria and fungi 
from the extensive sampling period (detailed in Chapter 4 and 6). Samples were taken 
around the time of cleaning, on each occasion it was determined from the cleaning staff 
if cleaning had been done. Experience during the whole of the study indicated that the 
samples taken ‘before cleaning’ were usually taken within one hour of the cleaning 
commensing and samples taken ‘after* were usually within the hour after cleaning had 
been completed. In total daily samples were taken on 13 occasions before and 17 
occasions after routine ICU ward cleaning. Each sample was given a unique code 
number that specifies the type of environment sampled and the hospital from which the 
sample was taken. The DNA was extracted from each swab and stored at -20 °C in 
the 703/-20/2 freezer in room 703 BMRC labelled with the codes from Table 7.1 a/b.
7.3 Results
7.3.1 Detection of eubacterial DNA before and after routine ICU ward 
cleaning from RHH and NGH environments
There was a 50% reduction in the proportion of ICU environmental swab samples 
yielding eubacterial DNA after routine ICU ward cleaning. Before the ward was 
cleaned eubacterial DNA was detected in 65-67% of environmental swab samples; 
after cleaning eubacterial DNA was detected in 31-33% of environmental swab 
samples (Figure 7.1). Using chi-squared data analysis the reduction in eubacterial 
DNA detection after cleaning was significant (Figure 7.1)
The proportion of swab samples positive for eubacterial DNA was lower after routine 
ICU ward cleaning from all environmental sites (ICU patient chair, ICU floor, ICU ward 
sink plughole and sluice room sink plughole) (Figure 7.2). There was a 28% reduction
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Figure 7.1 PCR detection of eubacterial DNA in RHH and NGH ICU environmental 
swab samples before and after routine ward cleaning
* p = 0.05 
(Chi-squared analysis)
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Figure 7.2 PCR detection of eubacterial DNA in RHH and NGH ICU environmental 
sample sites before and after routine ward cleaning
Total number of swab samples before cleaning: - Chair and floor, each n = 26
Plughole and sluice plughole, each n = 13 
Total number of swab samples after cleaning: - Chair and floor, each n = 34
Plughole and sluice plughole, each n = 17
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in ICU floor samples yielding eubacterial DNA (before 64%, after 36%), 25% in ICU 
patient chair samples (before 62.5%, after 37.5%), 20% in sluice room sink plughole 
samples (before 60%, after 40%) and 17% in ICU ward sink plughole samples (before 
58.3%, after 41.7%) (Figure 7.2).
PCR-amplified fragments of 16S rRNA genes were retrieved from environmental swab 
samples (ICU ward sink plughole, ICU floor and ICU patient chair) taken on occasions 
before and after routine ICU ward cleaning and analysed by PCR-DGGE (Table 7.2 
and representative gel shown in Figure 7.3)
Bacterial diversity was greatest in ICU ward sink plughole swab samples on occasions 
before and after routine ICU ward cleaning compared to ICU floor and ICU patient chair 
swab samples (Table 7.2). The retrieval of the same or similar DGGE bands from 
swab samples taken on occasions before and after routine ICU ward cleaning indicates 
the presence of the same microorganism. ICU ward sink plughole swab samples 
contained the most number of similar DGGE bands on occasions before and after 
routine ICU ward cleaning. From occasions before routine ICU ward cleaning, eight 
similar DGGE bands were retrieved after cleaning from ICU ward sink plughole swab 
samples. From ICU floor swab samples, two similar DGGE bands were retrieved on 
occasions before and after routine ICU ward cleaning (Table 7.2).
Sequences similar to Gram-positive organisms could only be retrieved before routine 
ward cleaning; Gram-negative sequences could be retrieved from DGGE bands before 
and after routine ICU ward cleaning (Table 7.2). Sequences most similar to the genus 
Burkholderia were retrieved from ICU floor and ICU ward sink plughole swab samples 
taken before and after routine ICU ward cleaning. Sequences with highest similarity to 
uncultured organisms (associated with human skin and blood), Staphylococcus 
hominis (CNS), faecalibacterium and firmicutes (associated with gut flora) could only
be retrieved before routine ICU ward cleaning.
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Table 7.2 Retrieval of bacterial sequences before and after routine ICU ward 
cleaning from NGH and RHH environmental swab samples after PCR-DGGE 
(continued over page)
Sample
site
Representative 
DGGE band
Retrieval 
before 
routine 
ICU ward 
cleaning
Retrieval 
after 
routine 
ICU ward 
cleaning
Gram-
positive
(+)or
Gram-
negative
B
Sequences 
similar to and 
percentage 
identity (%)
ICU
X - Burkholderia spp. 
93 *
patient
chair 2 X + Staphylococcusepidermidis
78"
1 X X - Acinetobacter spp. 
49
2 X X - Burkholderia spp.
ICU floor 3 X + Propionibacteriumspp.
100*
4 X + Staphylococcus
hominis
100’
1 X X - Alcaligenes spp. 
69*'
2 X - Bacteroidetes sop. 
96’
3 X Beta-
proteobacterium
93’
ICU ward
4 X X - Burkholderia spp. 
98’
sink
plughole
5 X X Burkholderia
cenocepacia
98’
6 X X Burkholderia
cepacia
99*
7 X X Burkholderia
vietnamiensis
92"
8 X + Faecalibacterium
94"
9 X + Firmicutes
81"
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Sample
site
Representative 
DGGE band
Retrieval 
before 
routine 
ICU ward 
cleaning
Retrieval 
after 
routine 
ICU ward 
cleaning
Gram-
positive
(+)or
Gram-
negative
(-)
Sequences 
similar to and 
percentage 
identity (%)
10 X X - Ralstonia spp. 
72“
ICU ward 
sink 
plughole
11 X X Ralstonia
metallidurans
97*
12 X X Stenotrophomonas
maltoohilia
92“
13 X + TS13_a03d2
Faecalibacterium
82”
14 X — Variovorax spp. 
99*
’ Clearly defined DNA sequence
“  Sequence interrupted due to unassigned residues
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Figure 7.3 DGGE gel showing bacterial diversity from RHH ICU environmental 
swab samples taken before and after routine ward cleaning
Lanes 1-7 PCR products from template DNA purified from environmental swab 
samples (sites -  ICU ward sink plughole after cleaning x2 from session 2 03/03/0S, 
04/03/09. ICU ward sink plughole before cleaning x2 from session 2 05/03/09, 06/03/09, 
sluice room sink plughole after cleaning x2 from session 1 03/03/09 and session 3 
18/03/09, sluice room sink plughole before cleaning from session 1 05/03/09
respectively)
(Using nt 341-926 16S rDNA fragment-specific primers detailed in the materials and
methods)
Sequences relatively similar to opportunistic species; Stenotrophomonas maltophilia 
and Acinetobacter spp. were retrieved before and after routine ICU ward cleaning from 
ICU floor and ICU ward sink plughole samples. The majority of sequences could not 
be retrieved after routine ward cleaning from the ICU patient chair and ICU floor, 
however 57% of sequences detected before cleaning were still retrieved after routine 
ward cleaning from ICU ward sink plughole swab samples (Table 7.2).
7.3.2 Isolation of fungi from the RHH and NGH ICU environment 
before and after routine ward cleaning
The number of fungal colonies isolated was reduced after routine ICU ward cleaning 
from ICU floor samples (before 16, after 3), ICU ward sink plughole samples (before 
124, after 47) and sluice room sink plughole samples (before 32, after 14). There was 
an increase in the number of fungal colonies isolated from ICU patient chair samples 
after routine ward cleaning (before 9, after 12) (Figure 7.4),
7.3.3 Detection of mecA and bla genes in the RHH and NGH ICU 
environment before and after routine ward cleaning
Only samples which were positive for eubacterial DNA by PCR were screened for 
antibiotic resistance determinants (RHH = 45 swab samples, NGH = 44 swab samples).
All (3) bla-TEM amplified from NGH swab samples and five (out of eight) RHH swab 
samples were detected before routine ICU ward cleaning and were not detected in 
DNA from samples of the same site after 24 hours (Table 7.3a/b). However, blaTEM 
was amplified in DNA from three (out of eight) RHH swab samples taken after cleaning.
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Figure 7.4 Number of fungal colonies before and after routine ward cleaning for 
each sample site from RHH and NGH ICU environment
Total number of swab samples before cleaning: - Chair and floor, each n = 26
Plughole and sluice plughole, each n = 13 
Total number of swab samples after cleaning: - Chair and floor, each n = 34
Plughole and sluice plughole, each n = 17
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Table 7.3a Distribution and classification of antibiotic resistance determinants before and
after routine ward cleaning in the RHH ICU environment
Sample site Floor
(ICU)
Patient chair 
(ICU)
Plughole 
(ICU ward sink)
Sluice room 
sink plughole
Sample 
session 1 
02/03/09
PBP281 
S. hominis*
03/03/09 - - -
04/03/09
05/03/09 +
TEM-1
Native3
06/03/09 - - -
Sample 
session 2 
09/03/09
4*
TEM-1
Native3
10/03/09 +
TEM-1
Native3
TEM-1
Native3
11/03/09 ♦
TEM-1
Native3
12/03/09 +
TEM-1 
Native3 
Klebsiella spp.4
+
TEM-1 
Native3 
Bacillus 
subtilis5
13/03/09 ♦
TEM-1
Native3
Sample 
session 3 
16/03/09
17/03/09 - - -
18/03/09 h h h h
19/03/09
20/03/09 - - -
1 PBP2a is the altered penicillin binding protein encoded by the mecA gene responsible for the
MRSA phenotype
* Staphylococcus hominis was identified as the gene-carrying organism 
J Native beta-lactamase genes were identified not ESBLs
4 Klebsiella spp. was identified as the gene-carrying organism
5 Bacillus subtilis was identified as the gene-carrying organism 
Background colour Bli After routine ward cleaning 
Background colour Before routine cleaning
- = negative samples
Blank boxes = sample not tested for antibiotic resistance determinants
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Table 7.3b Distribution and classification of antibiotic resistance determinants
before and after routine ward cleaning in the NGH ICU environment
Sample site Floor
(ICU)
Patient chair 
(ICU)
Plughole 
(ICU ward sink)
Sluice room 
sink plughole
Sample 
session 1 
02/03/09
03/03/09 H H H H U H
04/03/09 W rW M 1
05/03/09 -
06/03/09 - - -
Sample 
session 2 
09/03/09
10/03/09 ■HHHHHHI
11/03/09 - *
12/03/09 H H H H H -
13/03/09 - ■HHHHMI
Sample 
session 3 
16/03/09
+
TEM-1
Native1
♦
TEM-1
Native1
17/03/09 ++ 
TEM-1 
Native' 
Bacillus spp/
18/03/09 -
19/03/09 - - -
20/03/09 SBHHHHHHI - ■ H n n *#
*  One blaJEM PCR positive sample 
++ Two blaTem PCR positive samples
1 Native beta-lactamase genes were identified not ESBLs
2 Bacillus spp. were identified as the gene-carrying organisms 
Background colour Blue = After routine ward cleaning 
Background colour Before routine cleaning
- = negative samples
Blank boxes = sample not tested for antibiotic resistance determinants
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b la TEM  persisted in the RHH ICU ward sink plughole for approximately 72 hours 
because b la TBA was detected in DNA from three swab samples on consecutive days.
Target gene-carrying organisms could only be cultured from sessions before routine 
ICU ward cleaning. DNA sequencing of eubacterial DNA identified Bacillus spp., &  
subtilis and Klebsiella spp. as blaTEM gene-carrying organisms (Table 7.3a/b).
DNA sequencing was used to differentiate between native and ESBL blaJEM genes. All 
positive amplicons were identified as native TEM beta-lactamases and not ESBLs 
(Table 7.3a/b).
The mecA gene was detected after routine ICU ward cleaning in a RHH sluice room 
sink plughole swab sample (Table 7.3a), and after 24 hours from a sample of the same 
site mecA was not detected. The mecA gene-carrying organism was cultured and 
isolated DNA was used to sequence eubacterial DNA; the organism was identified as S, 
hominis (Table 7.3a).
7.4 Discussion
A number of guidelines have been implemented to combat HAIs particularly in relation 
to effective cleaning (Department of Health, 2008). Previous research has shown that 
organisms associated with HAI outbreaks can persist in the hospital environment after 
cleaning (Naas et ah, 2002; Wilcox et al., 2003; Denton et a l 2004; Whittington et 
at.t 2009). This chapter demonstrates that there is a difference in the microbial ecology 
in the ICU environment on occasions before and after routine ICU ward cleaning. 
Antibiotic resistance determinants were detected before and after routine ICU ward 
cleaning, however mecA and blaTem gene-carrying organisms could only be isolated on 
occasions before cleaning.
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Previous research has shown that in many environments <1% of bacterial species are 
culturable (Amann et al., 1995; Pace, 1997). The use of PCR-DGGE enabled 
sequence based identification of the genera and species present where bacteria could 
not be cultured on non-selective media (NA, CLED and blood agar). However, retrieval 
of bacterial sequences implies the presence of bacterial cells, which may or may not be 
viable.
The routine ICU ward cleaning regime was only effective on hard surfaces. The 
majority of DGGE bands were not detected from samples on occasions after routine 
ward cleaning. However, the DGGE bands giving sequences similar to opportunistic 
species (Burkholderia spp., Acinetobacter spp. and Stenotrophomonas spp.) were 
detected from samples on occasions before and after routine ICU ward cleaning.
Previous research has shown opportunistic species including Acinetobacter spp. to 
persist in the environment after cleaning (Wilcox et al., 2003; Denton et al., 2004; 
HPA, 2006b). Sinks have been shown previously to harbour pathogenic bacteria 
(particularly during outbreaks) and act as a reservoir (Brooke et al., 2008; Hota et al.t 
2009). These and the results from this present study underline the need for an 
effective cleaning regime to ensure the removal of organisms to prevent transmission, 
especially if the organisms are present in an infective dose,
interestingly, only Gram-negative organisms were detected in samples taken after 
routine ICU ward cleaning. This suggests routine ICU ward cleaning is able to remove 
Gram-positive organisms and there is a build-up between cleaning sessions. The 
source of Gram-positive organisms is likely to be constant skin shedding and hand 
contact by patients and hospital staff (Andersson et al., 1999; Lee et al., 2007; 
Rintala et al., 2008). In contrast, Gram-negative organisms remain, particularly from 
areas linked to biofilms (e.g. sinks).
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A possibility for this observation may be due to the action of cleaning, for example the 
cleaning agent may simply be more effective against Gram-positive organisms. Many 
disinfectants (which have a bactericidal action) work by causing bacterial cell lysis. 
The Gram-negative cell wall is surrounded by an outer membrane (which contains 
lipopolysaccharide and lipoproteins) which is not present in Gram-positive organisms 
(Mims et al., 1998c). The outer membrane can provide Gram-negative organisms with 
a greater intrinsic resistance against the action of bactericidal cleaning agents. Gram- 
positive organisms therefore are more permeable and susceptible to the action of 
biocides because the cell wall is not protected by an outer membrane. This could in 
part account for why Gram-negative organisms remain after routine ICU ward cleaning.
Observations during the whole of the present study showed that cleaning of hospital 
sinks consisted of pouring disinfectant into the plughole, therefore, the cleaning action 
may not be vigorous enough to remove cells (e.g. Acinetobacter spp. and Burkholderia 
spp.) known to persist in biofilms (Davies et al., 1998; Costerton et al., 1999; 
Conway ef al., 2002). Burfoot et al. (2009) demonstrated the need for pressure 
washing of stainless steel surfaces (in food production) to remove a biofilm of P. 
aeruginosa. The use of cold water for less than 60 s did not reduce the number of 
organisms however an increase in cleaning time did reduce the microbial load. 
Oulahal et al. (2004) used ultrasound in combination with chelating agents to remove £. 
coli or S. aureus biofilms. They concluded that the effectiveness in removing biofilms 
can depend on the type of microflora present. This indicates that different cleaning 
methods can affect Gram-positive and negative organisms in biofilms differently. The 
majority of detergents in use to remove surface contamination are not generally tested 
against microbes in biofilms (Rayner et al., 2004). Therefore the hospital cleaning 
agents may not be effective against organisms known to persist in biofilms. This may 
In part explain why during this present study only Gram-negative organisms known to 
persist in biofilms were detected on occasions after routine ICU ward cleaning.
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Fungi could be isolated before and after routine ICU ward cleaning. Gniadek and 
Macura (2007) reported a lower number of fungal CFUs in the evening compared to 
morning sampling. Since samples during this present study were only taken in the 
morning there is no data to compare morning and evening. However routine ICU ward 
cleaning did reduce the number of fungal CFUs isolated. The observation by Gniadek 
and Macura may also be due to routine cleaning as this was not accounted for during 
their study. During this present study, there is a build-up of fungi (non-albicans 
Candida spp.) in the ICU environment between cleaning sessions. This suggests 
either fungal growth in the ICU environment or a constant re-introduction of fungal 
species, potentially from commensal fungi on patient, visitor or hospital staff skin 
(Sullivan eta!., 1996; Hobson, 2003).
Since the emergence of MRSA and ESBL-producing organisms, several 
cleaning/disinfection procedures have been applied to remove these persistant 
organisms after outbreaks (Wilcox et al., 2003; Naiemi et al., 2005; Dancer et al., 
2009). During this study target gene-carrying organisms (blaTEM and mecA) could only 
be isolated on occasions before routine ICU ward cleaning. However, the antibiotic 
resistance determinant {mecA or blaTEm) could be detected by PCR. This suggests that 
the cleaning regime kills/destroys the organism and the DNA containing the antibiotic 
resistance determinant remains (i.e. after cell lysis).
There is no evidence from the data presented in this chapter to suggest a permanent 
reservoir of antibiotic resistance on the wards. Previous cultural studies have, however, 
shown that TEM ESBL-producing organisms can persist in the ICU environment (Naas 
et al., 2002; Mammina et al., 2007). In this present study blaTem genes persisted only 
in the ICU ward sink plughole, where they remained for three consecutive sampling 
periods over approximately 72 hours.
191
From data presented in previous chapters (Chapter 4 and 6) there was variability in the 
frequency of eubacterial DNA detection and fungal isolation, which may have been due 
to routine ICU ward cleaning. Data presented in this chapter indicates that routine ICU 
ward cleaning could account for the variability previously observed from hard surfaces; 
however cleaning did not affect the frequency of detection of some DGGE bands 
assigned as opportunistic organisms (Burkholderia spp. and Stenotrophomonas spp.).
Overall the data in this chapter indicates that the routine ICU ward cleaning regime had 
a substantial and statistically significant effect on the frequency of detection of 
eubacterial DNA. Cleaning reduced the number of fungal colonies, although fungi 
could be isolated before and after cleaning. The detection of antibiotic resistance 
determinants was of a low frequency and target gene-carrying organisms could only be 
isolated before cleaning, indicating no permanent persistence of antibiotic resistant 
organisms. Although DGGE bands assigned to opportunistic organisms (i.e. 
Burkholderia spp., Acinetobacter spp. and Stenotrophomonas spp.) were detected after 
routine ICU ward cleaning from sites of low patient contact, improvement in the 
cleaning regime may be beneficial.
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8. Discussion
This study used cultural and molecular approaches to establish the microbial ecology 
of the ICU and HDU environment. The presence of important antibiotic resistance 
determinants was also assessed. Currently, there is great controversy about the role 
the ward environment plays in HAIs. Research is based heavily on the acquisition of 
HAIs, transmission between patients (Shiomori et a/., 2002; French et al., 2004; 
Oztoprak et al., 2007; Howie and Ridley, 2008; Khan et al., 2009) and the 
identification of outbreak sources within the ward environment (Neely et al., 1999; 
Bures et al., 2000; Naas et al., 2002; Hartmann et al., 2004). However, little is 
known about the microbial ecology of hospital wards, especially the ICU and HDU 
environments during periods of normal operation.
Throughout this present study the use of molecular techniques was essential to 
establish the microbial ecology of the ICU and HDU environments, particularly from 
sites where bacteria could not be cultured. Bacteria were infrequently cultured from a 
variety of ICU environmental sites (e.g. plugholes) however the detection of eubacterial 
DNA implies the presence of microorganisms. The use of PCR-DGGE enabled 
bacterial species, diversity and communities to be identified. Antibiotic resistant 
organisms could only be cultured before routine ICU ward cleaning, however, the use 
of molecular techniques (PCR) enabled the detection of antibiotic resistance 
determinants in the absence of gene-carrying organisms.
The data presented in this study therefore imply that the ICU and HDU environments 
were not acting as reservoirs of MRSA or ESBL-possessing organisms (detailed in 
Chapter 5). However, the data show non-albicans Candida species (C. parapsilosis, C. 
tropicalis, C. glabrata) (detailed in Chapter 6) and opportunistic Gram-negative species 
(Stenotrophomonas spp., Burkholdena spp., Acinetobacter spp.) (detailed in Chapter 4
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and 7) were present. CNS and Micrococcus spp. were also frequently isolated from 
the ICU and HDU environments (detailed in Chapter 4).
The ICU sinks, floors and patient chairs were identified as environmental sites 
potentially acting as reservoirs of bacteria, fungi and antibiotic resistance determinants. 
The hospital sinks (interior surface of pipe below sink plughole) yielded the highest 
bacterial detection, yeast isolation and antibiotic resistance determinant detection. 
Routine ICU ward cleaning was also not effective against Gram-negative opportunistic 
species in the hospital sinks. Therefore, from this study the hospital sinks were the site 
of greatest environmental and hence potential clinical significance.
There was a widespread distribution of Burkholderia spp., Stenotrophomonas spp. (as 
detailed in Section 4.3.1 and 4.3.3 Chapter 4) and b/ajEM genes in the ICU environment 
(as detailed in Section 5.3.1 and 5.3.4 Chapter 5). The widespread distribution of 
Burkholderia spp. and Stenotrophomonas spp. during this present study is consistent 
with the hospital sink being the source/reservoir of general contamination with these 
organisms, although there are other explanations for this widespread distribution. 
Despite Burkholderia spp. not being isolated on B. cepacia complex specific media and 
the fact that blaTEM gene-carrying organisms could only be isolated before routine ICU 
ward cleaning during this present study, there is evidence from previous studies that 
hospital sinks can act as sources of widespread contamination onto other sites, as 
detailed below.
Even though the majority of sites in the ICU are not areas of patient contact, hospital
staff can come into contact (generally hand contact) with contaminated surfaces.
Bhalla et al. (2004) did not provide evidence of patient-to-patient transmission; however
they did show that contaminated environmental sites can significantly add to the
contamination of hospital staff hands, which are the most recognised vehicle of
nosocomial pathogen transmission. Hota et al. (2009) also demonstrated that,
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dependent upon the ward design, it is possible that splash back from sinks can result in 
organisms (e.g. P. aeruginosa) travelling up to 1 m which can lead to the contamination 
of nearby medical equipment and devices. Another study showed that although the 
source of the P. aeruginosa outbreak was not defined, there was environmental 
contamination of the plughole (Lango ef al., 2007).
Besides organism transmission from sinks onto medical equipment, it has previously 
been reported that after hand washing in a contaminated sink (P. aeruginosa or B. 
cepacia) positive hand cultures for P.aeruginosa and B. cepacia are observed (Doring 
et al., 1996). Other studies have also demonstrated contamination of hospital staff 
hands with P. aeruginosa from backsplash and aerosols during hand washing (Kohn, 
1970; Brown et al., 1977; Noone et al., 1983; Doring et al., 1993). One study at a 
US teaching hospital isolated high CFUs of pathogenic bacteria (P. aeruginosa, 
Stenotrophomonas maitophia and Serratia marscens) from the sink exit section of 
drains (plughole) (Brooke, 2008). The same study also indicated the potential for back 
splash to occur transferring pathogens onto hospital staff hands. This confirms that 
organisms in hospital sinks can be transmitted onto hospital staff hands or medical 
equipment, leading to the potential for pathogen transmission within the ward.
There is therefore a need to break the chain of transmission, for example, effectively 
cleaning hospital sinks would remove potential reservoirs. However, cleaning studies 
have previously identified the potential for re-distribution of organisms during cleaning 
and the effect of exposure time. One Welsh ICU study confirmed that the susceptibility 
of organisms to cleaning agents (e.g. sodium dichloroisocyanurate -  NaDCC) is 
dependent upon exposure time (Williams et al., 2009a). For example, for NaDCC to 
kill MRSA it requires an exposure time >2 min, therefore the effectiveness of cleaning 
is not only affected by the cleaning agent but also method application (Williams et al., 
2009a). Mops used during cleaning have been associated with picking up pathogenic
bacteria and potentially redistributing them on the floor (Dharan et al., 1999).
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Disinfectant wipes are commonly used to clean other hard surfaces, however, if the 
wipes are reused this can also lead to the redistribution of organisms (Williams et al., 
2009b). Since this present study does not permit conclusions about the source of 
widespread Burkholderia spp. and Stenotrophomonas spp. in the ICU environment, it is 
not possible to assess the potential role of cleaning in the re-distribution of organisms 
in the ICU. Hence in spite of the fact cleaning appears to reduce the number of 
organisms on the ward, the possibility that it plays a role in the re-distribution of 
organisms around the ICU environment can not be excluded.
From the data obtained during this present study, it is unknown if the microbial build-up 
between cleaning sessions is due to environmental organism growth or re-introduction 
of the same organisms either within the ward or from the external environment. Future 
work would be necessary to investigate the time period for maximum microbial build-up 
between cleaning sessions (e.g. by taking samples every hour between sessions).
A possible explanation for the microbial build-up of Gram-negative organisms in sinks 
may be because the organisms detected during this present study are commonly 
associated with potable water (drinking water) and their persistence in biofilms (Davies 
et al., 1998; Costerton et al., 1999; Conway et al., 2002; Oulahal et al., 2004; 
Burfoot et al., 2009). Burkholdena spp. occupy a vast number of ecological niches 
including water and the hospital environment (Zanetti et al., 2000; Coenye and 
Vandamme, 2003; Stoyanova et al., 2007). Acinetobacter spp. can be commensals 
on human skin and are often identified in water or moist sites. Acinetobacter spp. are 
severely problematic due to their ability to survive in dry environments also (Baumann, 
1968; Berlau et al., 1999; Paterson, 2006). Stenotrophomonas spp. has also been 
found to survive in bottled water and output water from microfiltered water dispensers 
(leading directly to tap water), consistent with its survival primarily in moist 
environments (Wilkinson and Kerr, 1998; Gales etaI., 2001; Sacchetti et al., 2009),
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Therefore the presence of these organisms in moist environments e.g. hospital sinks, is 
not uncommon.
In addition, the organisms that persist during cleaning (Acinetobacter spp. and 
Stenotrophomonas spp.) had also been isolated from ICU clinical samples during this 
present study. One possibility is that hospital staff may have come into contact with an 
infected patient resulting in the organism being detected in the hospital sink after hand 
washing. Evidence for this route (patient to staff) has been shown in previous research 
(Bauer et al., 1990; Bhalla eta!., 2004; French etaI., 2004).
Organisms present in biofilms are difficult to remove by cleaning. Since the emergence 
of MRSA and VRE as dangerous antibiotic resistant organisms in the hospital setting, 
studies have focused on development of cleaning agents to target these persistent 
Gram-positive organisms (Wilcox et al., 2003; Denton et al., 2004; Williams et al.t 
2009a; Williams ef al., 2009b). This may in part explain why Gram-negative 
organisms could be detected in hospital sinks after routine ICU ward cleaning during 
this present study. Evidence to support this is shown from previous outbreak studies. 
In these previous studies, the sinks were not specifically identified as the source of 
infection, but the outbreak could only be halted/stopped after the ward sinks had either 
been extensively cleaned or removed (Bukholm et al., 2002; Naas et al., 2002; Wilks 
et al., 2006; Kotsanas et al., 2008).
it is widely acknowledged that sinks have a high bacterial density and diversity (Davies
et al., 1998; Costerton et al., 1999; Conway et al., 2002), which could lead to gene
transfer. Despite a lack of culturable bacteria, the hospital sinks in this present study
yielded antibiotic resistance determinants at low frequency. Cleaning agents
commonly result in cell death leading to cell lysis and liberation of DNA so the gene
can be detected in the absence of the organism before DNA degradation. However,
organisms that are still present after cleaning may be able to take up this naked DNA
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by transformation to acquire antibiotic resistance (as suggested by Tenover, 2006). 
Previous studies have shown the ability for lateral gene transfer of blaTEM (Elwell et al., 
1977; Weill et al., 2004; Lachmayr et al., 2009). There is a high probability of blajEm 
gene transfer due to their association with plasmids and transposons (Livermore, 1995; 
Naiemi ef al., 2005; Manzur et al., 2007). Therefore hospital sinks are a potential site 
for gene transfer, where multiple Gram-negative organisms are present. It is also 
possible for wild type blaTEm genes to mutate to an ESBL (Wu et al., 1994; Paterson & 
Bonomo, 2005; Hammond et al., 2005) which is of clinical significance particularly 
from the evidence discussed, of transmission from hospital sinks onto staff hands and 
medical equipment.
In comparing the effect of cleaning on the detection of eubacterial DNA from the RHH 
and NGH ICU environments there was no statistical difference despite the NGH ICU 
being cleaned three times a day as opposed to twice at the RHH ICU. However, if the 
number of cleaning sessions were reduced at the NGH ICU this could potentially have 
an impact on the detection of bacteria and fungi. As mentioned, the NGH ICU has a 
higher patient intake and a greater number of hospital staff compared to the RHH ICU. 
Therefore, the extra cleaning session at the NGH may be required to prevent increased 
microbial build-up in the ICU environment from internal or external sources. Further 
investigation would be needed to decide whether cleaning sessions could be reduced 
or increased at either hospital ICU,
From the data presented in this study it can be concluded, that the routine ICU ward
Cleaning regime was only effective on hard surfaces. ICU ward sinks are a potential
cause for concern as they yielded opportunistic Gram-negative species, non-albicans
Candida spp. and antibiotic resistance determinants before and after routine ICU ward
cleaning. Targeted additional cleaning could further improve infection control, to
ensure the removal of pathogenic organisms (e.g. S. maltophilia, Acinetobacter spp.
and Burkholderia spp.) from the ICU environment. Alternatively, indicator organisms
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e.g. Acinetobacter spp. in sinks and CNS on hand-touch sites could be used to indicate 
the build-up of microbes in the ward environment and the potential benefit of extra 
cleaning.
Future work: -
A number of tetracycline resistant colonies were cultured but the tet gene was not 
identified, further work would be to identify which other tet genes were present from the 
colonies identified in the ICU environment, using a macro-array.
Burkholderia spp.-like sequences were matched from DGGE bands from the sites of 
greatest eubacterial DNA detection (ICU/HDU patient chair, ICU floor and ICU ward 
sink plugholes), future work could be done to try and observe if these sequences are 
present in other sites of the ICU environment.
The question still remains as to whether the environment becomes contaminated from 
the patient or vice versa. Further sampling and close monitoring of patient intake 
followed by typing and sequencing of environmental and clinical isolates may enable 
this question to be answered in part
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South Yorkshire Research Ethics Committee
1 st Floor Vickers Corridor 
Northern General Hospital 
Herries Road 
Sheffield 
S5 7AU
Telephone: 0114 226 9153 
Facsimile: 0114 256 2469 
Email: joan.brown@sth.nhs.uk
07 February 2008
Dr Tom Smith
Senior Lecturer
Sheffield Hallam University
BMRC, Faculty of Health & Wellbeing
Sheffield Hallam University
City Campus
Sheffield
S1 1WB
Dear Dr Smith
Full title  o f study: M icrobial Ecology o f the Intensive Care Unit
REC reference number: 08/H1310/2
The Research Ethics Committee reviewed the above application at the meeting held on the 
31 January 2008. Thank you for attending to discuss the study.
Discussion
Three members of the Research Team attended the meeting i.e. yourself, Dr K Stanley and 
Ms G Kay. It was observed there were no major ethical concerns in relation to this study 
and it was a useful piece of research that was well supported.
You were asked to clarify the relationship between the data you were hoping to collect from 
the floors, walls, surfaces etc and the access to patients' clinical data as well as the 
timeframe involved. It was explained that the clinical data you would be using was from 
samples taken from the patient on a routine basis and the team would be particularly 
interested in samples that were obtained at the same time as they were sampling. 
Arrangements had been made with the Clinical Microbiologist at the hospital that samples 
could be obtained in order that the micro-organisms could be stored if necessary. The 
clinical data would be available to the research team one or two days after the samples had 
been taken.
It was confirmed that arrangements were in place for the relevant Consultants to be 
informed of any findings in order that they could take whatever action they felt was 
necessary and it was acknowledged that patient care should always take priority over the 
research. The Infection Control Team would also be notified of any findings.
The team acknowledged the possibility that the behaviour of staff on the Unit, who were 
being observed over quite a long period of time, may change (i.e. the Hawthorne effect) but 
it was felt that the chances of that happening were remote and that was the reason why the 
team were taking the approach in the Unit that this was an ecological study.
This Research Ethics Committee is an advisory committee to Yorkshire and The Humber Strategic Health Authority 
The National Research Ethics Service (NRES) represents the NRES D irectorate w ith in  
the N ational Patient Safety Agency and Research Ethics Committees in  England
310/2 Page 2
It was queried whether there was a quantitative aspect to the research as well as 
qualitative. It was clarified that the study was essentially qualitative in that the team would 
be trying to ascertain which organisms were present rather than how many times they 
appeared.
The team was asked to clarify the timeframe for the sampling and it was explained you 
would be looking to take samples throughout the eighteen month period of the study. In the 
first instance you would be taking samples on a weekly basis with regular reviews to 
ascertain whether more or less samples were required. In addition there would be intensive 
periods of sampling once a week with regular reviews in which any trends identified could 
be clarified.
Ethical opinion
The members of the Committee present gave a favourable ethical opinion of the above 
research on the basis described in the application form, protocol and supporting 
documentation.
Ethical review of research sites
The Committee agreed that all sites in this study should be exempt from site-specific 
assessment (SSA). There is no need to submit the Site-Specific Information Form to any 
Research Ethics Committee. The favourable opinion for the study applies to all sites 
involved in foe research.
Conditions of approval
The favourable opinion is given provided that you comply with the conditions set out in the 
attached document. You are advised to study the conditions carefully.
Approved documents
The documents reviewed and approved at the meeting were:
Docum ent Version D ate
Application 21 December 2007
Investigator CV
Protocol 1 19 December 2007
Covering Letter 20 December 2007
Letter from Sponsor 21 December 2007
Peer Review 19 December 2007
Project Summary for ICU Staff 1 23 May 2007
Key Collaborator's CV - Gary H Mills
Key Collaborator's CV - Karen Stanley
Flowchart of Protocol 1 19 December 2007
R&D approval
You should arrange for the R&D office at all relevant NHS care organisations to be notified 
that the research will be taking place, and provide a copy of the REC application, the 
protocol and this letter.
This Research Ethics Committee is an advisory committee to Yorkshire and The Humber Strategic Health Authority
The National Research Ethics Service (NRES) represents the NRES directorate within 
The National Patient Safety Agency and Research Ethics Committees in England
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AH researchers and research collaborators who will be participating in the research at a 
NHS site must obtain final approval from the R&D office before commencing any research 
procedures
Membership of the Committee
The members of the Ethics Committee who were present at the meeting are listed on the 
attached sheet
Statement of compliance
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK.
After ethical review
Now that you have completed the application process please visit the National Research 
Ethics Website > After Review
Here you will find links to the following
a) Providing feedback. You are invited to give your view of the service that you have 
received from the National Research Ethics Service on the application procedure. If 
you wish to make your views known please use the feedback form available on the 
website.
b) Progress Reports. Please refer to the attached Standard conditions of approval by 
Research Ethics Committees.
c) Safety Reports. Please refer to the attached Standard conditions of approval by 
Research Ethics Committees
d) Amendments. Please refer to the attached Standard conditions of approval by 
Research Ethics Committees.
e) End of Study/Project Please refer to the attached Standard conditions of approval 
by Research Ethics Committees.
We would also like to inform you that we consult regularly with stakeholders to improve our 
service. If you would like to join our Reference Group please email
referenceQroup@nationalres.orq.uk.
( 08/H1310/2 ~  Please quote this number on all correspondence
With the Committee’s best wishes for the success of this project 
Yours sincerely
0 Jo Abbott 
\  Chair
This Research Ethics Committee is an advisory committee to Yorkshire and The Humber Strategic Health Authority
The National Research Ethics Service (NRES) represents the NRES directorate within 
The National Patient Safety Agency and Research Ethics Committees in England
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Sheffield Teaching Hospitals
NHS Foundation Trust
NHS
Human Resources Department 
4 Claremont Place 
Sheffield 
S10 2TB
Please ask for: Lynn Winter 
Telephone: (0114) 271 2796 
Date: 21 March 2007
Private & Confidential
Gemma Kay
Apartment 56
Jet Centro
79 St Marys Road
Sheffield
S2 4AU
Dear G em m a 
LETTER OF AUTHORITY
I w rite to inform  you that Authority  is granted to enable you to take environm enta l sam ples 
from  surfaces in the  Intensive Care Unit, at the  Royal H a llam shire  Hospita l one day per 
week from  09 M arch 2007 to 21 Decem ber 2009.
During th is period you w ill be under the supervision o f Dr G ary Mills, Research Lead 
fo r Intensive Care, Anaesthesia  and Theatres.
In accordance w ith norm al procedure th is authority is subject to satis facto ry m edical 
fitness.
W ith the exception o f sm all valuables handed to the Authority fo r safekeep ing, the  
Trust accepts no responsib ility  fo r dam age to, or loss of, personal property, you are 
there fore recom m ended to take out an insurance policy to cover you r personal 
property.
During th is p lacem ent you m ay have access to confidentia l in fo rm ation concern ing 
the hospita l and its patients. You must, therefore, observe the  fo llow ing guidelines:
No in form ation shall be disclosed to any third party in respect of any patient.
No in form ation shall be disclosed to any third party in respect of any em ployee.
No in form ation shall be disclosed to any third party in respect o f the hospita l, its 
statistics and its finances.
If you intend to te rm inate  th is p lacem ent before the stated date, p lease inform  m e as 
soon as possible.
Please note that you will be unable to attend for your visit i f  you do not have a copy o f this 
letter on the day of your visit to the department.
Chairman: David Stone OBE • Chief Executive: Andrew Cash OBE
Fina lly, I w ou ld  like  to  w e lco m e  you to  the  Sheffie ld  T each ing  H o sp ita ls  N H S  Trust 
and I hope th a t the  period  spe n t w ith  us w ill p rove in te resting  and bene fic ia l.
Y ours s incere ly
L _  . I / O  V.
Lynn W in te r 
HR Assistant
Please sign both copies o f this letter and return one copy to the Human Resources Departmen
I have read and un de rs tood  you r le tte r da ted 21 M arch 2007  and I un de rta ke  to  ab ide 
by the  con tents.
Name Gremmc*.
Date
Signature
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Ref: STH 14947/AD
04 March 2008
Dr Gary Mills 
Intensive Care Unit 
R Floor 
RHH
Sheffield Teaching Hospitals NHS
NHS Foundation Trust
Dear Dr Mills
STH ref: 
S tudy tit le :
A utho risa tion  o f p ro ject
S TH 14947
Molecular Microbial Ecology of the Intensive Care Unit
C h ie f Inve s tiga to r (Local C ontact): Dr Gary Mills, STH
P rinc ipa l Inve s tiga to r (S tudent): Ms Gemma Kay
S ponsor:
Funder:
Sheffield Hallam University 
Sheffield Hallam University
The Research D epartm ent has rece ived the requ ired d o cum enta tion  fo r  the  s tu d y  as 
lis ted  be low :
1. S po nso rsh ip  IMP s tud ies  (non-com m erc ia l) 
S po nso rsh ip  re sp o n s ib ilit ie s  between in s titu tio n s  
R e spo ns ib ilitie s  o f in ves tig a to rs
M on ito rin g  A rrangem ents
2. STH reg is tra tio n  docum en t: com ple ted and s igned
3. Evidence o f favourab le  sc ie n tif ic  review
4. P ro toco l -  f ina l ve rs ion
5. P a rtic ipa n t In fo rm a tion  sheet -  fina l ve rs ion
6. C onsent fo rm  -  fin a l ve rs ion
7. S igned le tte rs  o f indem n ity
8. ARSAC I IRMER ce rtifica te
9. Evidence o f ho s ting  approva l from  STH d irec to ra te
10. Evidence o f approva l from  STH Data P ro tection  
O ffice r
11. Le tte r o f approva l from  REC
12. P roo f o f lo ca lity  approva l
NA
NA
NA
NA
STH Finance Form, D rG  
Mills, 20 February 08
Sheffield Hallam University, 
17 December 07
Version 1, December 07
NA
NA
NA
NA
STH Finance Form, Dr M 
Richmond, 20 February 08
STH Finance Form, Mr P 
Wilson, 27 February 08
South Yorkshire REC, 
08/H1310/2, 07 February 
08
NA
A
Chairman: David Stone QBE • Acting Chief Executive: Christopher Welsh
sm ote-fifee
hospitals
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Ref: STH 14947/AD
13. Clinical Trial Authorisation from MHRA NA
14. Honorary Contract Gemma Kay, Letter of 
Authority, 09 March 07
15. Associated documents NA
16. Signed financial agreement/contract STH Finance Form, Mrs L 
Fraser, 26 February 08
The project has been reviewed by the Research Department and authorised by the Director of 
R&D on behalf of STH NHS Foundation Trust to begin.
Yours sincerely
i r r o T e s s o r  o  n e u e r
Director of R&D, Sheffield Teaching Hospitals NHS Foundation Trust 
Telephone +44 (0) 114 2265934 
Fax +44 (0) 114 2265937
cc. Gemma Kay, SHU
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RHH ICU and HDU swab samples for DNA extraction and microbe enumeration (after culturing) (continued over page)
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ABgene
Bio-Rad
Cherwell Laboratories
E&O Laboratories
Eppendorf
ABgene Ltd 
ABgene House 
Blenheim Road 
Epsom 
Surrey 
KT19 9AP
Bio-Rad Laboratories Ltd 
Bio-Rad House 
Maxted Road 
Hemel Hempstead 
Hertfordshire 
HP2 7DX
Cherwell Laboratories Ltd 
7 & 8 Launton Business Centre 
Murdock Road 
Bicester 
0X26 4XB
E&O Laboratories
Burnhouse
Bonnybridge
Scotland
FK4 2HH
Eppendorf UK Limited 
Endurance House 
Chivers Way
Eurofins
Fermentas
Gallenkamp
Heraeus
Histon 
Cambridge 
CB24 9ZR
Eurofins Genetic Services Ltd 
318 Worple Road 
Raynes Park 
London 
SW20 8QU
Fermentas GMBH 
Opelstrasse 9 
D-68789 
St Leon-Rot
Weiss-Gallenkamp 
Units 37-38
The Technology Centre 
Epinal Way 
Loughborough 
LE11 3GE
Mandel Scientific Company Inc
2 Admiral Place
Guelph
Ontario
Canada
N1G4N4
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invitrogen
New England Biolabs
Qiagen Ltd
Roche
invitrogen 
3 Fountain Drive 
Inchinnan Business Park 
Paisiey 
PA4 9RF
New England Biolabs
75-77 Knowl Piece
Wilbury Way
Hitchin
Herts
SG4 OTY
Qiagen Ltd 
Qiagen House 
Fleming Way 
Crawley 
West Sussex 
RH10 9NQ
Roche Products Limited 
6 Falcon Way 
Shire Park 
Hexagon Place 
Welwyn Garden City 
Hertfordshire 
AL7 1TW
248
Sigma
Stuart Scientific
Thermo Fisher Scientific
UVP
Sigma-Aldrich 
The Old Brickyard 
New Road 
Gillingham 
Dorset 
SP84XT
Rhys International Ltd 
Unit 41
Halliwell Business Park 
Rossini Street 
Bolton
Greater Manchester 
BL1 8DL
Bishop Meadow Road 
Loughborough 
Leicestershire 
LE11 5RG
Ultra-Violet Products Ltd 
Unit 1
Trinity Hall Farm Estate 
Nuffield Road 
Cambridge 
CB4 1T
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